Georgia Doris Tomaras | Scholars@Duke

Georgia Doris Tomaras
Professor in Surgery

Research in the Tomaras Laboratory in the Duke Human Vaccine Institute and Departments of Surgery, Immunology, and Molecular Genetics and Microbiology at Duke University Medical Center, focuses on the identification of immune correlates of protection for preventative vaccines and identification of the mechanisms responsible for potent inhibition of human pathogens.

Current Appointments & Affiliations

Professor in Surgery, Surgery, Surgical Sciences, Surgery 2015
Professor in Immunology, Immunology, Basic Science Departments 2015
Professor in Molecular Genetics and Microbiology, Molecular Genetics and Microbiology, Basic Science Departments 2015
Member of the Duke Human Vaccine Institute, Duke Human Vaccine Institute, Institutes and Centers 2007
Affiliate, Duke Global Health Institute, Duke Global Health Institute, University Institutes and Centers 2014

Contact Information

Box 103020 DUMC, Durham, NC 27710
Rm 4079 MSRB II, 106 Research Drive, Durham, NC 27710
gdt@duke.edu (919) 681-5598
Duke Identifies Shortcomings In HIV Vaccine
Duke scientists find potent antibody to HIV-1

Background
Education, Training, & Certifications
- Postdoctoral Fellowship, Center For Aids Research, Department Of Surgery, Duke University 1998 - 2001
- Ph.D., SUNY Upstate Medical University 1998
Duke Appointment History
- Associate Professor of Surgery, Surgery, Surgical Sciences, Surgery 2011 - 2015
- Associate Research Professor in Molecular Genetics and Microbiology, Molecular Genetics and Microbiology, Basic Science Departments 2011 - 2015
- Associate Professor in Immunology, Immunology, Basic Science Departments 2012 - 2015
- Assistant Research Professor in Immunology, Immunology, Basic Science Departments 2005 - 2012
- Assistant Professor of Surgery, Surgery, Surgical Sciences, Surgery 2006 - 2011
- Assistant Research Professor in Molecular Genetics and Microbiology, Molecular Genetics and Microbiology, Basic Science Departments 2007 - 2011
- Assistant Research Professor in Surgery, Surgery, Surgical Sciences, Surgery 2001 - 2006
Recognition
In the News
- DEC 28, 2017 Duke Health News
  
  Duke-Led Team Develops More Accurate Tool to Track New HIV Infections
- MAR 20, 2014
  
  Past HIV Vaccine Trials Reveal New Path to Success
Awards & Honors
Expertise
Global Scholarship
- Research
  - South Africa (Country)
Research
Selected Grants
- Transplant Infectious Diseases Interdisciplinary Research Training Grant awarded by National Institutes of Health 2018 - 2023
- Quantitative Methods for HIV/AIDS Research awarded by National Institutes of Health 2018 - 2023
- Duke Resident Physician-Scientist Program- NIAID awarded by National Institutes of Health 2018 - 2022
- Functional profile to HIV vaccine elicited antibodies in infants awarded by National Institutes of Health 2017 - 2022
- Bioinformatics and Computational Biology Training Program awarded by National Institutes of Health 2005 - 2021
- Bridging Antibody Fc-mediated Antiviral Functions Across Humans and Non-human Primates awarded by National Institutes of Health 2016 - 2021
- Interdisciplinary Research Training Program in AIDS awarded by National Institutes of Health 2010 - 2020
- Identifying key determinants of IgG transplacental transfer from HIV-infected mothers to their fetus awarded by National Institutes of Health 2017 - 2020
- PRO HIV-013 Humoral Immune Response awarded by GlaxoSmithKline 2018 - 2020
- Basic Immunology Training Program awarded by National Institutes of Health 2014 - 2019
- Viral Oncology Training Grant awarded by National Institutes of Health 1980 - 2019
- Harnessing Mucin-IgG Interactions to Enhance HIV Vaccine Function awarded by Northwestern University 2016 - 2019
- Nonhuman Primate Core awarded by National Institutes of Health 2018 - 2019
- HIV Research for Prevention 2018: Vaccine, Microbicide and ARV-based Prevention Science (HIVR4P) awarded by National Institutes of Health 2018
- HVTN Laboratory Center: HVTN 117 awarded by Fred Hutchinson Cancer Research Center 2017 - 2018
- HVTN Laboratory Center: HVTN 118 awarded by Fred Hutchinson Cancer Research Center 2017 - 2018
- HIV Vaccine Trials Network: LC P5 PF awarded by Fred Hutchinson Cancer Research Center 2015 - 2018
- HIV Vaccine Trials Network: LC Phase 1 PF awarded by Fred Hutchinson Cancer Research Center 2015 - 2018
- LC: HIV Vaccine Trials Network awarded by Fred Hutchinson Cancer Research Center 2006 - 2018
- Humoral and cellular immunity during acute HIV-1 awarded by Henry M. Jackson Foundation 2014 - 2018
- Focus 2: Clearance of HIV Antigen-Positive Cells awarded by University of North Carolina - Chapel Hill 2016 - 2018
- Nonhuman Primate Core-Option 6 awarded by National Institutes of Health 2012 - 2018
- Statistical methods for HIV-1 immune correlates studies awarded by Fred Hutchinson Cancer Research Center 2016 - 2018
- The duality of vaccine elicited HIV specific-IgA antibodies: Providing protection or diminishing protection awarded by National Institutes of Health 2016 - 2017
- HVTN 117 awarded by Fred Hutchinson Cancer Research Center 2016 - 2017
- HVTN - A004 awarded by Fred Hutchinson Cancer Research Center 2015 - 2017
- HVTN 505 Protocol awarded by Fred Hutchinson Cancer Research Center 2015 - 2017
- Early Infection Response awarded by Wistar Institute of Anatomy and Biology 2011 - 2017
- Animal Models of Infectious Diseases Part A awarded by National Institutes of Health 2010 - 2017
- Statistical methods for HIV-1 immune correlates studies awarded by Fred Hutchinson Cancer Research Center 2015 - 2016
- HIV Vaccine Trials Network: LC P5 PF awarded by Fred Hutchinson Cancer Research Center 2014 - 2015
- HVTN 505 Protocol awarded by Fred Hutchinson Cancer Research Center 2014 - 2015
- HVTN LC: Virion Capture awarded by Fred Hutchinson Cancer Research Center 2014 - 2015
- LC: HIV Vaccine Trials Network: Phase 1 PF awarded by Fred Hutchinson Cancer Research Center 2014 - 2015
- McElrath Objective 3-Evaluate potential mucosal quality indicators awarded by Fred Hutchinson Cancer Research Center 2014 - 2015
- Vaccine-induced HIV antibody responses in infants awarded by National Institutes of Health 2012 - 2015
- Harnessing Antibody-Mucus Interaction to Prevent HIV Transmission awarded by Northwestern University 2011 - 2015
- Education - Training awarded by University of Copenhagen 2015
- HIV-1 Gene Suppression by CD8+ T Cells awarded by National Institutes of Health 2002 - 2015
- Testing the ability of antibody-mucin interactions to provide vaccine function awarded by Northwestern University 2013 - 2015
- Epigenetic Control of the CD8+ T-cell Response to HIV awarded by National Institutes of Health 2013 - 2014
- McElrath Objective 3-Evaluate potential mucosal quality indicators awarded by Fred Hutchinson Cancer Research Center 2014
- AIDS International Training and Research Program awarded by National Institutes of Health 2003 - 2014
- Non-human Primate Binding Antibody Evaluation awarded by National Institutes of Health 2008 - 2012
- Large Scale Antibody and TCell Epitope Discovery awarded by National Institutes of Health 2004 - 2011
- Elucidation of the Mechanisms of CD8+ T Cell Noncytolytic Antiviral Response awarded by National Institutes of Health 2009 - 2010
- Central Laboratory for the HIV Vaccines Trial Network awarded by National Institutes of Health 2000 - 2006
- NCRR FACSAria Cell Sorter awarded by National Center for Research Resources 2004 - 2006
Publications & Artistic Works
Selected Publications
- Conference Papers
  - Felber, B, Singh, S, Valentin, A, Rosati, M, Ramierz, E, Doueiri, R, Hu, X, Bear, J, Hirsch, V, Broderick, K, Sardesai, N, Reed, S, Trinh, H, Rao, M, Montefiori, D, Ferrari, G, Shen, X, Tomaras, G, and Pavlakis, G. "DNA and protein co-delivery vaccines using TLR-4-based adjuvants induce potent immune responses able to delay heterologous SIV acquisition." : WILEY, October 1, 2018. Link to Item
  - Sparger, E, Chang, W, Deere, J, Kieu, H, Castillo, D, Blozis, S, Lifson, J, Shen, X, Tomaras, G, Shacklett, B, and Barry, P. "Impact of a TLR-5 Ligand as Adjuvant on Immunogenicity and Efficacy of a RhCMV-SIV Vaccine." : WILEY, October 1, 2018. Link to Item
  - Jones, A, Das, R, Wyatt, L, LaBranche, C, Shen, X, Tomaras, G, Montefiori, D, Moss, B, Clements, J, Barouch, D, Kozlowski, P, Varadarajan, R, and Amara, RR. "Oral MVA/protein HIV vaccination with a needle-free injector induces robust systemic and mucosal antibody responses in rhesus macaques." : JOHN WILEY & SONS LTD, July 1, 2018. Link to Item
  - Tomaka, F, Stieh, D, Barouch, D, Robb, M, Michael, N, Tomaras, G, Alter, G, McElrath, J, Lavreys, L, Nijs, S, Callewaert, K, Hendriks, J, Euler, Z, Pau, M, and Schuitemaker, H. "Long-term data from APPROACH: phase 1/2a randomized, double-blind, placebo-controlled study evaluating safety/tolerability and immunogenicity of vaccine regimens using combinations of Ad26.Mos.HIV, MVA-mosaic and gp140 envelope protein." : JOHN WILEY & SONS LTD, July 1, 2018. Link to Item
  - Schneider, J, Bastian, A, Orlandi, C, Shen, S, Lucas, J, Ashley, V, Kelleher, N, Veazey, R, Kiser, P, Lewis, G, Tomaras, G, and Hope, T. "Mucin-binding IgG: Characterizing a novel antibody effector function and discovery of a new Fc receptor." August 2017. Link to Item
  - Buchbinder, S, Grunenberg, N, Sanchez, B, Seaton, K, Ferrari, G, Moody, MA, Frahm, N, Montefiori, D, Goepfert, P, Baden, L, Hay, C, Yu, X, Gilbert, P, McElrath, MJ, Huang, Y, Robinson, H, Tomaras, G, and Grp, HVTNS. "DNA/MVA HIV Vaccine Producing Virus-like Particles (VLPs) Is Well-tolerated and Induces Durable Functional Antibodies (Abs) in HVTN 094." October 2016. Link to Item
  - Felber, BK, Valentin, A, Salazar, ER, Doueiri, R, Rosati, M, Hu, X, Alicea, C, Bear, J, Hirsch, VM, Broderick, KE, Sardesai, NY, Reed, SG, Montefiori, DC, Shen, X, Tomaras, GD, and Pavlakis, GN. "DNA and Protein Co-delivery Vaccines Using TLR-4-based Adjuvants Induce Potent Immune Responses Able to Delay Heterologous SIV Acquisition." October 2016. Link to Item
  - Huang, Y, Tomaras, G, Andersen-Nissen, E, Dintwe, O, Morris, L, Grunenberg, N, Issacs, A, DiazGranados, C, Sinangil, F, Laher, F, Swann, E, DeRosa, S, Ferrari, G, Montefiori, D, Gilbert, P, McElrath, J, Corey, L, Gray, G, and HVTN097, . "The Relationship between Immune Responses to Tetanus Vaccine, Hepatitis B Vaccine and a Pox-protein HIV Vaccine Regimen." October 2016. Link to Item
  - Pala, P, Levin, J, Nanvubya, A, Kibengo, F, Namuniina, A, Kitandwe, P, Serwanga, J, Yates, N, Mayer, B, Montefiori, D, Tomaras, G, Robb, M, Lee, C, Wagner, R, Vooijs, D, Chinyenze, K, Priddy, F, Ding, S, Pantaleo, G, Kaleebu, P, and Teams, ES. "EV06 Trial: Modulation of the Immunogenicity of the DNA-HIV-PT123 and AIDSVAX (R) B/E combination HIV vaccine in adult Ugandans by S. mansoni Infection." October 2016. Link to Item
  - Pantaleo, G, Janes, H, Tomaras, G, Montefiori, D, Frahm, N, Grant, S, Bart, P-A, Rettby, N, Tapia, G, Sinangil, F, Lee, C, Wagner, R, Esteban, M, Phogat, S, Venneker, E, Ding, S, Tartaglia, J, Corey, L, and Karuna, S. "Comparing Different Priming Strategies to Optimize HIV Vaccine Antibody Responses: Results from HVTN 096/EV04 (NCT01799954)." October 2016. Link to Item
  - Parks, C, Yuan, M, Coleman, J, Destefano, J, Zhang, X, Yates, N, Barouch, D, Ackerman, M, Decamp, A, Alter, G, Tomaras, G, Montefiori, D, Rasmussen, B, Morrow, G, and Koff, W. "Protection from Rectal SHIV Infection Induced by Mucosal Vaccination with a Replication-competent VSV-HIV Chimera Delivering Env Trimers." October 2016. Link to Item
  - Schneider, J, Bastian, AR, Orlandi, C, Shen, S, Lucas, J, Ashley, V, Smith, A, Kelleher, N, Veazey, R, Kiser, P, Lewis, G, Tomaras, G, and Hope, T. "Mucin-binding IgG: Characterizing a Novel Antibody Effector Function and Discovery of a New Fc Receptor." October 2016. Link to Item
  - Shen, X, Basu, R, Kwa, S, Labranche, C, Beaumont, D, Ferrari, G, Wyatt, L, Moss, B, Montefiori, D, Tomaras, G, and Robinson, H. "MVA-expressed gp140 Boosts More Durable V1/V2 and gp120 Antibody Responses than gp120 Protein in Alum." October 2016. Link to Item
  - Tomaras, G. "Overview of Humoral and Cellular Immune Responses to HIV Vaccination." October 2016. Link to Item
  - Asbach, B, Koestler, J, Perdiguero, B, Esteban, M, Jacobs, BL, Montefiori, DC, LaBranche, CC, Yates, NL, Tomaras, GD, Ferrari, G, Foulds, KE, Roederer, M, Landucci, G, Forthal, DN, Seaman, MS, Hawkins, N, Self, SG, Phogat, S, Tartaglia, J, Barnett, SW, Burke, B, Cristillo, AD, Ding, S, Heeney, JL, Pantaleo, G, and Wagner, R. "Priming with a potent HIV-1 DNA vaccine frames the quality of T cell and antibody responses prior to a poxvirus and protein boost." September 26, 2016. Link to Item
  - Bekker, L-G, Laher, F, Moodie, Z, Tomaras, G, Grunenberg, N, Allen, M, Daniels, B, Innes, C, Mngadi, K, Malahleha, M, Gilbert, P, Michael, N, Phogat, S, Granados, CD, Kanesa-Thasan, N, Corey, L, Gray, G, McElrath, J, and Team, HVTNS. "Meeting the "Go'' criteria: immunogenicity from HVTN100, a phase 1/2 randomized, double blind, placebo-controlled trial of clade C ALVAC-(R) (vCP2438) and Bivalent Subtype C gp120/MF59 (R) in HIV-uninfected South African adults." July 2016. Link to Item
  - Schmitz, F, Gerdts, S, Flach, B, Moore, M, Perkins, J, Robins, H, Aderem, A, Spearman, P, Tomaras, G, De Rosa, S, McElrath, MJ, and Heit, A. "D-107 Vaccination establishes CXCR5+PD1+CD4+ peripheral blood germinal center T follicular helper cell relatives in humans." January 2016. Full Text
  - Valentin, A, Li, J, Jalah, R, Patel, V, Rosati, M, Kulkarni, V, Alicea, C, Vargas-Inchaustegui, DA, Guan, Y, Venzon, D, Sardesai, NY, Fouts, TR, Pinter, A, Robert-Guroff, M, Montefiori, DC, Shen, X, Tomaras, GD, Pavlakis, GN, and Felber, BK. "DNA AND PROTEIN CO-IMMUNIZATION IMPROVES THE MAGNITUDE, LONGEVITY, AND MUCOSAL DISSEMINATION OF IMMUNE RESPONSES." October 2015. Link to Item
  - Prentice, H, Tomaras, G, Geraghty, D, Apps, R, Fong, Y, Ehrenberg, P, Rolland, M, Kijak, G, Nelson, W, Decamp, A, Shen, X, Yates, N, Zolla-Pazner, S, Nitayaphan, S, Rerks-Ngarm, S, Pitisuttithum, P, Ferrari, G, Montefiori, D, McElrath, J, Bailer, R, Koup, R, O'Connell, R, Robb, M, Michael, N, Kim, J, and Thomas, R. "HIV-1-specific IgG antibody levels correlate with the presence of a specific HLA class II allele to impact acquisition and vaccine efficacy." July 2015. Full Text Link to Item
  - Pavlakis, G, Valentin, A, Li, J, Jalah, R, Patel, V, Rosati, M, Kulkarni, V, Alicea, C, Vargas-Inchaustegui, D, Guan, Y, Venzon, D, Sardesai, N, Fouts, T, Pinter, A, Robert-Guroff, M, Montefiori, D, Shen, S, Tomaras, G, and Felber, B. "A-112 DNA and Protein Co-immunization Improves the Magnitude, Longevity, and mucosal dissemination of Immune Responses." November 2014. Full Text
  - De Rosa, S, Frahm, N, Diaz, G, Newling, P, Morris, D, Morgan, C, Graham, B, Swann, E, Tomaras, G, Maenza, J, Duerr, A, and McElrath, MJ. "No Increase in Activated T Cells and Limited Increase in Adenovirus-specific T Cells in Colon and Rectal Mucosa Following HIV-1 DNA/rAd5 Immunization." October 2014. Full Text
  - Fouda, G, Pollara, J, McGuire, E, Rountree, W, Overman, G, Tegha, G, Kamwendo, D, Kumwenda, J, Nelson, J, Liao, L, Ellington, S, King, C, Jamieson, D, Van der Horst, C, Kourtis, A, Tomaras, G, Ferrari, G, and Permar, S. "Association of HIV-1 Env Antibody Responses with Postnatal Mother-to-Child Transmission of HIV-1 via Breastfeeding." October 2014. Full Text
  - Gray, GE, Andersen-Nissen, E, Grunenberg, N, Huang, Y, Roux, S, Laher, F, Innes, C, Gu, N, DiazGranados, C, Phogat, S, Lee, C, Swann, E, Kim, J, O'Connell, R, Michael, N, Flach, B, DeRosa, S, Frahm, N, Morris, L, Montefiori, D, Gilbert, P, Tomaras, G, McElrath, J, and Corey, L. "HVTN 097: Evaluation of the RV144 Vaccine Regimen in HIV Uninfected South African Adults." October 2014. Full Text
  - Hay, CM, Wilson, GJ, Elizaga, M, Li, S, Kochar, N, Allen, M, Sobieszczyk, M, Frank, I, Frahm, N, Tomaras, GD, Egan, M, Pensiero, M, and Eldridge, J. "An HIV DNA Vaccine Delivered by Electroporation and Boosted by rVSV HIV-1 Gag Is Safe and Immunogenic in Healthy HIV-uninfected Adults." October 2014. Full Text
  - Le Grand, R, Bosquet, NN, Dispinseri, S, Gosse, L, Des Jardins, D, Shen, S, Tomaras, G, Hopewell, N, Barnett, S, Saidi, H, Thiebaut, R, Scarlatti, G, Cope, A, and Shattock, RJ. "Microbicide-vaccine Combination Provides Significant Protection against Vaginal SHIV-162P3 Challenge in Cynomolgous Monkeys." October 2014. Full Text
  - Liao, LH, Trama, AM, Williams, WB, Moody, MA, Vandergrift, N, Tomaras, GD, Marshall, DJ, Gurley, T, Whitesides, J, Eudailey, J, Foulger, A, Parks, R, Stolarchuk, C, Lloyd, KE, Soderberg, K, Mascola, JR, Koup, R, Corey, L, Nabel, GB, Gilber, P, Morgan, C, Maenza, J, Keefer, M, Hammer, S, Churchyard, G, Montefior, DC, Graham, BS, Baden, LR, Kepler, TB, and Haynes, BF. "Role of Intestinal Microbiota in Shaping the B Cell Repertoire in HIV Infection and Env Vaccination." October 1, 2014. Full Text Link to Item
  - Moody, MA, Easterhoff, D, Gurley, TC, Whitesides, JF, Marshall, DJ, Foulger, A, Lloyd, KE, Parks, R, Pollara, J, Duffy, R, Shen, S, Kim, JH, Michael, NL, Robb, ML, O'Connell, RJ, Vasan, S, Excler, JL, Rerks-Ngarm, S, Kaewkungwal, J, Pitisuttithum, P, Nitayaphan, S, Sinangil, F, Francis, D, Lee, C, Kepler, TB, Alam, SM, Ferrari, G, Montefiori, DC, Liao, HX, Tomaras, GD, and Haynes, BF. "Induction of Antibodies with Long Variable Heavy Third Complementarity Determining Regions by Repetitive Boosting with AIDSVAX® B/E in RV144 Vaccinees." October 2014. Full Text
  - Pavlakis, GN, Jalah, R, Li, J, Valentin, A, Rosati, M, Patel, V, Kulkarni, V, Alicea, C, Kelly, RB, Guan, YJ, Lifson, JD, Hirsch, VM, Venzon, D, Broderick, KE, Sardesai, NY, Fouts, TR, Pinter, A, Labranche, C, Montefiori, DC, Shen, S, Tomaras, GD, and Felber, BK. "OPTIMIZATION OF SYSTEMIC AND MUCOSAL IMMUNE RESPONSES TO SIV AND HIV-1 ANTIGENS USING DIFFERENT PROTOCOLS OF DNA AND PROTEIN IMMUNIZATION IN MACAQUES." October 2014. Link to Item
  - Pavlakis, GN, Li, J, Valentin, A, Jalah, R, Patel, V, Rosati, M, Kulkarni, V, Alicea, C, Vargas-Inchaustegui, DA, Guan, Y, Venzon, D, Sardesai, N, Fouts, TR, Pinter, A, Robert-Guroff, M, Montefiori, DC, Shen, X, Tomaras, GD, and Felber, BK. "DNA and Protein Co-immunization Improves the Magnitude, Longevity, and Mucosal Dissemination of Immune Responses." October 2014. Full Text
  - Prentice, H, Geraghty, D, Tomaras, GD, Fong, Y, Nelson, W, Kijak, G, Zolla-Pazner, S, Nitayaphan, S, Rerks-Ngarm, S, Kaewkungwal, J, Pitisuttithum, P, Michael, NL, Gilbert, P, Kim, JH, and Thomas, R. "Immune Correlates Identified in the RV144 Vaccine Efficacy Trial Impact HIV-1 Acquisition Only in the Presence of Certain HLA Class II Genes." October 2014. Full Text
  - Schifanella, L, Binello, N, Vaccari, M, Gordon, SN, Caccuri, F, Blackburn, M, Doster, M, Liynage, N, Pegu, P, Shen, X, Tomaras, GD, Venzon, D, Stablien, D, Barnett, SW, Barouch, D, Phogat, S, and Franchini, G. "Plasmablast Phenotype and Mucosal Antibodies to V2 in Vaccine-induced Protection Against SIVmac251." October 2014. Full Text
  - Schneider, JR, Shansab, M, Gunn, B, Shen, S, Lucas, J, Smith, A, Kelleher, N, Tomaras, G, Alter, G, Veazey, R, and Hope, T. "Utilizing Mucin-tethered HIV IgG to Enhance HIV Vaccine Function." October 2014. Full Text
  - Shen, X, Williams, W, Yates, N, Francica, J, Reimann, K, Montefiori, D, McElrath, J, Seder, R, and Tomaras, G. "HIV ENV-SPECIFIC IGG3 RESPONSES ARE DIFFERENTIALLY ELICITED IN NONHUMAN PRIMATE BY ENV VACCINES WITH DIFFERENT ADJUVANTS." October 2014. Link to Item
  - Vaccari, M, Gordon, SN, Fourati, S, Schifanella, L, Cameron, M, Keele, BF, Shen, X, Tomaras, G, Billings, E, Rao, M, Liyanage, NP, Vargas-Inchaustegui, DA, Whitney, S, Doster, MN, Binello, N, Pegu, P, Montefiori, DC, Foulds, K, Quinn, DS, Donaldson, M, Liang, F, Lore, K, Roederer, M, Koup, R, McDermott, A, Ma, ZM, Christopher, M, Phan, TB, Forthal, DN, Blackburn, M, Caccuri, F, Ferrari, G, Robert-Guroff, M, Ratto-Kim, S, Kim, J, Michael, N, Phogat, S, Barnett, SW, Tartaglia, J, Venzon, D, Stablein, DM, Sekaly, RP, and Franchini, G. "Adjuvant Dependent Mucosal V2 Responses and RAS Activation in Vaccine Induced Protection from SIVmac251 Acquisition." October 2014. Full Text
  - Archary, D, Seaton, K, Yates, NL, Werner, L, Bergin, PJ, Liebenberg, LJ, Samsunder, N, Garrett, N, Abdool Karim, Q, Abdool Karim, SS, Liao, H, Passmore, J, Morris, L, and Tomaras, GD. "HIV-1 Specific Binding Antibody Titres in Blood Predict Detection in the Female Genital Tract in Women Who Became Infected in the CAPRISA 004 Microbicide." November 1, 2013. Link to Item
  - Blasi, M, Negri, D, Santra, S, Parks, R, Shen, X, Tomaras, G, Permar, S, Montefiori, D, LaBranche, C, Ferrari, G, Alam, M, Liao, H, Moody, AM, Haynes, BF, Klotman, ME, and Cara, A. "A Single Immunization with Integrase Defective Lentiviral Vector Expressing gp140 Induces Persistent and Functional Immune Response in Rhesus Monkeys." Conference on AIDS Vaccine. Barcelona, SPAIN. October 7, 2013 - October 10, 2013.: MARY ANN LIEBERT, INC, November 1, 2013. Link to Item
  - Caskey, M, Trumpfheller, C, Schlesinger, S, Pollak, S, Sinnenberg, L, Pring, J, Hurley, A, Shimeliovich, I, Sarma, P, Yipp, B, Mehandru, S, Anandasabapathy, N, Steinman, R, Keler, T, Koup, R, Bailer, R, Tomaras, G, and Sato, A. "In Vivo Targeting of HIV Gag to Dendritic Cells Given with Poly ICLC Is Safe and Induces Durable CD4 T Cell and B Cell Responses in Healthy Volunteers." November 1, 2013. Link to Item
  - Fouda, GG, Cunningham, CK, McFarland, EJ, Borkowsky, W, Muresan, P, Liebl, BE, Liao, H, Haynes, BF, Overman, R, Yates, NL, Tomaras, GD, and Permar, SR. "HIV-1 gp120 Vaccination Elicits a Robust and Durable Anti-V1/V2 IgG Response and Yet No HIV-1 Env-Specific IgA Response in HIV-Exposed Infants." November 1, 2013. Link to Item
  - Fouts, TR, Prado, I, Bobb, K, Xu, R, Egan, M, Tomaras, G, Montefiori, D, Lewis, G, DeVico, A, and Eldridge, J. "Rhesus Full Length Single Chain (rhFLSC) Protects Rhesus Macaques from Heterologous Intrarectal Challenge with Multiple Low Doses of SHIV162P3." November 1, 2013. Link to Item
  - Gordon, SN, Vaccari, M, Doster, MN, Liyanage, NP, Pegu, P, Schifanella, L, Caccuri, F, Keele, BF, Foulds, KE, Shen, X, Tomaras, GD, Montefiori, DC, Roederer, M, Ferrari, G, Venzon, D, Stablien, D, Barouch, DH, Felber, BK, Pavlakis, GN, Michael, NL, Tartaglia, J, and Franchini, G. "Priming with Adenovirus26 Vaccines Affects ALVAC-SIV/gp120 Vaccine Efficacy Tested in a SIVmac251 Challenge Model Performed One-Month Post-Vaccination." November 1, 2013. Link to Item
  - Hammer, S, Sobieszczyk, M, Janes, H, Gilbert, P, Karuna, S, Grove, D, Ramirez, S, Bentley, C, Anude, C, Mulligan, M, Koblin, B, Buchbinder, S, Keefer, M, Hural, J, McElrath, J, Frahm, N, Tomaras, G, Graham, B, Enama, M, Broder, G, Maynard, J, Wakefield, S, Holt, R, DeJesus, E, Frank, I, Novak, R, Martinez, A, Kublin, J, Corey, L, and Network, HIVVT. "HVTN 505: Efficacy of a Multi-Gene DNA Prime/Recombinant Adeno 5 (rAd5) Vector Boost Vaccine in Men & Transgender Women (TGW) Who Have Sex with Men." November 1, 2013. Link to Item
  - Heeney, JL, Jacobs, B, Esteban, M, Wagner, R, Foulds, K, Roederer, M, Self, S, Barnett, S, Tartaglia, J, Montefiori, D, Tomaras, G, and Pantaleo, G. "Increased HIV-1 Immunogenicity of Replication Competent NYVAC." November 1, 2013. Link to Item
  - Li, SS, Gilbert, PB, Tomaras, GD, Kijak, G, Ferrari, G, Thomas, R, Zolla-Pazner, S, Evans, DT, Li, Y, Gottardo, R, Dai, JY, Janes, H, Morris, D, Fong, Y, Edlefsen, PT, Li, F, Magaret, CA, Frahm, N, Alpert, MD, Rerks-Ngarm, S, Pitisuttithum, P, Kaewkungwal, J, Nitayaphan, S, Robb, ML, O'Connell, RJ, Michael, NL, Kim, JH, McElrath, MJ, and Geraghty, DE. "Association of Fc gamma RIIC Polymorphism with Vaccine Efficacy and Correlates of HIV-1 Infection Risk in RV144." November 1, 2013. Link to Item
  - Liyanage, NP, Gordon, SN, Vaccari, M, Pegu, P, Doster, MN, Tomaras, GD, Venzon, D, Stablien, D, Tartaglia, J, Barnett, SW, Kim, JH, Michael, NL, and Franchini, G. "Alum and MF59, in Combination with ALVAC-SIV and Gp120 Vaccines Recruit Functionally Different NK Cells to the Gut of Vaccinated Rhesus Macaque." November 1, 2013. Link to Item
  - Morris, L, Mkhize, NN, Hermanus, T, Chung, E, Sato, A, Grant, S, Gu, N, Williamson, C, Williamson, A, Barnett, S, Bekker, L, Allen, M, Pensiero, MN, Hural, J, McElrath, J, Elizaga, M, Mayer, K, Tomaras, G, Montefiori, D, and Gray, G. "Boosting Antibody Responses with gp140 Protein Two Years After DNA/MVA Priming: Results from the HVTN 073E Phase I Vaccine Trial." November 1, 2013. Link to Item
  - Nabi, R, Wei, Q, Moldoveanu, Z, Golub, ET, Landay, AL, Tomaras, GD, Mestecky, J, and Kozlowski, PA. "Systemic IgG and IgA Responses to gp70V1V2 and C1 in HIV-Infected Elite Controllers Versus Controllers and Noncontrollers on HAART." November 1, 2013. Link to Item
  - Pavlakis, GN, Jalah, R, Li, J, Valentin, A, Rosati, M, Patel, V, Kulkarni, V, Alicea, C, Beach, RK, Guan, Y, Lifson, JD, Hirsch, VM, Venzon, D, Broderick, KE, Sardesai, NY, Fouts, TR, Pinter, A, LaBranche, C, Montefiori, DC, Shen, S, Tomaras, GD, and Felber, BK. "Optimization of Systemic and Mucosal Immune Responses to SIV and HIV-1 Antigens Using Different Protocols of DNA and Protein Immunization in Macaques." November 1, 2013. Link to Item
  - Pollara, J, Bonsignori, M, Moody, M, Alam, S, Hwang, K, Gurley, TC, Kozink, DM, Marshall, DJ, Whitesides, JF, Tsao, C, Kaewkungwal, J, Nitayaphan, S, Pitisuttithum, P, Rerks-Ngarm, S, Tomaras, GD, Kim, JH, Michael, NL, Montefiori, DC, Liao, H, Haynes, BF, Ferrari, G, and Immunology, CHIVAIDSV. "Heterogeneity of Anti-V2 ADCC Ab Responses and Implications for Vaccine Development." November 1, 2013. Link to Item
  - Prentice, H, Geraghty, DE, Tomaras, GD, Fong, Y, Nelson, W, Kijak, GH, Zolla-Pazner, S, Nitayaphan, S, Rerks-Ngarm, S, Kaewkungwal, J, Pitisuttithum, P, Gilbert, PB, Haynes, BF, Kim, JH, Michael, N, and Thomas, R. "HLA Class II Genes Interact with the Immune Correlates from the RV144 Vaccine Efficacy Trial and Impact HIV-1 Acquisition." November 1, 2013. Link to Item
  - Rolland, M, Edlefsen, PT, Gottardo, R, Montefiori, DC, Zolla-Pazner, S, Moody, A, Liao, LH, Liu, P, Tomaras, GD, Haynes, BF, Bailer, RT, Koup, RA, Mascola, JR, Shen, X, Korber, BT, Tovanabutra, S, Rerks-Ngarm, S, Nitayaphan, S, Pitisuttihum, P, Kaewkungwal, J, Robb, ML, Michael, NL, Mullins, JI, Gilbert, PB, and Kim, JH. "Genetic and Immunological Evidence for a Role of Env-V3 Antibodies in the RV144 Trial." November 1, 2013. Link to Item
  - Schifanella, L, Gordon, S, Vaccari, M, Binello, N, Caccuri, F, Blackburn, M, Fenizia, C, Doster, M, Pegu, P, Liynage, N, Shen, X, Tomaras, G, Rao, M, Ferrari, G, Venzon, D, Stablien, D, Barnett, S, Tartaglia, J, and Franchini, G. "MF59 and ALUM, in Combination with an ALVAC-SIV/gp120 Vaccine, Induce Plasmablasts that Differ in the Expression of Homing Markers." November 1, 2013. Link to Item
  - Seaton, K, Yates, N, Williams, W, Liao, L, deCamp, A, Fong, Y, Montefiori, D, Spearman, P, Elizaga, M, Barnett, S, Koutsoukos, M, Bourguignon, P, McElrath, J, Corey, L, Michael, N, Pitisuttithum, P, Rerks-Ngarm, S, Kim, J, Voss, G, Gilbert, P, Haynes, B, Tomaras, G, Team, GP, Team, HP, Team, RP, and Team, VP. "Human HIV-1 Vaccine Induced Antibody Durability and Env IgG3 Responses." November 1, 2013. Link to Item
  - Shen, X, Howington, R, Park, H, Sadagopal, S, Kwa, S, Cope, A, Ding, S, Bolton, D, Roederer, M, Amara, R, Picker, L, Seder, R, McElrath, J, Barnett, S, Shattock, R, Felber, B, Pavlakis, G, Pantaleo, G, Montefiori, D, and Tomaras, G. "Vaccine Induced Epitope Specific Antibodies to the SIV Envelope Are Distinct from Those Induced to the HIV-1 Envelope." November 1, 2013. Link to Item
  - Trama, AM, Liao, H, Jaeger, FH, Alam, SM, Wiehe, K, Jr, JTL, Foulger, A, Williams, WT, Marshall, DJ, Stolarchuk, C, Lloyd, KE, Parks, R, Soderberg, K, Kepler, TB, Vandergrift, N, Jackson, KJ, Fire, AZ, Boyd, SD, Whitesides, JF, Tomaras, GD, Moody, MA, and Haynes, BF. "Intestinal Commensal Bacteria Shape the Pre-transmission Antibody Repertoire to HIV-1 Infection." November 1, 2013. Link to Item
  - Vaccari, M, Gordon, SN, Doster, M, Liynage, N, Pegu, P, Schifanella, L, Keele, BF, Shen, X, Tomaras, GD, Rao, M, Montefiori, DC, Ferrari, G, Foulds, K, Roederer, M, Venzon, D, Stablein, DM, Kim, JH, Michael, NL, Phogat, S, Barnett, SW, Tartaglia, J, and Franchini, G. "Protection from SIVmac251 Acquisition by an ALVAC/SIV/gp120 Regimen Is Not Improved by the Increase of Anti-Envelope Antibodies and T Cell Responses." November 1, 2013. Link to Item
  - Wiehe, K, Easterhoff, D, Luo, K, Williams, W, Vandergrift, N, Lloyd, E, Stolarchuk, C, Parks, R, Nicely, N, Kaewkungwal, J, Nitayaphan, S, Pitisuttithum, P, Rerks-Ngarm, S, Michael, N, Kim, J, Tomaras, G, Bonsignori, M, Kepler, TB, Moody, AM, Liao, H, and Haynes, BF. "Phylogenetic Conservation of a Dominant Antibody Light Chain HIV Env V2 Binding Motif in Human and rhesus Macaque Antibodies." November 1, 2013. Link to Item
  - Williams, WB, Jones, K, Liu, P, Trama, AM, Seaton, K, Moody, MA, Vandergrift, N, Wiehe, K, Liao, H, Montefiori, DC, Ochsenbauer, C, Kappes, J, Hammer, SM, Mascola, J, Koup, R, Corey, L, Nabel, G, Gilbert, P, Morgan, CA, Churchyard, G, Maenza, J, Baden, LR, Keefer, M, Graham, BS, Tomaras, GD, and Haynes, BF. "Antibody Repertoire Induced by the Multiclade (Env A, B, C) HIV-1 DNA Prime, rAd5 Boost VRC Vaccine." November 1, 2013. Link to Item
  - Pavlakis, GN, Jalah, R, Valentin, A, Rosati, M, Patel, V, Kulkarni, V, Alicea, C, Kelly, RB, Guan, Y, Lifson, JD, Hirsch, VM, Venzon, D, Broderick, KE, Sardesai, NY, LaBranche, C, Montefiori, DC, Shen, S, Tomaras, G, and Felber, BK. "Comparison of systemic and mucosal responses after DNA and protein co-immunization." April 2013. Link to Item
  - Tomaras, GD. "HIV-1 Vaccine Elicited IgA and IgG Antibody Specificities." April 2013. Link to Item
  - Blackinton, J, Thompson, M, Mukherjee, N, Freel, S, Tomaras, G, and Keene, J. "Integration of global techniques to implicate post-transcriptional regulation in HIV infection." October 2012. Link to Item
  - Amos, JD, Wilks, AB, Fouda, GG, Smith, SD, Overman, GR, Beck, K, Moody, MA, Tomaras, GD, and Permar, SR. "Strong SIV gp120-specific IgG/IgA responses in milk of African green monkeys may contribute to the rarity of postnatal transmission in this species." September 13, 2012. Full Text Link to Item
  - Hertz, T, Gartland, A, Janes, H, Li, S, Fong, Y, Tomaras, GD, Morris, D, Geraghty, D, Kijak, GH, Edlefsen, PT, Rolland, M, Larsen, BB, Tovanabutra, S, Sanders-Buell, E, DeCamp, AC, Magaret, CA, Ahmed, H, Nariya, S, Wong, K, Zhao, H, Deng, W, Maust, BS, Bose, M, Howell, S, Lazzaro, M, Bates, A, Lei, E, Bradfield, A, Ibitamuno, G, Assawadarachai, V, O'Connel, RJ, DeSouza, MS, Nitayaphan, S, Rerks-Ngarm, S, Robb, ML, McElrath, MJ, Haynes, BF, Michael, NL, Gilbert, PB, Mullins, JI, and Kim, JH. "T-cell based sieve analysis ties HLA A*02 to vaccine efficacy and IgA-C1 immune correlate in RV144 Thai trial." September 13, 2012. Full Text Link to Item
  - Liao, L, Bonsignori, M, Hwang, K, Moody, AM, Park, R, Crawford, S, Chen, H, Jeffries, TL, Cooper, M, Lu, X, De, R, Karasavvas, N, Rerks-Ngarm, S, Nitayaphan, S, Kaewkungwal, J, Tovanabutra, S, Pitisuttithum, P, Tartaglia, J, Sinangil, F, Kim, J, Michael, NL, Tomaras, GD, Yang, Z, Dai, K, Pancera, M, Nabel, GJ, Mascola, JR, Kwong, PD, Pinter, A, Zolla-Pazner, S, Alam, MS, and Haynes, BF. "Design of an HIV Env antigen that binds with high affinity to antibodies against linear, conformational and broadly neutralizing epitopes within V1/V2." September 13, 2012. Full Text Link to Item
  - Montefiori, DC, Huang, Y, Karuna, S, Allen, M, Kochar, N, Chappuis, S, Gaillard, J, Tomaras, G, Graham, B, Bart, P, and Pantaleo, G. "rAd5/NYVAC-B is superior to NYVAC-B/rAd5 and is dependent on rAd5 dose for neutralizing antibody responses against HIV-1." September 13, 2012. Full Text Link to Item
  - Moody, M, Drinker, MS, Gurley, TC, Amos, JD, Eudailey, JA, Armand, LC, Parks, R, Gray, ES, Morris, L, Finzi, A, Yang, X, Sodroski, J, Liao, H, Tomaras, GD, Montefiori, DC, and Haynes, BF. "Isolation of a clonal lineage of IgA broadly neutralizing antibodies from a chronically infected Tanzanian subject." September 13, 2012. Full Text Link to Item
  - Moody, M, Trama, AM, Bonsignori, M, Tsao, C, Drinker, MS, Gurley, TC, Amos, JD, Eudailey, JA, Armand, LC, Parks, R, Lloyd, KE, Wang, S, Seo, K, Lee, J, Jackson, KJ, Hoh, R, Pham, T, Roskin, KM, Boyd, SD, Fire, AZ, Gray, ES, Morris, L, Liao, H, Tomaras, GD, Kepler, TB, Kelsoe, G, and Haynes, BF. "Antibody lineages with evidence of somatic hypermutation persisting for > 4 years in a South African subject with broad neutralizing activity." September 13, 2012. Full Text Link to Item
  - Pollara, J, Bonsignori, M, Moody, M, Alam, M, Liao, H, Hwang, K, Pickeral, J, Kappes, J, Ochsenbauer, C, Soderberg, K, Gurley, TC, Kozink, DM, Marshall, DJ, Whitesides, JF, Montefiori, D, Robinson, JE, Kaewkungwal, J, Nitayaphan, S, Pitisuttithum, P, Rerks-Ngarm, S, Kim, J, Michael, N, Tomaras, G, Haynes, BF, and Ferrari, G. "Vaccine-induced ADCC-mediating antibodies target unique and overlapping envelope epitopes." September 13, 2012. Full Text Link to Item
  - Trama, AM, Liao, H, Foulger, A, Marshall, DJ, Whitesides, JF, Parks, R, Meyerhoff, R, Lloyd, KE, Donathan, M, Lucas, J, Soderberg, K, Kepler, TB, Vandergrift, N, Yates, N, Tomaras, GD, Moody, MA, and Haynes, BF. "Lack of IgA envelope-reactive antibody producing cells in terminal ileum in early and chronic HIV-1 infection." September 13, 2012. Full Text Link to Item
  - Williams, WB, Jones, K, Krambrink, A, Grove, D, Liu, P, Yates, NL, Moody, MA, Ferrari, G, Pollara, J, Moodie, Z, Morgan, CA, Liao, H, Montefiori, DC, Ochsenbauer, C, Kappes, J, Hammer, S, Mascola, J, Koup, R, Corey, L, Nabel, G, Gilbert, P, Churchyard, G, Keefer, M, Graham, BS, Haynes, BF, and Tomaras, GD. "Multiple antibody specificities (gp41, V1V2, and V3) elicited in the phase II multiclade (A, B, C) HIV-1 DNA prime, rAd5 boost vaccine trial." September 13, 2012. Full Text Link to Item
  - Caskey, M, Trumpfheller, C, Pollak, S, Sinnenberg, L, Hurley, A, Pring, J, Shimeliovich, I, Yipp, B, Anandasabapathy, N, Mehandru, S, Sarma, P, Koup, R, Bailer, R, Tomaras, G, Sato, A, Keler, T, Steinman, R, and Schlesinger, S. "In vivo targeting of HIV gag to dendritic cells in combination with poly ICLC is safe and immunogenic in healthy volunteers." 2012. Full Text
  - Fuchs, J, Morgan, C, Bart, P, Kochar, N, Frahm, N, Swann, E, Gilbert, P, DeRosa, S, Graham, B, Nabel, G, Liao, H, Haynes, B, and Tomaras, G. "DNA and recombinant adenovirus serotype 35 and 5 preventive HIV-1 vaccines with Env A inserts elicit cross-clade binding and V1V2 antibodies." 2012. Full Text
  - Goepfert, P, Elizaga, M, Montefiori, D, Hural, J, DeRosa, S, Tomaras, G, Seaton, K, Sato, A, Ouedraogo, L, Donastorg, Y, Cardinali, M, Lama, J, Baden, L, Keefer, M, McElrath, J, Kalams, S, and Robinson, H. "Phase 2a safety and immunogenicity testing of DNA and recombinant modified vaccinia ankara virus vaccines expressing virus-like particles." 2012. Full Text
  - Spearman, P, Tomaras, G, Montefiori, D, Huang, Y, Ahmed, H, Elizaga, M, Hural, J, McElrath, J, Ouedraogo, L, Pensiero, M, Butler, C, Kalams, S, Overton, E, Barnett, S, and Group, N. "Rapid development of cross-clade neutralizing antibody responses after clade B gp120/gp140 protein priming and clade c gp140 protein boosting." 2012. Full Text
  - Billings, EA, Karasavvas, N, de Souza, MS, Currier, J, Pitisuttithum, P, Kaewkunwal, J, Nitayaphan, S, Gilbert, PB, Tomaras, GD, Zolla-Pazner, SB, Haynes, BF, Michael, NL, Rerks-Ngarm, S, Kim, JH, and Rao, M. "Surface Plasmon Resonance Analysis of Anti-gp120 V2-Specific IgG Antibodies Generated in the RV144 Thai Trial." October 2011. Link to Item
  - Bonsignori, M, Wu, X, Moody, MA, Liao, H, Hwang, K, Crump, JA, Capiga, SH, Sam, NE, Tomaras, GD, Chen, X, Tsao, C, Alam, SM, Nabel, GJ, Kwong, PD, Morris, L, Montefiori, D, Mascola, JR, and Haynes, BF. "Isolation of CD4-Binding Site and V2/V3 Conformational (Quaternary) Broadly Neutralizing Antibodies from the Same HIV-1 Infected African Subject." October 2011. Link to Item
  - Ferrari, G, Pollara, J, Kozink, D, Harms, T, Drinker, M, Freel, S, Moody, MA, Tomaras, GD, Ochsenbauer, C, Kappes, JC, Shaw, GM, Hoxie, JA, Robinson, JE, Montefiori, DC, Haynes, BF, and Teams, CHAVICAVD-VIMC. "Mapping of ADCC Activity: The A32 Conformational C1 Epitope is a Dominant Target for ADCC Antibodies in Chronically HIV-1 Infected Subjects." October 2011. Link to Item
  - Fouda, G, Yates, N, Pollara, J, Overman, G, Mahlokozera, T, Wilks, A, Kang, H, Ferrari, G, Tomaras, G, Montefiori, D, and Permar, S. "HIV Neutralization in Breast Milk Mirrors that of Plasma and Is Mainly Mediated by IgG Antibodies." October 2011. Link to Item
  - Frahm, N, Friedrich, DP, Walsh, P, De Rosa, S, Spearman, P, Barnett, S, Keefer, M, Goepfert, P, Robinson, H, Graham, B, Liao, H, Tomaras, G, Haynes, B, Rerks-Ngarm, S, Kim, J, and McElrath, MJ. "A DNA Prime/Protein Boost Vaccine Leads to Higher B-Cell Responses than a Vector Prime/Protein Boost or DNA Prime/Vector Boost Regimens." October 2011. Link to Item
  - Freel, SA, Picking, RA, Ferrari, G, Ochsenbauer, C, Kappes, JC, Kirchherr, J, Weinhold, KJ, Soderberg, K, McMichael, AJ, Haynes, BF, and Tomaras, GD. "Ontogeny of CD8+T Cells in Acute HIV-1 that Inhibit Autologous and Heterologous Transmitted/Founder (T/F) Viruses." October 2011. Link to Item
  - Lynch, RM, Louder, MK, Tran, L, Yang, Z, Tomaras, G, Cohen, M, Gray, ES, Sibeko, S, Karim, SA, Euler, Z, Nabel, GJ, Schuitemaker, H, Montefiori, DC, Morris, L, Haynes, BF, and Mascola, J. "Detection of CD4-Binding Site Antibodies in Three HIV-1 Seroconverter Cohorts." October 2011. Link to Item
  - Pollara, J, Morris, L, Meguid, N, Pickeral, J, Hoxie, J, Kappes, J, Ochsenbauer, C, Soderberg, K, Tomaras, G, Haynes, B, Montefiori, D, Ferrari, G, and Teams, CHAVICAVD-CAVIMC. "Ontogeny, Breadth, and Specificity of Circulating ADCC-Mediating Antibodies in HIV-1 Infected Individuals." October 2011. Link to Item
  - Yang, H, Wu, H, Freel, SA, Yan, H, Huang, X, Xu, X, Birks, J, Tomaras, GD, McMichael, A, and Dorrell, L. "The CD8+T Cell Antiviral Inhibitory Activity Predicts the Rate of CD4+Cell Decline in Early HIV-1 Infection and Is Independent of Viral Subtype." October 2011. Link to Item
  - Zhu, Z, Qin, HR, Chen, W, Zhao, Q, Shen, X, Schutte, R, Wang, Y, Ofek, G, Streaker, E, Prabakaran, P, Fouda, GG, Liao, H, Owens, J, Louder, M, Yang, Y, Klaric, K, Moody, MA, Mascola, JR, Scott, JK, Kwong, PD, Montefiori, D, Haynes, BF, Tomaras, GD, and Dimitrov, DS. "2F5-like Cross-Reactive HIV-1-Neutralizing Monoclonal Antibodies with Low Number of Somatic Mutations." October 2011. Link to Item
  - Alam, S, Dennison, SM, Jaeger, F, Anasti, K, Sutherland, L, Bowman, C, Parks, R, Santra, S, Shen, S, Tomaras, G, Montefiori, D, Letvin, N, and Haynes, BF. "Induction of antibodies with specificity for gp41 neutralizing epitopes by membrane anchored gp41 immunogens." October 2010. Link to Item
  - Alam, S, Tomaras, GD, Liao, H, Parks, R, Meyerhoff, R, Jaeger, F, Foulger, A, Donathan, M, Lucas, J, Kelsoe, G, Kepler, T, and Haynes, BF. "Reverted unmutated ancestor 2F5 VH2-5 alleles differentially bind gp41 and bacterial proteins: a genetic basis for gp41 neutralizing B cell responses." October 2010. Link to Item
  - Cirulli, ET, Forthal, D, Shianna, KV, Pandey, J, Sinangil, F, Fellay, J, Perez, K, Landucci, G, Tomaras, G, Haynes, BF, and Goldstein, DB. "Genome-Wide Significant Association of the GM 23 Allotype with gp120-Specific IgG2 Titers in an Efficacy Trial of AIDSVAX B/B." October 2010. Link to Item
  - Liao, H, Chen, X, Munshaw, S, Zhang, R, Marshall, D, Whitesides, J, Foulger, A, Lu, X, Yu, J, Chen, H, Amos, J, Parks, R, Vandergrift, N, Ma, B, Donathan, M, Markowitz, M, Goepfert, P, Shaw, G, Walter, E, Alam, M, Alam, M, Margolis, D, Kelsoe, G, Tomaras, G, Moody, M, Kepler, TTB, and Haynes, B. "Early plasma B cell responses to transmitted HIV-1 are directed to envelope gp41 and originate by the activation of mutated B cell clones." October 2010. Link to Item
  - Liu, J, Keele, BF, Liu, H, Keating, S, Norris, PJ, Carville, A, Mansfield, KG, Tomaras, GD, Haynes, BF, Letvin, NL, Hahn, BH, Shaw, GM, and Barouch, DH. "Low Dose Mucosal SIV Infection Restricts Early Replication Kinetics and Transmitted Virus Variants in Rhesus Monkeys." October 2010. Link to Item
  - Moody, MA, Amos, JD, Gurley, TC, Drinker, MS, Luney, KD, Marshall, DJ, Whitesides, JF, Chen, X, Zhang, R, Derosa, K, Guogas, L, Vandergrift, NA, Voss, G, Liao, H, Tomaras, GD, and Haynes, BF. "Isolation of Human Monoclonal Antibodies from HIV-Uninfected Subjects Immunized with gp120/NefTat/AS01B by Dual-Color Antigen-Specific B Cell Sorting." October 2010. Link to Item
  - Pollara, J, Hart, L, Hoxie, J, Kappes, J, Ochsenbauer, C, Morris, L, Soderberg, K, Tomaras, G, Haynes, B, Montefiori, D, Ferrari, G, and Teams, CHAVICAVD-CAVIMC. "High titers of cross-clade ADCC-mediating antibodies are detectable in plasma samples collected from individuals with broadly neutralizing antibodies." October 2010. Link to Item
  - Pollara, J, Landucci, G, Trac, C, White, C, Yates, N, Kappes, J, Ochsenbauer, C, Shaw, G, Hahn, B, Hoxie, J, Liao, H, Cohen, M, Montefiori, D, Soderberg, K, Tomaras, G, Haynes, B, Forthal, D, Ferrari, G, and Team, CHAVI. "Early Appearance of ADCC- and ADCVI-mediating Antibody Responses Against Autologous HIV-1 Transmitted/Founder Virus." October 2010. Link to Item
  - Tomaras, G, Binley, J, Gray, E, Shen, X, Moore, P, Decker, J, Yates, N, Haynes, B, Cohen, M, Shaw, G, Montefiori, D, Mascola, J, Morris, L, Team, CHAVI, and Team, CAVD-CAVIMC. "Epitope Specificities of Elite Neutralizing Sera from HIV-1-Infected Individuals." October 2010. Link to Item
  - Yates, N, Shen, X, Liu, P, Barnett, S, Spearman, P, Lu, S, Ferrari, G, Alam, M, Overman, R, Lucas, J, Ashley, V, Vaine, M, Wang, S, Liao, H, Hural, J, Weinhold, K, McElrath, J, Haynes, B, Montefiori, D, and Tomaras, G. "Vaccine-Elicited IgG Subclasses and Functional Antibodies." October 2010. Link to Item
  - Zhu, Z, Qin, HR, Chen, W, Zhao, Q, Fouda, G, Schutte, R, Shen, X, Liao, H, Ofek, G, Owens, J, Streaker, E, Wang, Y, Kwong, PD, Montefiori, DC, Haynes, BF, Tomaras, GD, and Dimitrov, DS. "New broadly neutralizing human monoclonal antibodies targeting the 2F5 epitope." October 2010. Link to Item
  - Shen, X, Dennison, M, Gao, F, Montefiori, DC, Verkoczy, L, Haynes, B, Alam, M, and Tomaras, G. "OA021-04. HIV-1 gp41 envelope MPER mutation altered epitope conformation in lipid and increased sensitivity to 2F5 and 4E10 neutralizing antibodies." October 22, 2009. Full Text
  - Yates, NL, Lucas, J, Parks, R, Ashley, VC, Overman, G, Montefiori, DC, Weinhold, KJ, Shattock, R, Cohen, M, Haynes, BF, Tomaras, GD, and Team, CHAVI. "HIV Frequently Elicits Mucosal and Plasma Env-Specific IgA With a Rapid Initial Decline In Acute Infection." June 2009. Full Text Link to Item
  - Bonsignori, M, Moody, MA, Parks, RJ, Holl, TM, Kelsoe, G, Hicks, CB, Vandergrift, N, Tomaras, GD, and Haynes, BF. "P04-48. HIV-1 envelope induces memory B cell responses that correlate with plasma antibody levels after gp120 protein vaccination or chronic HIV-1 infection." 2009.
  - Freel, SA, Chattopadhyay, PK, Lamoreaux, L, Zarkowsky, D, Overman, RG, Ochsenbauer-Jambor, C, Kappes, JC, Cunningham, CK, Denny, TN, Weinhold, KJ, Ferrari, G, Koup, RA, Graham, BS, Haynes, BF, Roederer, M, and Tomaras, GD. "S01-04 OA. Phenotypic analyses of CD8+ T cells that mediate virus inhibition from HIV-1 vaccinees and HIV-1+ virus controllers." 2009.
  - Freel, SA, Chattopadhyay, PK, Lamoreaux, L, Zarkowsky, D, Overman, RG, Ochsenbauer-Jambor, C, Kappes, JC, Cunningham, CK, Denny, TN, Weinhold, KJ, Ferrari, G, Koup, RA, Graham, BS, Haynes, BF, Roederer, M, and Tomaras, GD. "Phenotypic analyses of CD8+T cells that mediate virus inhibition from HIV-1 vaccinees and HIV-1+virus controllers." 2009. Full Text Link to Item
  - Liao, L, Chen, X, Dixon, A, Munshaw, S, Moody, M, Zhang, R, Nagel, A, Foulger, A, Derosa, K, Parks, R, Mcparland, M, Whitesides, J, Marshall, D, Amos, J, Yang, Y, Gao, F, Shea, T, Margolis, D, Shaw, G, Markowitz, M, Denny, T, Kelsoe, G, Tomaras, G, Kepler, T, and Haynes, B. "P04-45. Characterization of the plasma cell repertoire in acute HIV-1 infection (AHI)." 2009.
  - Liao, L, Chen, X, Dixon, A, Munshaw, S, Moody, M, Zhang, R, Nagel, A, Foulger, A, Derosa, K, Parks, R, Mcparland, M, Whitesides, J, Marshall, D, Amos, J, Yang, Y, Gao, F, Shea, T, Margolis, D, Shaw, G, Markowitz, M, Denny, T, Kelsoe, G, Tomaras, G, Kepler, T, and Haynes, B. "P04-45. Characterization of the plasma cell repertoire in acute HIV-1 infection (AHI)." 2009. Full Text
  - Munshaw, S, Liao, H, Dixon, A, Chen, X, Nagel, A, Derosa, K, Parks, R, Amos, J, Whitesides, JF, Marshalls, DJ, Yang, Y, Gao, F, Tomaras, GD, Moody, MA, Kelsoe, GH, Shea, TC, Margolis, DM, Markowitz, M, Goepfert, P, Shaw, G, Haynes, BF, and Kepler, TB. "S021-04 OA. A large-scale analysis of immunoglobulin sequences derived from plasmablasts/plasma cells in acute HIV-1 infection subjects." 2009.
  - Munshaw, S, Liao, H, Dixon, A, Chen, X, Nagel, A, Derosa, K, Parks, R, Amos, J, Whitesides, JF, Marshalls, DJ, Yang, Y, Gao, F, Tomaras, GD, Moody, MA, Kelsoe, GH, Shea, TC, Margolis, DM, Markowitz, M, Goepfert, P, Shaw, G, Haynes, BF, and Kepler, TB. "A large-scale analysis of immunoglobulin sequences derived from plasmablasts/plasma cells in acute HIV-1 infection subjects." 2009. Full Text Link to Item
  - Robinson, H, Amara, R, Lai, L, Xu, Y, De Rosa, S, Defawe, O, Sato, A, Tomaras, G, Qin, L, Moss, B, Wyatt, L, Hay, C, and Goepfert, P. "P19-58 LB. Comparison of the immunogenicity in humans and rhesus macaques of vaccines consisting of DNA priming and MVA boosting and MVA priming and boosting." 2009. Full Text
  - Robinson, HL, Amara, RR, Lai, L, Xu, Y, De Rosa, S, Defawe, O, Sato, A, Tomaras, GD, Qin, L, Moss, B, Wyatt, LS, Hay, C, and Goepfert, P. "Comparison of the immunogenicity in humans and rhesus macaques of vaccines consisting of DNA priming and MVA boosting and MVA priming and boosting." 2009. Full Text Link to Item
  - Saunders, K, Freel, S, Overman, R, Cunningham, C, and Tomaras, G. "P16-40. Inhibition of histone deacetylases modulates CD8+ T-lymphocyte mediated virus suppression by HIV-1 viral controllers." 2009. Full Text
  - Saunders, KO, Freel, SA, Overman, R, Cunningham, CK, and Tomaras, GD. "Inhibition of histone deacetylases modulates CD8+T-lymphocyte mediated virus suppression by HIV-1 viral controllers." 2009. Full Text Link to Item
  - Shen, X, Dennison, M, Gao, F, Montefiori, D, Verkoczy, L, Haynes, B, Alam, M, and Tomaras, G. "OA021-04. HIV-1 gp41 envelope MPER mutation altered epitope conformation in lipid and increased sensitivity to 2F5 and 4E10 neutralizing antibodies." 2009. Full Text
  - Liu, P, Yates, NL, Haynes, BF, and Tomaras, GD. "HIV-1 Immune Complexes are part of the Initial B cell Response in Acute HIV-1 infection." October 2008. Link to Item
  - Moody, MA, Plonk, MK, Fuller, L, Liao, H, Xia, S, Drinker, MS, Gurley, TC, Scearce, RM, Tomaras, GD, Chang, C, King, S, Kavlie, A, Thorpe, PE, Alam, SM, Chen, PP, Montefiori, DC, and Haynes, BF. "Anti-lipid Human Monoclonal Antibodies Inhibit HIV-1 Infection of PBMC by Binding to Host Cells." October 2008. Link to Item
  - Shen, X, Montefiori, D, Parks, R, Haynes, BF, and Tomaras, GT. "2F5-Like Antibody Identified from an HIV-Infected Patient Concurrent with the Development of Autoimmune Antibodies." October 2008. Link to Item
  - Tomaras, GD, and Taffet, SM. "Transcriptional regulation of the promoter and enhancer regions of TNF-alpha by GABP and NF-kappa B." 1997. Link to Item
- Journal Articles
  - Ackerman, ME, Das, J, Pittala, S, Broge, T, Linde, C, Suscovich, TJ, Brown, EP, Bradley, T, Natarajan, H, Lin, S, Sassic, JK, O'Keefe, S, Mehta, N, Goodman, D, Sips, M, Weiner, JA, Tomaras, GD, Haynes, BF, Lauffenburger, DA, Bailey-Kellogg, C, Roederer, M, and Alter, G. "Route of immunization defines multiple mechanisms of vaccine-mediated protection against SIV." Nature Medicine 24, no. 10 (October 2018): 1590-1598. Full Text
  - Bradley, T, Peppa, D, Pedroza-Pacheco, I, Li, D, Cain, DW, Henao, R, Venkat, V, Hora, B, Chen, Y, Vandergrift, NA, Overman, RG, Edwards, RW, Woods, CW, Tomaras, GD, Ferrari, G, Ginsburg, GS, Connors, M, Cohen, MS, Moody, MA, Borrow, P, and Haynes, BF. "RAB11FIP5 Expression and Altered Natural Killer Cell Function Are Associated with Induction of HIV Broadly Neutralizing Antibody Responses." Cell 175, no. 2 (October 2018): 387-399.e17. Full Text
  - Bar-On, Y, Gruell, H, Schoofs, T, Pai, JA, Nogueira, L, Butler, AL, Millard, K, Lehmann, C, Suárez, I, Oliveira, TY, Karagounis, T, Cohen, YZ, Wyen, C, Scholten, S, Handl, L, Belblidia, S, Dizon, JP, Vehreschild, JJ, Witmer-Pack, M, Shimeliovich, I, Jain, K, Fiddike, K, Seaton, KE, Yates, NL, Horowitz, J, Gulick, RM, Pfeifer, N, Tomaras, GD, Seaman, MS, Fätkenheuer, G, Caskey, M, Klein, F, and Nussenzweig, MC. "Safety and antiviral activity of combination HIV-1 broadly neutralizing antibodies in viremic individuals." Nature Medicine (September 26, 2018). Full Text
  - Mendoza, P, Gruell, H, Nogueira, L, Pai, JA, Butler, AL, Millard, K, Lehmann, C, Suárez, I, Oliveira, TY, Lorenzi, JCC, Cohen, YZ, Wyen, C, Kümmerle, T, Karagounis, T, Lu, C-L, Handl, L, Unson-O'Brien, C, Patel, R, Ruping, C, Schlotz, M, Witmer-Pack, M, Shimeliovich, I, Kremer, G, Thomas, E, Seaton, KE, Horowitz, J, West, AP, Bjorkman, PJ, Tomaras, GD, Gulick, RM, Pfeifer, N, Fätkenheuer, G, Seaman, MS, Klein, F, Caskey, M, and Nussenzweig, MC. "Combination therapy with anti-HIV-1 antibodies maintains viral suppression." Nature 561, no. 7724 (September 26, 2018): 479-484. Full Text
  - Dennison, SM, Reichartz, M, Seaton, KE, Dutta, S, Wille-Reece, U, Hill, AVS, Ewer, KJ, Rountree, W, Sarzotti-Kelsoe, M, Ozaki, DA, Alam, SM, and Tomaras, GD. "Qualified Biolayer Interferometry Avidity Measurements Distinguish the Heterogeneity of Antibody Interactions with Plasmodium falciparum Circumsporozoite Protein Antigens." Journal of Immunology (Baltimore, Md. : 1950) 201, no. 4 (August 2018): 1315-1326. Full Text
  - Singh, S, Ramírez-Salazar, EG, Doueiri, R, Valentin, A, Rosati, M, Hu, X, Keele, BF, Shen, X, Tomaras, GD, Ferrari, G, LaBranche, C, Montefiori, DC, Das, J, Alter, G, Trinh, HV, Hamlin, C, Rao, M, Dayton, F, Bear, J, Chowdhury, B, Alicea, C, Lifson, JD, Broderick, KE, Sardesai, NY, Sivananthan, SJ, Fox, CB, Reed, SG, Venzon, DJ, Hirsch, VM, Pavlakis, GN, and Felber, BK. "Control of Heterologous Simian Immunodeficiency Virus SIVsmE660 Infection by DNA and Protein Coimmunization Regimens Combined with Different Toll-Like-Receptor-4-Based Adjuvants in Macaques." Journal of Virology 92, no. 15 (August 2018). Full Text
  - Barouch, DH, Tomaka, FL, Wegmann, F, Stieh, DJ, Alter, G, Robb, ML, Michael, NL, Peter, L, Nkolola, JP, Borducchi, EN, Chandrashekar, A, Jetton, D, Stephenson, KE, Li, W, Korber, B, Tomaras, GD, Montefiori, DC, Gray, G, Frahm, N, McElrath, MJ, Baden, L, Johnson, J, Hutter, J, Swann, E, Karita, E, Kibuuka, H, Mpendo, J, Garrett, N, Mngadi, K, Chinyenze, K, Priddy, F, Lazarus, E, Laher, F, Nitayapan, S, Pitisuttithum, P, Bart, S, Campbell, T, Feldman, R, Lucksinger, G, Borremans, C, Callewaert, K, Roten, R, Sadoff, J, Scheppler, L, Weijtens, M, Feddes-de Boer, K, van Manen, D, Vreugdenhil, J, Zahn, R, Lavreys, L, Nijs, S, Tolboom, J, Hendriks, J, Euler, Z, Pau, MG, and Schuitemaker, H. "Evaluation of a mosaic HIV-1 vaccine in a multicentre, randomised, double-blind, placebo-controlled, phase 1/2a clinical trial (APPROACH) and in rhesus monkeys (NHP 13-19)." Lancet (London, England) 392, no. 10143 (July 6, 2018): 232-243. Full Text
  - Bekker, L-G, Moodie, Z, Grunenberg, N, Laher, F, Tomaras, GD, Cohen, KW, Allen, M, Malahleha, M, Mngadi, K, Daniels, B, Innes, C, Bentley, C, Frahm, N, Morris, DE, Morris, L, Mkhize, NN, Montefiori, DC, Sarzotti-Kelsoe, M, Grant, S, Yu, C, Mehra, VL, Pensiero, MN, Phogat, S, DiazGranados, CA, Barnett, SW, Kanesa-Thasan, N, Koutsoukos, M, Michael, NL, Robb, ML, Kublin, JG, Gilbert, PB, Corey, L, Gray, GE, McElrath, MJ, and HVTN 100 Protocol Team, . "Subtype C ALVAC-HIV and bivalent subtype C gp120/MF59 HIV-1 vaccine in low-risk, HIV-uninfected, South African adults: a phase 1/2 trial." The Lancet. Hiv 5, no. 7 (July 2018): e366-e378. Full Text
  - Vaccari, M, Fourati, S, Gordon, SN, Brown, DR, Bissa, M, Schifanella, L, Silva de Castro, I, Doster, MN, Galli, V, Omsland, M, Fujikawa, D, Gorini, G, Liyanage, NPM, Trinh, HV, McKinnon, KM, Foulds, KE, Keele, BF, Roederer, M, Koup, RA, Shen, X, Tomaras, GD, Wong, MP, Munoz, KJ, Gach, JS, Forthal, DN, Montefiori, DC, Venzon, DJ, Felber, BK, Rosati, M, Pavlakis, GN, Rao, M, Sekaly, R-P, and Franchini, G. "HIV vaccine candidate activation of hypoxia and the inflammasome in CD14+ monocytes is associated with a decreased risk of SIVmac251 acquisition." Nature Medicine 24, no. 6 (June 2018): 847-856. Full Text
  - Schiffner, T, Pallesen, J, Russell, RA, Dodd, J, de Val, N, LaBranche, CC, Montefiori, D, Tomaras, GD, Shen, X, Harris, SL, Moghaddam, AE, Kalyuzhniy, O, Sanders, RW, McCoy, LE, Moore, JP, Ward, AB, and Sattentau, QJ. "Structural and immunologic correlates of chemically stabilized HIV-1 envelope glycoproteins." Plos Pathogens 14, no. 5 (May 10, 2018): e1006986-null. Full Text
  - Pollara, J, Orlandi, C, Beck, C, Edwards, RW, Hu, Y, Liu, S, Wang, S, Koup, RA, Denny, TN, Lu, S, Tomaras, GD, DeVico, A, Lewis, GK, and Ferrari, G. "Application of area scaling analysis to identify natural killer cell and monocyte involvement in the GranToxiLux antibody dependent cell-mediated cytotoxicity assay." Cytometry. Part a : the Journal of the International Society for Analytical Cytology 93, no. 4 (April 2018): 436-447. Full Text
  - Saunders, KO, Santra, S, Parks, R, Yates, NL, Sutherland, LL, Scearce, RM, Balachandran, H, Bradley, T, Goodman, D, Eaton, A, Stanfield-Oakley, SA, Tartaglia, J, Phogat, S, Pantaleo, G, Esteban, M, Gomez, CE, Perdiguero, B, Jacobs, B, Kibler, K, Korber, B, Montefiori, DC, Ferrari, G, Vandergrift, N, Liao, H-X, Tomaras, GD, and Haynes, BF. "Immunogenicity of NYVAC Prime-Protein Boost Human Immunodeficiency Virus Type 1 Envelope Vaccination and Simian-Human Immunodeficiency Virus Challenge of Nonhuman Primates." Journal of Virology 92, no. 8 (April 2018). Full Text
  - Wills, S, Hwang, K-K, Liu, P, Dennison, SM, Tay, MZ, Shen, X, Pollara, J, Lucas, JT, Parks, R, Rerks-Ngarm, S, Pitisuttithum, P, Nitayapan, S, Kaewkungwal, J, Thomas, R, Kim, JH, Michael, NL, Robb, ML, McRaven, M, Montefiori, DC, Hope, TJ, Liao, H-X, Moody, MA, Ferrari, G, Haynes, BF, Alam, SM, Bonsignori, M, and Tomaras, GD. "HIV-1-Specific IgA Monoclonal Antibodies from an HIV-1 Vaccinee Mediate Galactosylceramide Blocking and Phagocytosis." Journal of Virology 92, no. 7 (April 2018). Full Text
  - Yates, NL, deCamp, AC, Korber, BT, Liao, H-X, Irene, C, Pinter, A, Peacock, J, Harris, LJ, Sawant, S, Hraber, P, Shen, X, Rerks-Ngarm, S, Pitisuttithum, P, Nitayapan, S, Berman, PW, Robb, ML, Pantaleo, G, Zolla-Pazner, S, Haynes, BF, Alam, SM, Montefiori, DC, and Tomaras, GD. "HIV-1 Envelope Glycoproteins from Diverse Clades Differentiate Antibody Responses and Durability among Vaccinees." Journal of Virology 92, no. 8 (April 2018). Full Text
  - Nguyen, QN, Martinez, DR, Himes, JE, Whitney Edwards, R, Han, Q, Kumar, A, Mangan, R, Nicely, NI, Xie, G, Vandergrift, N, Shen, X, Pollara, J, and Permar, SR. "Predominant envelope variable loop 2-specific and gp120-specific antibody-dependent cellular cytotoxicity antibody responses in acutely SIV-infected African green monkeys." Retrovirology 15, no. 1 (March 9, 2018): 24-null. Full Text
  - Fong, Y, Shen, X, Ashley, VC, Deal, A, Seaton, KE, Yu, C, Grant, SP, Ferrari, G, deCamp, AC, Bailer, RT, Koup, RA, Montefiori, D, Haynes, BF, Sarzotti-Kelsoe, M, Graham, BS, Carpp, LN, Hammer, SM, Sobieszczyk, M, Karuna, S, Swann, E, DeJesus, E, Mulligan, M, Frank, I, Buchbinder, S, Novak, RM, McElrath, MJ, Kalams, S, Keefer, M, Frahm, NA, Janes, HE, Gilbert, PB, and Tomaras, GD. "Modification of the Association Between T-Cell Immune Responses and Human Immunodeficiency Virus Type 1 Infection Risk by Vaccine-Induced Antibody Responses in the HVTN 505 Trial." The Journal of Infectious Diseases 217, no. 8 (March 2018): 1280-1288. Full Text
  - Jones, AT, Chamcha, V, Kesavardhana, S, Shen, X, Beaumont, D, Das, R, Wyatt, LS, LaBranche, CC, Stanfield-Oakley, S, Ferrari, G, Montefiori, DC, Moss, B, Tomaras, GD, Varadarajan, R, and Amara, RR. "A Trimeric HIV-1 Envelope gp120 Immunogen Induces Potent and Broad Anti-V1V2 Loop Antibodies against HIV-1 in Rabbits and Rhesus Macaques." Journal of Virology 92, no. 5 (March 2018). Full Text
  - Blasi, M, Negri, D, LaBranche, C, Alam, SM, Baker, EJ, Brunner, EC, Gladden, MA, Michelini, Z, Vandergrift, NA, Wiehe, KJ, Parks, R, Shen, X, Bonsignori, M, Tomaras, GD, Ferrari, G, Montefiori, DC, Santra, S, Haynes, BF, Moody, MA, Cara, A, and Klotman, ME. "IDLV-HIV-1 Env vaccination in non-human primates induces affinity maturation of antigen-specific memory B cells." Communications Biology 1 (January 2018): 134-null. Full Text
  - McGuire, EP, Fong, Y, Toote, C, Cunningham, CK, McFarland, EJ, Borkowsky, W, Barnett, S, Itell, HL, Kumar, A, Gray, G, McElrath, MJ, Tomaras, GD, Permar, SR, and Fouda, GG. "HIV-Exposed Infants Vaccinated with an MF59/Recombinant gp120 Vaccine Have Higher-Magnitude Anti-V1V2 IgG Responses than Adults Immunized with the Same Vaccine." Journal of Virology 92, no. 1 (January 2018). Full Text
  - Vaidya, NK, Ribeiro, RM, Liu, P, Haynes, BF, Tomaras, GD, and Perelson, AS. "Correlation Between Anti-gp41 Antibodies and Virus Infectivity Decay During Primary HIV-1 Infection." Frontiers in Microbiology 9 (January 2018): 1326-null. Full Text
  - Wen, Y, Trinh, HV, Linton, CE, Tani, C, Norais, N, Martinez-Guzman, D, Ramesh, P, Sun, Y, Situ, F, Karaca-Griffin, S, Hamlin, C, Onkar, S, Tian, S, Hilt, S, Malyala, P, Lodaya, R, Li, N, Otten, G, Palladino, G, Friedrich, K, Aggarwal, Y, LaBranche, C, Duffy, R, Shen, X, Tomaras, GD, Montefiori, DC, Fulp, W, Gottardo, R, Burke, B, Ulmer, JB, Zolla-Pazner, S, Liao, H-X, Haynes, BF, Michael, NL, Kim, JH, Rao, M, O'Connell, RJ, Carfi, A, and Barnett, SW. "Generation and characterization of a bivalent protein boost for future clinical trials: HIV-1 subtypes CR01_AE and B gp120 antigens with a potent adjuvant." Plos One 13, no. 4 (January 2018): e0194266-null. Full Text
  - Seaton, KE, Vandergrift, NA, Deal, AW, Rountree, W, Bainbridge, J, Grebe, E, Anderson, DA, Sawant, S, Shen, X, Yates, NL, Denny, TN, Liao, H-X, Haynes, BF, Robb, ML, Parkin, N, Santos, BR, Garrett, N, Price, MA, Naniche, D, Duerr, AC, CEPHIA group, , Keating, S, Hampton, D, Facente, S, Marson, K, Welte, A, Pilcher, CD, Cohen, MS, and Tomaras, GD. "Computational analysis of antibody dynamics identifies recent HIV-1 infection." JCI insight 2, no. 24 (December 21, 2017). Full Text
  - Saunders, KO, Verkoczy, LK, Jiang, C, Zhang, J, Parks, R, Chen, H, Housman, M, Bouton-Verville, H, Shen, X, Trama, AM, Scearce, R, Sutherland, L, Santra, S, Newman, A, Eaton, A, Xu, K, Georgiev, IS, Joyce, MG, Tomaras, GD, Bonsignori, M, Reed, SG, Salazar, A, Mascola, JR, Moody, MA, Cain, DW, Centlivre, M, Zurawski, S, Zurawski, G, Erickson, HP, Kwong, PD, Alam, SM, Levy, Y, Montefiori, DC, and Haynes, BF. "Vaccine Induction of Heterologous Tier 2 HIV-1 Neutralizing Antibodies in Animal Models." Cell Reports 21, no. 13 (December 2017): 3681-3690. Full Text
  - Shen, X, Basu, R, Sawant, S, Beaumont, D, Kwa, SF, LaBranche, C, Seaton, KE, Yates, NL, Montefiori, DC, Ferrari, G, Wyatt, LS, Moss, B, Alam, SM, Haynes, BF, Tomaras, GD, and Robinson, HL. "HIV-1 gp120 and Modified Vaccinia Virus Ankara (MVA) gp140 Boost Immunogens Increase Immunogenicity of a DNA/MVA HIV-1 Vaccine." Journal of Virology 91, no. 24 (December 2017). Full Text
  - Francica, JR, Zak, DE, Linde, C, Siena, E, Johnson, C, Juraska, M, Yates, NL, Gunn, B, De Gregorio, E, Flynn, BJ, Valiante, NM, Malyala, P, Barnett, SW, Sarkar, P, Singh, M, Jain, S, Ackerman, M, Alam, M, Ferrari, G, Tomaras, GD, O'Hagan, DT, Aderem, A, Alter, G, and Seder, RA. "Innate transcriptional effects by adjuvants on the magnitude, quality, and durability of HIV envelope responses in NHPs." Blood Advances 1, no. 25 (November 17, 2017): 2329-2342. Full Text
  - Mayer, KH, Seaton, KE, Huang, Y, Grunenberg, N, Isaacs, A, Allen, M, Ledgerwood, JE, Frank, I, Sobieszczyk, ME, Baden, LR, Rodriguez, B, Van Tieu, H, Tomaras, GD, Deal, A, Goodman, D, Bailer, RT, Ferrari, G, Jensen, R, Hural, J, Graham, BS, Mascola, JR, Corey, L, Montefiori, DC, HVTN 104 Protocol Team, , and and the NIAID HIV Vaccine Trials Network, . "Safety, pharmacokinetics, and immunological activities of multiple intravenous or subcutaneous doses of an anti-HIV monoclonal antibody, VRC01, administered to HIV-uninfected adults: Results of a phase 1 randomized trial." Plos Medicine 14, no. 11 (November 14, 2017): e1002435-null. Full Text
  - Li, SS, Kochar, NK, Elizaga, M, Hay, CM, Wilson, GJ, Cohen, KW, De Rosa, SC, Xu, R, Ota-Setlik, A, Morris, D, Finak, G, Allen, M, Tieu, H-V, Frank, I, Sobieszczyk, ME, Hannaman, D, Gottardo, R, Gilbert, PB, Tomaras, GD, Corey, L, Clarke, DK, Egan, MA, Eldridge, JH, McElrath, MJ, Frahm, N, and NIAID HIV Vaccine Trials Network, . "DNA Priming Increases Frequency of T-Cell Responses to a Vesicular Stomatitis Virus HIV Vaccine with Specific Enhancement of CD8+ T-Cell Responses by Interleukin-12 Plasmid DNA." Clinical and Vaccine Immunology : Cvi 24, no. 11 (November 6, 2017). Full Text
  - Han, Q, Williams, WB, Saunders, KO, Seaton, KE, Wiehe, KJ, Vandergrift, N, Von Holle, TA, Trama, AM, Parks, RJ, Luo, K, Gurley, TC, Kepler, TB, Marshall, DJ, Montefiori, DC, Sutherland, LL, Alam, MS, Whitesides, JF, Bowman, CM, Permar, SR, Graham, BS, Mascola, JR, Seed, PC, Van Rompay, KKA, Tomaras, GD, Moody, MA, and Haynes, BF. "HIV DNA-Adenovirus Multiclade Envelope Vaccine Induces gp41 Antibody Immunodominance in Rhesus Macaques." Journal of Virology 91, no. 21 (November 2017). Full Text
  - Shen, X, Bogers, WM, Yates, NL, Ferrari, G, Dey, AK, Williams, WT, Jaeger, FH, Wiehe, K, Sawant, S, Alam, SM, LaBranche, CC, Montefiori, DC, Martin, L, Srivastava, I, Heeney, J, Barnett, SW, and Tomaras, GD. "Cross-Linking of a CD4-Mimetic Miniprotein with HIV-1 Env gp140 Alters Kinetics and Specificities of Antibody Responses against HIV-1 Env in Macaques." Journal of Virology 91, no. 19 (October 2017). Full Text
  - Wang, K, Tomaras, GD, Jegaskanda, S, Moody, MA, Liao, H-X, Goodman, KN, Berman, PW, Rerks-Ngarm, S, Pitisuttithum, P, Nitayapan, S, Kaewkungwal, J, Haynes, BF, and Cohen, JI. "Monoclonal Antibodies, Derived from Humans Vaccinated with the RV144 HIV Vaccine Containing the HVEM Binding Domain of Herpes Simplex Virus (HSV) Glycoprotein D, Neutralize HSV Infection, Mediate Antibody-Dependent Cellular Cytotoxicity, and Protect Mice from Ocular Challenge with HSV-1." Journal of Virology 91, no. 19 (October 2017). Full Text
  - Meyerhoff, RR, Scearce, RM, Ogburn, DF, Lockwood, B, Pickeral, J, Kuraoka, M, Anasti, K, Eudailey, J, Eaton, A, Cooper, M, Wiehe, K, Montefiori, DC, Tomaras, G, Ferrari, G, Alam, SM, Liao, H-X, Korber, B, Gao, F, and Haynes, BF. "HIV-1 Consensus Envelope-Induced Broadly Binding Antibodies." Aids Research and Human Retroviruses 33, no. 8 (August 2017): 859-868. Full Text
  - Heit, A, Schmitz, F, Gerdts, S, Flach, B, Moore, MS, Perkins, JA, Robins, HS, Aderem, A, Spearman, P, Tomaras, GD, De Rosa, SC, and McElrath, MJ. "Vaccination establishes clonal relatives of germinal center T cells in the blood of humans." The Journal of Experimental Medicine 214, no. 7 (July 2017): 2139-2152. Full Text
  - Bradley, T, Pollara, J, Santra, S, Vandergrift, N, Pittala, S, Bailey-Kellogg, C, Shen, X, Parks, R, Goodman, D, Eaton, A, Balachandran, H, Mach, LV, Saunders, KO, Weiner, JA, Scearce, R, Sutherland, LL, Phogat, S, Tartaglia, J, Reed, SG, Hu, S-L, Theis, JF, Pinter, A, Montefiori, DC, Kepler, TB, Peachman, KK, Rao, M, Michael, NL, Suscovich, TJ, Alter, G, Ackerman, ME, Moody, MA, Liao, H-X, Tomaras, G, Ferrari, G, Korber, BT, and Haynes, BF. "Pentavalent HIV-1 vaccine protects against simian-human immunodeficiency virus challenge." Nature Communications 8 (June 8, 2017): 15711-null. Full Text
  - García-Arriaza, J, Perdiguero, B, Heeney, JL, Seaman, MS, Montefiori, DC, Yates, NL, Tomaras, GD, Ferrari, G, Foulds, KE, Roederer, M, Self, SG, Borate, B, Gottardo, R, Phogat, S, Tartaglia, J, Barnett, SW, Burke, B, Cristillo, AD, Weiss, DE, Lee, C, Kibler, KV, Jacobs, BL, Wagner, R, Ding, S, Pantaleo, G, and Esteban, M. "HIV/AIDS Vaccine Candidates Based on Replication-Competent Recombinant Poxvirus NYVAC-C-KC Expressing Trimeric gp140 and Gag-Derived Virus-Like Particles or Lacking the Viral Molecule B19 That Inhibits Type I Interferon Activate Relevant HIV-1-Specific B and T Cell Immune Functions in Nonhuman Primates." Journal of Virology 91, no. 9 (May 2017). Full Text
  - Martinez, DR, Vandergrift, N, Douglas, AO, McGuire, E, Bainbridge, J, Nicely, NI, Montefiori, DC, Tomaras, GD, Fouda, GG, and Permar, SR. "Maternal Binding and Neutralizing IgG Responses Targeting the C-Terminal Region of the V3 Loop Are Predictive of Reduced Peripartum HIV-1 Transmission Risk." Journal of virology 91, no. 9 (May 2017). Full Text
  - Zurawski, G, Shen, X, Zurawski, S, Tomaras, GD, Montefiori, DC, Roederer, M, Ferrari, G, Lacabaratz, C, Klucar, P, Wang, Z, Foulds, KE, Kao, S-F, Yu, X, Sato, A, Yates, NL, LaBranche, C, Stanfield-Oakley, S, Kibler, K, Jacobs, B, Salazar, A, Self, S, Fulp, W, Gottardo, R, Galmin, L, Weiss, D, Cristillo, A, Pantaleo, G, and Levy, Y. "Superiority in Rhesus Macaques of Targeting HIV-1 Env gp140 to CD40 versus LOX-1 in Combination with Replication-Competent NYVAC-KC for Induction of Env-Specific Antibody and T Cell Responses." Journal of Virology 91, no. 9 (May 2017). Full Text
  - Rerks-Ngarm, S, Pitisuttithum, P, Excler, J-L, Nitayaphan, S, Kaewkungwal, J, Premsri, N, Kunasol, P, Karasavvas, N, Schuetz, A, Ngauy, V, Sinangil, F, Dawson, P, deCamp, AC, Phogat, S, Garunathan, S, Tartaglia, J, DiazGranados, C, Ratto-Kim, S, Pegu, P, Eller, M, Karnasuta, C, Montefiori, DC, Sawant, S, Vandergrift, N, Wills, S, Tomaras, GD, Robb, ML, Michael, NL, Kim, JH, Vasan, S, O'Connell, RJ, and RV305 Study Team, . "Randomized, Double-Blind Evaluation of Late Boost Strategies for HIV-Uninfected Vaccine Recipients in the RV144 HIV Vaccine Efficacy Trial." The Journal of Infectious Diseases 215, no. 8 (April 2017): 1255-1263. Full Text
  - Ferrari, G, Pollara, J, Tomaras, GD, and Haynes, BF. "Humoral and Innate Antiviral Immunity as Tools to Clear Persistent HIV Infection." The Journal of Infectious Diseases 215, no. suppl_3 (March 2017): S152-S159. (Review) Full Text
  - Galarza-Muñoz, G, Briggs, FBS, Evsyukova, I, Schott-Lerner, G, Kennedy, EM, Nyanhete, T, Wang, L, Bergamaschi, L, Widen, SG, Tomaras, GD, Ko, DC, Bradrick, SS, Barcellos, LF, Gregory, SG, and Garcia-Blanco, MA. "Human Epistatic Interaction Controls IL7R Splicing and Increases Multiple Sclerosis Risk." Cell 169, no. 1 (March 2017): 72-84.e13. Full Text
  - Easterhoff, D, Moody, MA, Fera, D, Cheng, H, Ackerman, M, Wiehe, K, Saunders, KO, Pollara, J, Vandergrift, N, Parks, R, Kim, J, Michael, NL, O'Connell, RJ, Excler, J-L, Robb, ML, Vasan, S, Rerks-Ngarm, S, Kaewkungwal, J, Pitisuttithum, P, Nitayaphan, S, Sinangil, F, Tartaglia, J, Phogat, S, Kepler, TB, Alam, SM, Liao, H-X, Ferrari, G, Seaman, MS, Montefiori, DC, Tomaras, GD, Harrison, SC, and Haynes, BF. "Boosting of HIV envelope CD4 binding site antibodies with long variable heavy third complementarity determining region in the randomized double blind RV305 HIV-1 vaccine trial." Plos Pathogens 13, no. 2 (February 24, 2017): e1006182-null. Full Text
  - Huang, Y, Zhang, L, Janes, H, Frahm, N, Isaacs, A, Kim, JH, Montefiori, D, McElrath, MJ, Tomaras, GD, and Gilbert, PB. "Predictors of durable immune responses six months after the last vaccination in preventive HIV vaccine trials." Vaccine 35, no. 8 (February 2017): 1184-1193. Full Text
  - Saunders, KO, Nicely, NI, Wiehe, K, Bonsignori, M, Meyerhoff, RR, Parks, R, Walkowicz, WE, Aussedat, B, Wu, NR, Cai, F, Vohra, Y, Park, PK, Eaton, A, Go, EP, Sutherland, LL, Scearce, RM, Barouch, DH, Zhang, R, Von Holle, T, Overman, RG, Anasti, K, Sanders, RW, Moody, MA, Kepler, TB, Korber, B, Desaire, H, Santra, S, Letvin, NL, Nabel, GJ, Montefiori, DC, Tomaras, GD, Liao, H-X, Alam, SM, Danishefsky, SJ, and Haynes, BF. "Vaccine Elicitation of High Mannose-Dependent Neutralizing Antibodies against the V3-Glycan Broadly Neutralizing Epitope in Nonhuman Primates." Cell Reports 18, no. 9 (February 2017): 2175-2188. Full Text
  - Wiehe, K, Nicely, NI, Lockwood, B, Kuraoka, M, Anasti, K, Arora, S, Bowman, CM, Stolarchuk, C, Parks, R, Lloyd, KE, Xia, S-M, Duffy, R, Shen, X, Kyratsous, CA, Macdonald, LE, Murphy, AJ, Scearce, RM, Moody, MA, Alam, SM, Verkoczy, L, Tomaras, GD, Kelsoe, G, and Haynes, BF. "Immunodominance of Antibody Recognition of the HIV Envelope V2 Region in Ig-Humanized Mice." Journal of Immunology (Baltimore, Md. : 1950) 198, no. 3 (February 2017): 1047-1055. Full Text
  - Chang, WLW, Gonzalez, DF, Kieu, HT, Castillo, LD, Messaoudi, I, Shen, X, Tomaras, GD, Shacklett, BL, Barry, PA, and Sparger, EE. "Changes in Circulating B Cell Subsets Associated with Aging and Acute SIV Infection in Rhesus Macaques." Plos One 12, no. 1 (January 17, 2017): e0170154-null. Full Text
  - Bolton, DL, Song, K, Tomaras, GD, Rao, S, and Roederer, M. "Unique cellular and humoral immunogenicity profiles generated by aerosol, intranasal, or parenteral vaccination in rhesus macaques." Vaccine 35, no. 4 (January 2017): 639-646. Full Text
  - Buchbinder, SP, Grunenberg, NA, Sanchez, BJ, Seaton, KE, Ferrari, G, Moody, MA, Frahm, N, Montefiori, DC, Hay, CM, Goepfert, PA, Baden, LR, Robinson, HL, Yu, X, Gilbert, PB, McElrath, MJ, Huang, Y, Tomaras, GD, and HIV Vaccine Trials Network (HVTN) 094 Study Group, . "Immunogenicity of a novel Clade B HIV-1 vaccine combination: Results of phase 1 randomized placebo controlled trial of an HIV-1 GM-CSF-expressing DNA prime with a modified vaccinia Ankara vaccine boost in healthy HIV-1 uninfected adults." Plos One 12, no. 7 (January 2017): e0179597-null. Full Text
  - Gilbert, PB, Excler, J-L, Tomaras, GD, Carpp, LN, Haynes, BF, Liao, H-X, Montefiori, DC, Rerks-Ngarm, S, Pitisuttithum, P, Nitayaphan, S, Kaewkungwal, J, Kijak, GH, Tovanabutra, S, Francis, DP, Lee, C, Sinangil, F, Berman, PW, Premsri, N, Kunasol, P, O'Connell, RJ, Michael, NL, Robb, ML, Morrow, R, Corey, L, and Kim, JH. "Antibody to HSV gD peptide induced by vaccination does not protect against HSV-2 infection in HSV-2 seronegative women." PloS one 12, no. 5 (January 2017): e0176428-. Full Text
  - Ramesh, A, Darko, S, Hua, A, Overman, G, Ransier, A, Francica, JR, Trama, A, Tomaras, GD, Haynes, BF, Douek, DC, and Kepler, TB. "Structure and Diversity of the Rhesus Macaque Immunoglobulin Loci through Multiple De Novo Genome Assemblies." Frontiers in immunology 8 (January 2017): 1407-. Full Text
  - Tomaras, GD, and Plotkin, SA. "Complex immune correlates of protection in HIV-1 vaccine efficacy trials." Immunological Reviews 275, no. 1 (January 2017): 245-261. (Review) Full Text
  - Williams, LD, Ofek, G, Schätzle, S, McDaniel, JR, Lu, X, Nicely, NI, Wu, L, Lougheed, CS, Bradley, T, Louder, MK, McKee, K, Bailer, RT, O'Dell, S, Georgiev, IS, Seaman, MS, Parks, RJ, Marshall, DJ, Anasti, K, Yang, G, Nie, X, Tumba, NL, Wiehe, K, Wagh, K, Korber, B, Kepler, TB, Munir Alam, S, Morris, L, Kamanga, G, Cohen, MS, Bonsignori, M, Xia, S-M, Montefiori, DC, Kelsoe, G, Gao, F, Mascola, JR, Moody, MA, Saunders, KO, Liao, H-X, Tomaras, GD, Georgiou, G, and Haynes, BF. "Potent and broad HIV-neutralizing antibodies in memory B cells and plasma." Science Immunology 2, no. 7 (January 2017). Full Text
  - deCamp, AC, Rolland, M, Edlefsen, PT, Sanders-Buell, E, Hall, B, Magaret, CA, Fiore-Gartland, AJ, Juraska, M, Carpp, LN, Karuna, ST, Bose, M, LePore, S, Miller, S, O'Sullivan, A, Poltavee, K, Bai, H, Dommaraju, K, Zhao, H, Wong, K, Chen, L, Ahmed, H, Goodman, D, Tay, MZ, Gottardo, R, Koup, RA, Bailer, R, Mascola, JR, Graham, BS, Roederer, M, O'Connell, RJ, Michael, NL, Robb, ML, Adams, E, D'Souza, P, Kublin, J, Corey, L, Geraghty, DE, Frahm, N, Tomaras, GD, McElrath, MJ, Frenkel, L, Styrchak, S, Tovanabutra, S, Sobieszczyk, ME, Hammer, SM, Kim, JH, Mullins, JI, and Gilbert, PB. "Sieve analysis of breakthrough HIV-1 sequences in HVTN 505 identifies vaccine pressure targeting the CD4 binding site of Env-gp120." Plos One 12, no. 11 (January 2017): e0185959-null. Full Text
  - Luo, K, Liao, H-X, Zhang, R, Easterhoff, D, Wiehe, K, Gurley, TC, Armand, LC, Allen, AA, Von Holle, TA, Marshall, DJ, Whitesides, JF, Pritchett, J, Foulger, A, Hernandez, G, Parks, R, Lloyd, KE, Stolarchuk, C, Sawant, S, Peel, J, Yates, NL, Dunford, E, Arora, S, Wang, A, Bowman, CM, Sutherland, LL, Scearce, RM, Xia, S-M, Bonsignori, M, Pollara, J, Edwards, RW, Santra, S, Letvin, NL, Tartaglia, J, Francis, D, Sinangil, F, Lee, C, Kaewkungwal, J, Nitayaphan, S, Pitisuttithum, P, Rerks-Ngarm, S, Michael, NL, Kim, JH, Alam, SM, Vandergrift, NA, Ferrari, G, Montefiori, DC, Tomaras, GD, Haynes, BF, and Moody, MA. "Tissue memory B cell repertoire analysis after ALVAC/AIDSVAX B/E gp120 immunization of rhesus macaques." Jci Insight 1, no. 20 (December 8, 2016): e88522-null. Full Text
  - Astronomo, RD, Santra, S, Ballweber-Fleming, L, Westerberg, KG, Mach, L, Hensley-McBain, T, Sutherland, L, Mildenberg, B, Morton, G, Yates, NL, Mize, GJ, Pollara, J, Hladik, F, Ochsenbauer, C, Denny, TN, Warrier, R, Rerks-Ngarm, S, Pitisuttithum, P, Nitayapan, S, Kaewkungwal, J, Ferrari, G, Shaw, GM, Xia, S-M, Liao, H-X, Montefiori, DC, Tomaras, GD, Haynes, BF, and McElrath, JM. "Neutralization Takes Precedence Over IgG or IgA Isotype-related Functions in Mucosal HIV-1 Antibody-mediated Protection." Ebiomedicine 14 (December 2016): 97-111. Full Text Open Access Copy
  - Ferrari, G, Haynes, BF, Koenig, S, Nordstrom, JL, Margolis, DM, and Tomaras, GD. "Envelope-specific antibodies and antibody-derived molecules for treating and curing HIV infection." Nature Reviews. Drug Discovery 15, no. 12 (December 2016): 823-834. (Review) Full Text
  - Negri, D, Blasi, M, LaBranche, C, Parks, R, Balachandran, H, Lifton, M, Shen, X, Denny, T, Ferrari, G, Vescio, MF, Andersen, H, Montefiori, DC, Tomaras, GD, Liao, H-X, Santra, S, Haynes, BF, Klotman, ME, and Cara, A. "Immunization with an SIV-based IDLV Expressing HIV-1 Env 1086 Clade C Elicits Durable Humoral and Cellular Responses in Rhesus Macaques." Molecular Therapy : the Journal of the American Society of Gene Therapy 24, no. 11 (November 2016): 2021-2032. Full Text Open Access Copy
  - Negri, D, Blasi, M, LaBranche, C, Parks, R, Balachandran, H, Lifton, M, Shen, X, Denny, T, Ferrari, G, Vescio, MF, Andersen, H, Montefiori, DC, Tomaras, GD, Liao, H-X, Santra, S, Haynes, BF, Klotman, ME, and Cara, A. "Immunization with an SIV-based IDLV Expressing HIV-1 Env 1086 Clade C Elicits Durable Humoral and Cellular Responses in Rhesus Macaques." MOLECULAR THERAPY 24, no. 11 (November 2016): 2021-2032. Full Text Open Access Copy Link to Item
  - Andersson, A-MC, Ragonnaud, E, Seaton, KE, Sawant, S, Folgori, A, Colloca, S, Labranche, C, Montefiori, DC, Tomaras, GD, and Holst, PJ. "Effect of HIV-1 envelope cytoplasmic tail on adenovirus primed virus encoded virus-like particle immunizations." Vaccine 34, no. 44 (October 2016): 5344-5351. Full Text
  - Gordon, SN, Liyanage, NPM, Doster, MN, Vaccari, M, Vargas-Inchaustegui, DA, Pegu, P, Schifanella, L, Shen, X, Tomaras, GD, Rao, M, Billings, EA, Schwartz, J, Prado, I, Bobb, K, Zhang, W, Montefiori, DC, Foulds, KE, Ferrari, G, Robert-Guroff, M, Roederer, M, Phan, TB, Forthal, DN, Stablein, DM, Phogat, S, Venzon, DJ, Fouts, T, and Franchini, G. "Boosting of ALVAC-SIV Vaccine-Primed Macaques with the CD4-SIVgp120 Fusion Protein Elicits Antibodies to V2 Associated with a Decreased Risk of SIVmac251 Acquisition." Journal of Immunology (Baltimore, Md. : 1950) 197, no. 7 (October 2016): 2726-2737. Full Text
  - Iyer, SS, Gangadhara, S, Victor, B, Shen, X, Chen, X, Nabi, R, Kasturi, SP, Sabula, MJ, Labranche, CC, Reddy, PBJ, Tomaras, GD, Montefiori, DC, Moss, B, Spearman, P, Pulendran, B, Kozlowski, PA, and Amara, RR. "Virus-Like Particles Displaying Trimeric Simian Immunodeficiency Virus (SIV) Envelope gp160 Enhance the Breadth of DNA/Modified Vaccinia Virus Ankara SIV Vaccine-Induced Antibody Responses in Rhesus Macaques." Journal of Virology 90, no. 19 (October 2016): 8842-8854. Full Text
  - Safrit, JT, Tomaras, GD, Hanke, T, deCamp, AC, and Voronin, Y. "The Landscape of Targeted Immune Responses in the HIV-1 Vaccine Field." Aids Research and Human Retroviruses 32, no. 10-11 (October 2016): 944-946. (Letter) Full Text
  - Townsley, S, Mohamed, Z, Guo, W, McKenna, J, Cleveland, B, LaBranche, C, Beaumont, D, Shen, X, Yates, NL, Pinter, A, Tomaras, GD, Ferrari, G, Montefiori, DC, and Hu, S-L. "Induction of Heterologous Tier 2 HIV-1-Neutralizing and Cross-Reactive V1/V2-Specific Antibodies in Rabbits by Prime-Boost Immunization." Journal of Virology 90, no. 19 (October 2016): 8644-8660. Full Text
  - Vaccari, M, Gordon, SN, Fourati, S, Schifanella, L, Liyanage, NPM, Cameron, M, Keele, BF, Shen, X, Tomaras, GD, Billings, E, Rao, M, Chung, AW, Dowell, KG, Bailey-Kellogg, C, Brown, EP, Ackerman, ME, Vargas-Inchaustegui, DA, Whitney, S, Doster, MN, Binello, N, Pegu, P, Montefiori, DC, Foulds, K, Quinn, DS, Donaldson, M, Liang, F, Loré, K, Roederer, M, Koup, RA, McDermott, A, Ma, Z-M, Miller, CJ, Phan, TB, Forthal, DN, Blackburn, M, Caccuri, F, Bissa, M, Ferrari, G, Kalyanaraman, V, Ferrari, MG, Thompson, D, Robert-Guroff, M, Ratto-Kim, S, Kim, JH, Michael, NL, Phogat, S, Barnett, SW, Tartaglia, J, Venzon, D, Stablein, DM, Alter, G, Sekaly, R-P, and Franchini, G. "Corrigendum: Adjuvant-dependent innate and adaptive immune signatures of risk of SIVmac251 acquisition." Nature Medicine 22, no. 10 (October 2016): 1192-null. Full Text
  - Tay, MZ, Liu, P, Williams, LD, McRaven, MD, Sawant, S, Gurley, TC, Xu, TT, Dennison, SM, Liao, H-X, Chenine, A-L, Alam, SM, Moody, MA, Hope, TJ, Haynes, BF, and Tomaras, GD. "Antibody-Mediated Internalization of Infectious HIV-1 Virions Differs among Antibody Isotypes and Subclasses." Plos Pathogens 12, no. 8 (August 31, 2016): e1005817-null. Full Text
  - Abdulhaqq, SA, Zorrilla, C, Kang, G, Yin, X, Tamayo, V, Seaton, KE, Joseph, J, Garced, S, Tomaras, GD, Linn, KA, Foulkes, AS, Azzoni, L, VerMilyea, M, Coutifaris, C, Kossenkov, AV, Showe, L, Kraiselburd, EN, Li, Q, and Montaner, LJ. "HIV-1-negative female sex workers sustain high cervical IFNɛ, low immune activation, and low expression of HIV-1-required host genes." Mucosal Immunology 9, no. 4 (July 2016): 1027-1038. Full Text
  - Vaccari, M, Gordon, SN, Fourati, S, Schifanella, L, Liyanage, NPM, Cameron, M, Keele, BF, Shen, X, Tomaras, GD, Billings, E, Rao, M, Chung, AW, Dowell, KG, Bailey-Kellogg, C, Brown, EP, Ackerman, ME, Vargas-Inchaustegui, DA, Whitney, S, Doster, MN, Binello, N, Pegu, P, Montefiori, DC, Foulds, K, Quinn, DS, Donaldson, M, Liang, F, Loré, K, Roederer, M, Koup, RA, McDermott, A, Ma, Z-M, Miller, CJ, Phan, TB, Forthal, DN, Blackburn, M, Caccuri, F, Bissa, M, Ferrari, G, Kalyanaraman, V, Ferrari, MG, Thompson, D, Robert-Guroff, M, Ratto-Kim, S, Kim, JH, Michael, NL, Phogat, S, Barnett, SW, Tartaglia, J, Venzon, D, Stablein, DM, Alter, G, Sekaly, R-P, and Franchini, G. "Adjuvant-dependent innate and adaptive immune signatures of risk of SIVmac251 acquisition." Nature Medicine 22, no. 7 (July 2016): 762-770. Full Text
  - Gray, GE, Mayer, KH, Elizaga, ML, Bekker, L-G, Allen, M, Morris, L, Montefiori, D, De Rosa, SC, Sato, A, Gu, N, Tomaras, GD, Tucker, T, Barnett, SW, Mkhize, NN, Shen, X, Downing, K, Williamson, C, Pensiero, M, Corey, L, and Williamson, A-L. "Subtype C gp140 Vaccine Boosts Immune Responses Primed by the South African AIDS Vaccine Initiative DNA-C2 and MVA-C HIV Vaccines after More than a 2-Year Gap." Clinical and Vaccine Immunology : Cvi 23, no. 6 (June 6, 2016): 496-506. Full Text
  - Le Grand, R, Dereuddre-Bosquet, N, Dispinseri, S, Gosse, L, Desjardins, D, Shen, X, Tolazzi, M, Ochsenbauer, C, Saidi, H, Tomaras, G, Prague, M, Barnett, SW, Thiebaut, R, Cope, A, Scarlatti, G, and Shattock, RJ. "Superior Efficacy of a Human Immunodeficiency Virus Vaccine Combined with Antiretroviral Prevention in Simian-Human Immunodeficiency Virus-Challenged Nonhuman Primates." Journal of Virology 90, no. 11 (June 2016): 5315-5328. Full Text
  - Li, H, Wang, S, Kong, R, Ding, W, Lee, F-H, Parker, Z, Kim, E, Learn, GH, Hahn, P, Policicchio, B, Brocca-Cofano, E, Deleage, C, Hao, X, Chuang, G-Y, Gorman, J, Gardner, M, Lewis, MG, Hatziioannou, T, Santra, S, Apetrei, C, Pandrea, I, Alam, SM, Liao, H-X, Shen, X, Tomaras, GD, Farzan, M, Chertova, E, Keele, BF, Estes, JD, Lifson, JD, Doms, RW, Montefiori, DC, Haynes, BF, Sodroski, JG, Kwong, PD, Hahn, BH, and Shaw, GM. "Envelope residue 375 substitutions in simian-human immunodeficiency viruses enhance CD4 binding and replication in rhesus macaques." Proceedings of the National Academy of Sciences of the United States of America 113, no. 24 (June 2016): E3413-E3422. Full Text
  - O'Connell, RJ, Excler, J-L, Polonis, VR, Ratto-Kim, S, Cox, J, Jagodzinski, LL, Liu, M, Wieczorek, L, McNeil, JG, El-Habib, R, Michael, NL, Gilliam, BL, Paris, R, VanCott, TC, Tomaras, GD, Birx, DL, Robb, ML, and Kim, JH. "Safety and Immunogenicity of a Randomized Phase 1 Prime-Boost Trial With ALVAC-HIV (vCP205) and Oligomeric Glycoprotein 160 From HIV-1 Strains MN and LAI-2 Adjuvanted in Alum or Polyphosphazene." The Journal of infectious diseases 213, no. 12 (June 2016): 1946-1954. Full Text
  - Archary, D, Seaton, KE, Passmore, JS, Werner, L, Deal, A, Dunphy, LJ, Arnold, KB, Yates, NL, Lauffenburger, DA, Bergin, P, Liebenberg, LJ, Samsunder, N, Mureithi, MW, Altfeld, M, Garrett, N, Abdool Karim, Q, Abdool Karim, SS, Morris, L, and Tomaras, GD. "Erratum: Distinct genital tract HIV-specific antibody profiles associated with tenofovir gel." Mucosal Immunology 9, no. 3 (May 2016): 834-834. Full Text
  - Archary, D, Seaton, KE, Passmore, JS, Werner, L, Deal, A, Dunphy, LJ, Arnold, KB, Yates, NL, Lauffenburger, DA, Bergin, P, Liebenberg, LJ, Samsunder, N, Mureithi, MW, Altfeld, M, Garrett, N, Karim, QA, Karim, SA, Morris, L, and Tomaras, GD. "Distinct genital tract HIV-specific antibody profiles associated with tenofovir gel." Mucosal immunology 9, no. 3 (May 2016): 821-833. Full Text
  - Nelson, CS, Pollara, J, Kunz, EL, Jeffries, TL, Duffy, R, Beck, C, Stamper, L, Wang, M, Shen, X, Pickup, DJ, Staats, HF, Hudgens, MG, Kepler, TB, Montefiori, DC, Moody, MA, Tomaras, GD, Liao, H-X, Haynes, BF, Ferrari, G, Fouda, GGA, and Permar, SR. "Combined HIV-1 Envelope Systemic and Mucosal Immunization of Lactating Rhesus Monkeys Induces a Robust Immunoglobulin A Isotype B Cell Response in Breast Milk." Journal of Virology 90, no. 10 (May 2016): 4951-4965. Full Text
  - Asbach, B, Kliche, A, Köstler, J, Perdiguero, B, Esteban, M, Jacobs, BL, Montefiori, DC, LaBranche, CC, Yates, NL, Tomaras, GD, Ferrari, G, Foulds, KE, Roederer, M, Landucci, G, Forthal, DN, Seaman, MS, Hawkins, N, Self, SG, Sato, A, Gottardo, R, Phogat, S, Tartaglia, J, Barnett, SW, Burke, B, Cristillo, AD, Weiss, DE, Francis, J, Galmin, L, Ding, S, Heeney, JL, Pantaleo, G, and Wagner, R. "Potential To Streamline Heterologous DNA Prime and NYVAC/Protein Boost HIV Vaccine Regimens in Rhesus Macaques by Employing Improved Antigens." Journal of Virology 90, no. 8 (April 2016): 4133-4149. Full Text Open Access Copy
  - Huang, Y, DiazGranados, C, Janes, H, Huang, Y, deCamp, AC, Metch, B, Grant, S, Sanchez, B, Phogat, S, Koutsoukos, M, Kanesa-Thasan, N, Bourguignon, P, Collard, A, Buchbinder, S, Tomaras, GD, McElrath, J, Gray, G, Kublin, JG, Corey, L, and Gilbert, PB. "Selection of HIV vaccine candidates for concurrent testing in an efficacy trial." Current Opinion in Virology 17 (April 2016): 57-65. (Review) Full Text
  - Mkhize, NN, Durgiah, R, Ashley, V, Archary, D, Garrett, NJ, Karim, QA, Karim, SSA, Moore, PL, Yates, N, Passmore, J-AS, Tomaras, GD, and Morris, L. "Broadly neutralizing antibody specificities detected in the genital tract of HIV-1 infected women." AIDS (London, England) 30, no. 7 (April 2016): 1005-1014. Full Text
  - Zhang, R, Verkoczy, L, Wiehe, K, Munir Alam, S, Nicely, NI, Santra, S, Bradley, T, Pemble, CW, Zhang, J, Gao, F, Montefiori, DC, Bouton-Verville, H, Kelsoe, G, Larimore, K, Greenberg, PD, Parks, R, Foulger, A, Peel, JN, Luo, K, Lu, X, Trama, AM, Vandergrift, N, Tomaras, GD, Kepler, TB, Moody, MA, Liao, H-X, and Haynes, BF. "Initiation of immune tolerance-controlled HIV gp41 neutralizing B cell lineages." Science Translational Medicine 8, no. 336 (April 2016): 336ra62-null. Full Text
  - Havenar-Daughton, C, Lindqvist, M, Heit, A, Wu, JE, Reiss, SM, Kendric, K, Bélanger, S, Kasturi, SP, Landais, E, Akondy, RS, McGuire, HM, Bothwell, M, Vagefi, PA, Scully, E, IAVI Protocol C Principal Investigators, , Tomaras, GD, Davis, MM, Poignard, P, Ahmed, R, Walker, BD, Pulendran, B, McElrath, MJ, Kaufmann, DE, and Crotty, S. "CXCL13 is a plasma biomarker of germinal center activity." Proceedings of the National Academy of Sciences of the United States of America 113, no. 10 (March 2016): 2702-2707. Full Text
  - Walsh, SR, Moodie, Z, Fiore-Gartland, AJ, Morgan, C, Wilck, MB, Hammer, SM, Buchbinder, SP, Kalams, SA, Goepfert, PA, Mulligan, MJ, Keefer, MC, Baden, LR, Swann, EM, Grant, S, Ahmed, H, Li, F, Hertz, T, Self, SG, Friedrich, D, Frahm, N, Liao, H-X, Montefiori, DC, Tomaras, GD, McElrath, MJ, Hural, J, Graham, BS, Jin, X, and HVTN 083 Study Group and the NIAID HVTN, . "Vaccination With Heterologous HIV-1 Envelope Sequences and Heterologous Adenovirus Vectors Increases T-Cell Responses to Conserved Regions: HVTN 083." J Infect Dis 213, no. 4 (February 15, 2016): 541-550. Full Text Link to Item
  - Churchyard, G, Mlisana, K, Karuna, S, Williamson, A-L, Williamson, C, Morris, L, Tomaras, GD, De Rosa, SC, Gilbert, PB, Gu, N, Yu, C, Mkhize, NN, Hermanus, T, Allen, M, Pensiero, M, Barnett, SW, Gray, G, Bekker, L-G, Montefiori, DC, Kublin, J, and Corey, L. "Sequential Immunization with gp140 Boosts Immune Responses Primed by Modified Vaccinia Ankara or DNA in HIV-Uninfected South African Participants." Plos One 11, no. 9 (January 2016): e0161753-null. Full Text
  - Cosgrove, CA, Lacey, CJ, Cope, AV, Bartolf, A, Morris, G, Yan, C, Baden, S, Cole, T, Carter, D, Brodnicki, E, Shen, X, Joseph, S, DeRosa, SC, Peng, L, Yu, X, Ferrari, G, Seaman, M, Montefiori, DC, Frahm, N, Tomaras, GD, Stöhr, W, McCormack, S, and Shattock, RJ. "Comparative Immunogenicity of HIV-1 gp140 Vaccine Delivered by Parenteral, and Mucosal Routes in Female Volunteers; MUCOVAC2, A Randomized Two Centre Study." Plos One 11, no. 5 (January 2016): e0152038-null. Full Text
  - Sajadi, MM, Farshidpour, M, Brown, EP, Ouyang, X, Seaman, MS, Pazgier, M, Ackerman, ME, Robinson, H, Tomaras, G, Parsons, MS, Charurat, M, DeVico, AL, Redfield, RR, and Lewis, GK. "λ Light Chain Bias Associated With Enhanced Binding and Function of Anti-HIV Env Glycoprotein Antibodies." The Journal of infectious diseases 213, no. 1 (January 2016): 156-164. Full Text
  - Zurawski, G, Zurawski, S, Flamar, A-L, Richert, L, Wagner, R, Tomaras, GD, Montefiori, DC, Roederer, M, Ferrari, G, Lacabaratz, C, Bonnabau, H, Klucar, P, Wang, Z, Foulds, KE, Kao, S-F, Yates, NL, LaBranche, C, Jacobs, BL, Kibler, K, Asbach, B, Kliche, A, Salazar, A, Reed, S, Self, S, Gottardo, R, Galmin, L, Weiss, D, Cristillo, A, Thiebaut, R, Pantaleo, G, and Levy, Y. "Targeting HIV-1 Env gp140 to LOX-1 Elicits Immune Responses in Rhesus Macaques." Plos One 11, no. 4 (January 2016): e0153484-null. Full Text
  - Cubas, R, van Grevenynghe, J, Wills, S, Kardava, L, Santich, BH, Buckner, CM, Muir, R, Tardif, V, Nichols, C, Procopio, F, He, Z, Metcalf, T, Ghneim, K, Locci, M, Ancuta, P, Routy, J-P, Trautmann, L, Li, Y, McDermott, AB, Koup, RA, Petrovas, C, Migueles, SA, Connors, M, Tomaras, GD, Moir, S, Crotty, S, and Haddad, EK. "Reversible Reprogramming of Circulating Memory T Follicular Helper Cell Function during Chronic HIV Infection." Journal of immunology (Baltimore, Md. : 1950) 195, no. 12 (December 2015): 5625-5636. Full Text
  - Corey, L, Gilbert, PB, Tomaras, GD, Haynes, BF, Pantaleo, G, and Fauci, AS. "Immune correlates of vaccine protection against HIV-1 acquisition." Science Translational Medicine 7, no. 310 (October 2015): 310rv7-null. (Review) Full Text
  - Pollara, J, McGuire, E, Fouda, GG, Rountree, W, Eudailey, J, Overman, RG, Seaton, KE, Deal, A, Edwards, RW, Tegha, G, Kamwendo, D, Kumwenda, J, Nelson, JAE, Liao, H-X, Brinkley, C, Denny, TN, Ochsenbauer, C, Ellington, S, King, CC, Jamieson, DJ, van der Horst, C, Kourtis, AP, Tomaras, GD, Ferrari, G, and Permar, SR. "Association of HIV-1 Envelope-Specific Breast Milk IgA Responses with Reduced Risk of Postnatal Mother-to-Child Transmission of HIV-1." Journal of Virology 89, no. 19 (October 2015): 9952-9961. Full Text Open Access Copy
  - Fuchs, JD, Frank, I, Elizaga, ML, Allen, M, Frahm, N, Kochar, N, Li, S, Edupuganti, S, Kalams, SA, Tomaras, GD, Sheets, R, Pensiero, M, Tremblay, MA, Higgins, TJ, Latham, T, Egan, MA, Clarke, DK, Eldridge, JH, HVTN 090 Study Group and the National Institutes of Allergy and Infectious Diseases HIV Vaccine Trials Network, , Mulligan, M, Rouphael, N, Estep, S, Rybczyk, K, Dunbar, D, Buchbinder, S, Wagner, T, Isbell, R, Chinnell, V, Bae, J, Escamilla, G, Tseng, J, Fair, R, Ramirez, S, Broder, G, Briesemeister, L, and Ferrara, A. "First-in-Human Evaluation of the Safety and Immunogenicity of a Recombinant Vesicular Stomatitis Virus Human Immunodeficiency Virus-1 gag Vaccine (HVTN 090)." Open Forum Infectious Diseases 2, no. 3 (September 2015): ofv082-null. Full Text
  - Moody, MA, Gao, F, Gurley, TC, Amos, JD, Kumar, A, Hora, B, Marshall, DJ, Whitesides, JF, Xia, S-M, Parks, R, Lloyd, KE, Hwang, K-K, Lu, X, Bonsignori, M, Finzi, A, Vandergrift, NA, Alam, SM, Ferrari, G, Shen, X, Tomaras, GD, Kamanga, G, Cohen, MS, Sam, NE, Kapiga, S, Gray, ES, Tumba, NL, Morris, L, Zolla-Pazner, S, Gorny, MK, Mascola, JR, Hahn, BH, Shaw, GM, Sodroski, JG, Liao, H-X, Montefiori, DC, Hraber, PT, Korber, BT, and Haynes, BF. "Strain-Specific V3 and CD4 Binding Site Autologous HIV-1 Neutralizing Antibodies Select Neutralization-Resistant Viruses." Cell Host & Microbe 18, no. 3 (September 2015): 354-362. Full Text
  - Santra, S, Tomaras, GD, Warrier, R, Nicely, NI, Liao, H-X, Pollara, J, Liu, P, Alam, SM, Zhang, R, Cocklin, SL, Shen, X, Duffy, R, Xia, S-M, Schutte, RJ, Pemble Iv, CW, Dennison, SM, Li, H, Chao, A, Vidnovic, K, Evans, A, Klein, K, Kumar, A, Robinson, J, Landucci, G, Forthal, DN, Montefiori, DC, Kaewkungwal, J, Nitayaphan, S, Pitisuttithum, P, Rerks-Ngarm, S, Robb, ML, Michael, NL, Kim, JH, Soderberg, KA, Giorgi, EE, Blair, L, Korber, BT, Moog, C, Shattock, RJ, Letvin, NL, Schmitz, JE, Moody, MA, Gao, F, Ferrari, G, Shaw, GM, and Haynes, BF. "Human Non-neutralizing HIV-1 Envelope Monoclonal Antibodies Limit the Number of Founder Viruses during SHIV Mucosal Infection in Rhesus Macaques." Plos Pathogens 11, no. 8 (August 3, 2015): e1005042-null. Full Text Open Access Copy
  - García-Arriaza, J, Perdiguero, B, Heeney, J, Seaman, M, Montefiori, DC, Labranche, C, Yates, NL, Shen, X, Tomaras, GD, Ferrari, G, Foulds, KE, McDermott, A, Kao, S-F, Roederer, M, Hawkins, N, Self, S, Yao, J, Farrell, P, Phogat, S, Tartaglia, J, Barnett, SW, Burke, B, Cristillo, A, Weiss, D, Lee, C, Kibler, K, Jacobs, B, Asbach, B, Wagner, R, Ding, S, Pantaleo, G, and Esteban, M. "Head-to-Head Comparison of Poxvirus NYVAC and ALVAC Vectors Expressing Identical HIV-1 Clade C Immunogens in Prime-Boost Combination with Env Protein in Nonhuman Primates." Journal of Virology 89, no. 16 (August 2015): 8525-8539. Full Text
  - Shen, X, Duffy, R, Howington, R, Cope, A, Sadagopal, S, Park, H, Pal, R, Kwa, S, Ding, S, Yang, OO, Fouda, GG, Le Grand, R, Bolton, D, Esteban, M, Phogat, S, Roederer, M, Amara, RR, Picker, LJ, Seder, RA, McElrath, MJ, Barnett, S, Permar, SR, Shattock, R, DeVico, AL, Felber, BK, Pavlakis, GN, Pantaleo, G, Korber, BT, Montefiori, DC, and Tomaras, GD. "Vaccine-Induced Linear Epitope-Specific Antibodies to Simian Immunodeficiency Virus SIVmac239 Envelope Are Distinct from Those Induced to the Human Immunodeficiency Virus Type 1 Envelope in Nonhuman Primates." Journal of Virology 89, no. 16 (August 2015): 8643-8650. Full Text
  - Williams, WB, Liao, H-X, Moody, MA, Kepler, TB, Alam, SM, Gao, F, Wiehe, K, Trama, AM, Jones, K, Zhang, R, Song, H, Marshall, DJ, Whitesides, JF, Sawatzki, K, Hua, A, Liu, P, Tay, MZ, Seaton, KE, Shen, X, Foulger, A, Lloyd, KE, Parks, R, Pollara, J, Ferrari, G, Yu, J-S, Vandergrift, N, Montefiori, DC, Sobieszczyk, ME, Hammer, S, Karuna, S, Gilbert, P, Grove, D, Grunenberg, N, McElrath, MJ, Mascola, JR, Koup, RA, Corey, L, Nabel, GJ, Morgan, C, Churchyard, G, Maenza, J, Keefer, M, Graham, BS, Baden, LR, Tomaras, GD, and Haynes, BF. "HIV-1 VACCINES. Diversion of HIV-1 vaccine-induced immunity by gp41-microbiota cross-reactive antibodies." Science (New York, N.Y.) 349, no. 6249 (August 2015): aab1253-null. Full Text
  - Fong, Y, Datta, S, Georgiev, IS, Kwong, PD, and Tomaras, GD. "Kernel-based logistic regression model for protein sequence without vectorialization." Biostatistics (Oxford, England) 16, no. 3 (July 2015): 480-492. Full Text
  - Permar, SR, Fong, Y, Vandergrift, N, Fouda, GG, Gilbert, P, Parks, R, Jaeger, FH, Pollara, J, Martelli, A, Liebl, BE, Lloyd, K, Yates, NL, Overman, RG, Shen, X, Whitaker, K, Chen, H, Pritchett, J, Solomon, E, Friberg, E, Marshall, DJ, Whitesides, JF, Gurley, TC, Von Holle, T, Martinez, DR, Cai, F, Kumar, A, Xia, S-M, Lu, X, Louzao, R, Wilkes, S, Datta, S, Sarzotti-Kelsoe, M, Liao, H-X, Ferrari, G, Alam, SM, Montefiori, DC, Denny, TN, Moody, MA, Tomaras, GD, Gao, F, and Haynes, BF. "Maternal HIV-1 envelope-specific antibody responses and reduced risk of perinatal transmission." The Journal of Clinical Investigation 125, no. 7 (July 2015): 2702-2706. Full Text Open Access Copy
  - Prentice, HA, Tomaras, GD, Geraghty, DE, Apps, R, Fong, Y, Ehrenberg, PK, Rolland, M, Kijak, GH, Krebs, SJ, Nelson, W, DeCamp, A, Shen, X, Yates, NL, Zolla-Pazner, S, Nitayaphan, S, Rerks-Ngarm, S, Kaewkungwal, J, Pitisuttithum, P, Ferrari, G, McElrath, MJ, Montefiori, DC, Bailer, RT, Koup, RA, O'Connell, RJ, Robb, ML, Michael, NL, Gilbert, PB, Kim, JH, and Thomas, R. "HLA class II genes modulate vaccine-induced antibody responses to affect HIV-1 acquisition." Science Translational Medicine 7, no. 296 (July 2015): 296ra112-null. Full Text
  - Lin, L, Finak, G, Ushey, K, Seshadri, C, Hawn, TR, Frahm, N, Scriba, TJ, Mahomed, H, Hanekom, W, Bart, P-A, Pantaleo, G, Tomaras, GD, Rerks-Ngarm, S, Kaewkungwal, J, Nitayaphan, S, Pitisuttithum, P, Michael, NL, Kim, JH, Robb, ML, O'Connell, RJ, Karasavvas, N, Gilbert, P, C De Rosa, S, McElrath, MJ, and Gottardo, R. "COMPASS identifies T-cell subsets correlated with clinical outcomes." Nature Biotechnology 33, no. 6 (June 2015): 610-616. Full Text
  - Fuchs, JD, Bart, P-A, Frahm, N, Morgan, C, Gilbert, PB, Kochar, N, DeRosa, SC, Tomaras, GD, Wagner, TM, Baden, LR, Koblin, BA, Rouphael, NG, Kalams, SA, Keefer, MC, Goepfert, PA, Sobieszczyk, ME, Mayer, KH, Swann, E, Liao, H-X, Haynes, BF, Graham, BS, McElrath, MJ, and NIAID HIV Vaccine Trials Network, . "Safety and Immunogenicity of a Recombinant Adenovirus Serotype 35-Vectored HIV-1 Vaccine in Adenovirus Serotype 5 Seronegative and Seropositive Individuals." Journal of AIDS & clinical research 6, no. 5 (May 23, 2015). Full Text
  - Jin, X, Morgan, C, Yu, X, DeRosa, S, Tomaras, GD, Montefiori, DC, Kublin, J, Corey, L, Keefer, MC, and NIAID HIV Vaccine Trials Network, . "Multiple factors affect immunogenicity of DNA plasmid HIV vaccines in human clinical trials." Vaccine 33, no. 20 (May 2015): 2347-2353. Full Text
  - Kwa, S, Sadagopal, S, Shen, X, Hong, JJ, Gangadhara, S, Basu, R, Victor, B, Iyer, SS, LaBranche, CC, Montefiori, DC, Tomaras, GD, Villinger, F, Moss, B, Kozlowski, PA, and Amara, RR. "CD40L-adjuvanted DNA/modified vaccinia virus Ankara simian immunodeficiency virus (SIV) vaccine enhances protection against neutralization-resistant mucosal SIV infection." Journal of Virology 89, no. 8 (April 2015): 4690-4695. Full Text
  - Bogers, WM, Oostermeijer, H, Mooij, P, Koopman, G, Verschoor, EJ, Davis, D, Ulmer, JB, Brito, LA, Cu, Y, Banerjee, K, Otten, GR, Burke, B, Dey, A, Heeney, JL, Shen, X, Tomaras, GD, Labranche, C, Montefiori, DC, Liao, H-X, Haynes, B, Geall, AJ, and Barnett, SW. "Potent immune responses in rhesus macaques induced by nonviral delivery of a self-amplifying RNA vaccine expressing HIV type 1 envelope with a cationic nanoemulsion." The Journal of Infectious Diseases 211, no. 6 (March 2015): 947-955. Full Text
  - Sacha, CR, Vandergrift, N, Jeffries, TL, McGuire, E, Fouda, GG, Liebl, B, Marshall, DJ, Gurley, TC, Stiegel, L, Whitesides, JF, Friedman, J, Badiabo, A, Foulger, A, Yates, NL, Tomaras, GD, Kepler, TB, Liao, HX, Haynes, BF, Moody, MA, and Permar, SR. "Restricted isotype, distinct variable gene usage, and high rate of gp120 specificity of HIV-1 envelope-specific B cells in colostrum compared with those in blood of HIV-1-infected, lactating African women." Mucosal Immunology 8, no. 2 (March 2015): 316-326. Full Text
  - Tomescu, C, Seaton, KE, Smith, P, Taylor, M, Tomaras, GD, Metzger, DS, and Montaner, LJ. "Innate activation of MDC and NK cells in high-risk HIV-1-exposed seronegative IV-drug users who share needles when compared with low-risk nonsharing IV-drug user controls." Journal of Acquired Immune Deficiency Syndromes (1999) 68, no. 3 (March 2015): 264-273. Full Text
  - Hancock, G, Yang, H, Yorke, E, Wainwright, E, Bourne, V, Frisbee, A, Payne, TL, Berrong, M, Ferrari, G, Chopera, D, Hanke, T, Mothe, B, Brander, C, McElrath, MJ, McMichael, A, Goonetilleke, N, Tomaras, GD, Frahm, N, and Dorrell, L. "Identification of effective subdominant anti-HIV-1 CD8+ T cells within entire post-infection and post-vaccination immune responses." Plos Pathogens 11, no. 2 (February 27, 2015): e1004658-null. Full Text
  - Fouda, GG, Cunningham, CK, McFarland, EJ, Borkowsky, W, Muresan, P, Pollara, J, Song, LY, Liebl, BE, Whitaker, K, Shen, X, Vandergrift, NA, Overman, RG, Yates, NL, Moody, MA, Fry, C, Kim, JH, Michael, NL, Robb, M, Pitisuttithum, P, Kaewkungwal, J, Nitayaphan, S, Rerks-Ngarm, S, Liao, H-X, Haynes, BF, Montefiori, DC, Ferrari, G, Tomaras, GD, and Permar, SR. "Infant HIV type 1 gp120 vaccination elicits robust and durable anti-V1V2 immunoglobulin G responses and only rare envelope-specific immunoglobulin A responses." The Journal of Infectious Diseases 211, no. 4 (February 2015): 508-517. Full Text
  - Wiehe, K, Easterhoff, D, Luo, K, Nicely, NI, Bradley, T, Jaeger, FH, Dennison, SM, Zhang, R, Lloyd, KE, Stolarchuk, C, Parks, R, Sutherland, LL, Scearce, RM, Morris, L, Kaewkungwal, J, Nitayaphan, S, Pitisuttithum, P, Rerks-Ngarm, S, Sinangil, F, Phogat, S, Michael, NL, Kim, JH, Kelsoe, G, Montefiori, DC, Tomaras, GD, Bonsignori, M, Santra, S, Kepler, TB, Alam, SM, Moody, MA, Liao, H-X, and Haynes, BF. "Antibody light-chain-restricted recognition of the site of immune pressure in the RV144 HIV-1 vaccine trial is phylogenetically conserved." Immunity 41, no. 6 (December 2014): 909-918. Full Text
  - Bart, P-A, Huang, Y, Karuna, ST, Chappuis, S, Gaillard, J, Kochar, N, Shen, X, Allen, MA, Ding, S, Hural, J, Liao, H-X, Haynes, BF, Graham, BS, Gilbert, PB, McElrath, MJ, Montefiori, DC, Tomaras, GD, Pantaleo, G, and Frahm, N. "HIV-specific humoral responses benefit from stronger prime in phase Ib clinical trial." The Journal of Clinical Investigation 124, no. 11 (November 2014): 4843-4856. Full Text
  - Frey, SE, Peiperl, L, McElrath, MJ, Kalams, S, Goepfert, PA, Keefer, MC, Baden, LR, Lally, MA, Mayer, K, Blattner, WA, Harro, CD, Hammer, SM, Gorse, GJ, Hural, J, Tomaras, GD, Levy, Y, Gilbert, P, deCamp, A, Russell, ND, Elizaga, M, Allen, M, and Corey, L. "Phase I/II randomized trial of safety and immunogenicity of LIPO-5 alone, ALVAC-HIV (vCP1452) alone, and ALVAC-HIV (vCP1452) prime/LIPO-5 boost in healthy, HIV-1-uninfected adult participants." Clinical and Vaccine Immunology : Cvi 21, no. 11 (November 2014): 1589-1599. Full Text
  - Stieh, DJ, King, DF, Klein, K, Liu, P, Shen, X, Hwang, KK, Ferrari, G, Montefiori, DC, Haynes, B, Pitisuttithum, P, Kaewkungwal, J, Nitayaphan, S, Rerks-Ngarm, S, Michael, NL, Robb, ML, Kim, JH, Denny, TN, Tomaras, GD, and Shattock, RJ. "Aggregate complexes of HIV-1 induced by multimeric antibodies." Retrovirology 11 (October 2, 2014): 78-null. Full Text Open Access Copy
  - Sixsmith, JD, Panas, MW, Lee, S, Gillard, GO, White, K, Lifton, MA, Balachandran, H, Mach, L, Miller, JP, Lavine, C, DeMarco, CT, Tomaras, GD, Gee, C, Porcelli, SA, Larsen, MH, Frothingham, R, Schmitz, JE, Jacobs, WR, Haynes, BF, Letvin, NL, and Korioth-Schmitz, B. "Recombinant Mycobacterium bovis bacillus Calmette-Guérin vectors prime for strong cellular responses to simian immunodeficiency virus gag in rhesus macaques." Clinical and Vaccine Immunology : Cvi 21, no. 10 (October 2014): 1385-1395. Full Text
  - Li, SS, Gilbert, PB, Tomaras, GD, Kijak, G, Ferrari, G, Thomas, R, Pyo, C-W, Zolla-Pazner, S, Montefiori, D, Liao, H-X, Nabel, G, Pinter, A, Evans, DT, Gottardo, R, Dai, JY, Janes, H, Morris, D, Fong, Y, Edlefsen, PT, Li, F, Frahm, N, Alpert, MD, Prentice, H, Rerks-Ngarm, S, Pitisuttithum, P, Kaewkungwal, J, Nitayaphan, S, Robb, ML, O'Connell, RJ, Haynes, BF, Michael, NL, Kim, JH, McElrath, MJ, and Geraghty, DE. "FCGR2C polymorphisms associate with HIV-1 vaccine protection in RV144 trial." The Journal of Clinical Investigation 124, no. 9 (September 2014): 3879-3890. Full Text
  - Payne, TL, Blackinton, J, Frisbee, A, Pickeral, J, Sawant, S, Vandergrift, NA, Freel, SA, Ferrari, G, Keene, JD, and Tomaras, GD. "Transcriptional and posttranscriptional regulation of cytokine gene expression in HIV-1 antigen-specific CD8+ T cells that mediate virus inhibition." Journal of Virology 88, no. 17 (September 2014): 9514-9528. Full Text
  - Dennison, SM, Anasti, KM, Jaeger, FH, Stewart, SM, Pollara, J, Liu, P, Kunz, EL, Zhang, R, Vandergrift, N, Permar, S, Ferrari, G, Tomaras, GD, Bonsignori, M, Michael, NL, Kim, JH, Kaewkungwal, J, Nitayaphan, S, Pitisuttithum, P, Rerks-Ngarm, S, Liao, H-X, Haynes, BF, and Alam, SM. "Vaccine-induced HIV-1 envelope gp120 constant region 1-specific antibodies expose a CD4-inducible epitope and block the interaction of HIV-1 gp140 with galactosylceramide." Journal of Virology 88, no. 16 (August 2014): 9406-9417. Full Text
  - Gartland, AJ, Li, S, McNevin, J, Tomaras, GD, Gottardo, R, Janes, H, Fong, Y, Morris, D, Geraghty, DE, Kijak, GH, Edlefsen, PT, Frahm, N, Larsen, BB, Tovanabutra, S, Sanders-Buell, E, deCamp, AC, Magaret, CA, Ahmed, H, Goodridge, JP, Chen, L, Konopa, P, Nariya, S, Stoddard, JN, Wong, K, Zhao, H, Deng, W, Maust, BS, Bose, M, Howell, S, Bates, A, Lazzaro, M, O'Sullivan, A, Lei, E, Bradfield, A, Ibitamuno, G, Assawadarachai, V, O'Connell, RJ, deSouza, MS, Nitayaphan, S, Rerks-Ngarm, S, Robb, ML, Sidney, J, Sette, A, Zolla-Pazner, S, Montefiori, D, McElrath, MJ, Mullins, JI, Kim, JH, Gilbert, PB, and Hertz, T. "Analysis of HLA A*02 association with vaccine efficacy in the RV144 HIV-1 vaccine trial." Journal of Virology 88, no. 15 (August 2014): 8242-8255. Full Text
  - Trama, AM, Moody, MA, Alam, SM, Jaeger, FH, Lockwood, B, Parks, R, Lloyd, KE, Stolarchuk, C, Scearce, R, Foulger, A, Marshall, DJ, Whitesides, JF, Jeffries, TL, Wiehe, K, Morris, L, Lambson, B, Soderberg, K, Hwang, K-K, Tomaras, GD, Vandergrift, N, Jackson, KJL, Roskin, KM, Boyd, SD, Kepler, TB, Liao, H-X, and Haynes, BF. "HIV-1 envelope gp41 antibodies can originate from terminal ileum B cells that share cross-reactivity with commensal bacteria." Cell Host & Microbe 16, no. 2 (August 2014): 215-226. Full Text Open Access Copy
  - Goepfert, PA, Elizaga, ML, Seaton, K, Tomaras, GD, Montefiori, DC, Sato, A, Hural, J, DeRosa, SC, Kalams, SA, McElrath, MJ, Keefer, MC, Baden, LR, Lama, JR, Sanchez, J, Mulligan, MJ, Buchbinder, SP, Hammer, SM, Koblin, BA, Pensiero, M, Butler, C, Moss, B, Robinson, HL, HVTN 205 Study Group, , and National Institutes of Allergy and Infectious Diseases HIV Vaccines Trials Network, . "Specificity and 6-month durability of immune responses induced by DNA and recombinant modified vaccinia Ankara vaccines expressing HIV-1 virus-like particles." The Journal of Infectious Diseases 210, no. 1 (July 2014): 99-110. Full Text
  - Haynes, BF, Moody, MA, Alam, M, Bonsignori, M, Verkoczy, L, Ferrari, G, Gao, F, Tomaras, GD, Liao, H-X, and Kelsoe, G. "Progress in HIV-1 vaccine development." The Journal of Allergy and Clinical Immunology 134, no. 1 (July 2014): 3-11. (Review) Full Text
  - Pollara, J, Bonsignori, M, Moody, MA, Liu, P, Alam, SM, Hwang, K-K, Gurley, TC, Kozink, DM, Armand, LC, Marshall, DJ, Whitesides, JF, Kaewkungwal, J, Nitayaphan, S, Pitisuttithum, P, Rerks-Ngarm, S, Robb, ML, O'Connell, RJ, Kim, JH, Michael, NL, Montefiori, DC, Tomaras, GD, Liao, H-X, Haynes, BF, and Ferrari, G. "HIV-1 vaccine-induced C1 and V2 Env-specific antibodies synergize for increased antiviral activities." Journal of Virology 88, no. 14 (July 2014): 7715-7726. Full Text
  - Tomaras, GD, and Haynes, BF. "Lessons from babies: inducing HIV-1 broadly neutralizing antibodies." Nature Medicine 20, no. 6 (June 2014): 583-585. Full Text
  - Liu, P, Williams, LD, Shen, X, Bonsignori, M, Vandergrift, NA, Overman, RG, Moody, MA, Liao, H-X, Stieh, DJ, McCotter, KL, French, AL, Hope, TJ, Shattock, R, Haynes, BF, and Tomaras, GD. "Capacity for infectious HIV-1 virion capture differs by envelope antibody specificity." Journal of Virology 88, no. 9 (May 2014): 5165-5170. Full Text
  - Tomaras, GD, and Montefiori, DC. "Spectrum of HIV antibodies in vaccine and disease." Current Opinion in Hiv and Aids 9, no. 3 (May 2014): 207-209. Full Text
  - Nair, SK, Tomaras, GD, Sales, AP, Boczkowski, D, Chan, C, Plonk, K, Cai, Y, Dannull, J, Kepler, TB, Pruitt, SK, and Weinhold, KJ. "High-throughput identification and dendritic cell-based functional validation of MHC class I-restricted Mycobacterium tuberculosis epitopes." Scientific reports 4 (April 23, 2014): 4632-. Full Text
  - Bonsignori, M, Wiehe, K, Grimm, SK, Lynch, R, Yang, G, Kozink, DM, Perrin, F, Cooper, AJ, Hwang, K-K, Chen, X, Liu, M, McKee, K, Parks, RJ, Eudailey, J, Wang, M, Clowse, M, Criscione-Schreiber, LG, Moody, MA, Ackerman, ME, Boyd, SD, Gao, F, Kelsoe, G, Verkoczy, L, Tomaras, GD, Liao, H-X, Kepler, TB, Montefiori, DC, Mascola, JR, and Haynes, BF. "An autoreactive antibody from an SLE/HIV-1 individual broadly neutralizes HIV-1." The Journal of Clinical Investigation 124, no. 4 (April 2014): 1835-1843. Full Text
  - Moody, MA, Santra, S, Vandergrift, NA, Sutherland, LL, Gurley, TC, Drinker, MS, Allen, AA, Xia, S-M, Meyerhoff, RR, Parks, R, Lloyd, KE, Easterhoff, D, Alam, SM, Liao, H-X, Ward, BM, Ferrari, G, Montefiori, DC, Tomaras, GD, Seder, RA, Letvin, NL, and Haynes, BF. "Toll-like receptor 7/8 (TLR7/8) and TLR9 agonists cooperate to enhance HIV-1 envelope antibody responses in rhesus macaques." Journal of Virology 88, no. 6 (March 2014): 3329-3339. Full Text
  - Tomaras, GD, and Haynes, BF. "Advancing Toward HIV-1 Vaccine Efficacy through the Intersections of Immune Correlates." Vaccines 2, no. 1 (March 2014): 15-35. Full Text
  - Yates, NL, Liao, H-X, Fong, Y, deCamp, A, Vandergrift, NA, Williams, WT, Alam, SM, Ferrari, G, Yang, Z-Y, Seaton, KE, Berman, PW, Alpert, MD, Evans, DT, O'Connell, RJ, Francis, D, Sinangil, F, Lee, C, Nitayaphan, S, Rerks-Ngarm, S, Kaewkungwal, J, Pitisuttithum, P, Tartaglia, J, Pinter, A, Zolla-Pazner, S, Gilbert, PB, Nabel, GJ, Michael, NL, Kim, JH, Montefiori, DC, Haynes, BF, and Tomaras, GD. "Vaccine-induced Env V1-V2 IgG3 correlates with lower HIV-1 infection risk and declines soon after vaccination." Science Translational Medicine 6, no. 228 (March 2014): 228ra39-null. Full Text
  - Hwang, K-K, Trama, AM, Kozink, DM, Chen, X, Wiehe, K, Cooper, AJ, Xia, S-M, Wang, M, Marshall, DJ, Whitesides, J, Alam, M, Tomaras, GD, Allen, SL, Rai, KR, McKeating, J, Catera, R, Yan, X-J, Chu, CC, Kelsoe, G, Liao, H-X, Chiorazzi, N, and Haynes, BF. "IGHV1-69 B cell chronic lymphocytic leukemia antibodies cross-react with HIV-1 and hepatitis C virus antigens as well as intestinal commensal bacteria." Plos One 9, no. 3 (January 2014): e90725-null. Full Text Open Access Copy
  - Jalah, R, Kulkarni, V, Patel, V, Rosati, M, Alicea, C, Bear, J, Yu, L, Guan, Y, Shen, X, Tomaras, GD, LaBranche, C, Montefiori, DC, Prattipati, R, Pinter, A, Bess, J, Lifson, JD, Reed, SG, Sardesai, NY, Venzon, DJ, Valentin, A, Pavlakis, GN, and Felber, BK. "DNA and protein co-immunization improves the magnitude and longevity of humoral immune responses in macaques." Plos One 9, no. 3 (January 2014): e91550-null. Full Text
  - Kepler, TB, Munshaw, S, Wiehe, K, Zhang, R, Yu, J-S, Woods, CW, Denny, TN, Tomaras, GD, Alam, SM, Moody, MA, Kelsoe, G, Liao, H-X, and Haynes, BF. "Reconstructing a B-Cell Clonal Lineage. II. Mutation, Selection, and Affinity Maturation." Frontiers in Immunology 5 (January 2014): 170-null. Full Text Open Access Copy
  - Roederer, M, Keele, BF, Schmidt, SD, Mason, RD, Welles, HC, Fischer, W, Labranche, C, Foulds, KE, Louder, MK, Yang, Z-Y, Todd, J-PM, Buzby, AP, Mach, LV, Shen, L, Seaton, KE, Ward, BM, Bailer, RT, Gottardo, R, Gu, W, Ferrari, G, Alam, SM, Denny, TN, Montefiori, DC, Tomaras, GD, Korber, BT, Nason, MC, Seder, RA, Koup, RA, Letvin, NL, Rao, SS, Nabel, GJ, and Mascola, JR. "Immunological and virological mechanisms of vaccine-mediated protection against SIV and HIV." Nature 505, no. 7484 (January 2014): 502-508. Full Text Open Access Copy
  - Seaton, KE, Ballweber, L, Lan, A, Donathan, M, Hughes, S, Vojtech, L, Moody, MA, Liao, H-X, Haynes, BF, Galloway, CG, Richardson, BA, Karim, SA, Dezzutti, CS, McElrath, MJ, Tomaras, GD, and Hladik, F. "HIV-1 specific IgA detected in vaginal secretions of HIV uninfected women participating in a microbicide trial in Southern Africa are primarily directed toward gp120 and gp140 specificities." PloS one 9, no. 7 (January 2014): e101863-. Full Text
  - Zolla-Pazner, S, deCamp, A, Gilbert, PB, Williams, C, Yates, NL, Williams, WT, Howington, R, Fong, Y, Morris, DE, Soderberg, KA, Irene, C, Reichman, C, Pinter, A, Parks, R, Pitisuttithum, P, Kaewkungwal, J, Rerks-Ngarm, S, Nitayaphan, S, Andrews, C, O'Connell, RJ, Yang, Z-Y, Nabel, GJ, Kim, JH, Michael, NL, Montefiori, DC, Liao, H-X, Haynes, BF, and Tomaras, GD. "Vaccine-induced IgG antibodies to V1V2 regions of multiple HIV-1 subtypes correlate with decreased risk of HIV-1 infection." Plos One 9, no. 2 (January 2014): e87572-null. Full Text
  - Hammer, SM, Sobieszczyk, ME, Janes, H, Karuna, ST, Mulligan, MJ, Grove, D, Koblin, BA, Buchbinder, SP, Keefer, MC, Tomaras, GD, Frahm, N, Hural, J, Anude, C, Graham, BS, Enama, ME, Adams, E, DeJesus, E, Novak, RM, Frank, I, Bentley, C, Ramirez, S, Fu, R, Koup, RA, Mascola, JR, Nabel, GJ, Montefiori, DC, Kublin, J, McElrath, MJ, Corey, L, Gilbert, PB, and HVTN 505 Study Team, . "Efficacy trial of a DNA/rAd5 HIV-1 preventive vaccine." The New England Journal of Medicine 369, no. 22 (November 2013): 2083-2092. Full Text
  - Amos, JD, Wilks, AB, Fouda, GG, Smith, SD, Colvin, L, Mahlokozera, T, Ho, C, Beck, K, Overman, RG, DeMarco, CT, Hodge, TL, LaBranche, CC, Montefiori, DC, Denny, TN, Liao, H-X, Tomaras, GD, Moody, MA, and Permar, SR. "Lack of B cell dysfunction is associated with functional, gp120-dominant antibody responses in breast milk of simian immunodeficiency virus-infected African green monkeys." Journal of Virology 87, no. 20 (October 2013): 11121-11134. Full Text Open Access Copy
  - Kulkarni, V, Rosati, M, Valentin, A, Jalah, R, Alicea, C, Yu, L, Guan, Y, Shen, X, Tomaras, GD, LaBranche, C, Montefiori, DC, Irene, C, Prattipati, R, Pinter, A, Sullivan, SM, Pavlakis, GN, and Felber, BK. "Vaccination with Vaxfectin(®) adjuvanted SIV DNA induces long-lasting humoral immune responses able to reduce SIVmac251 Viremia." Human Vaccines & Immunotherapeutics 9, no. 10 (October 2013): 2069-2080. Full Text
  - Imholte, GC, Sauteraud, R, Korber, B, Bailer, RT, Turk, ET, Shen, X, Tomaras, GD, Mascola, JR, Koup, RA, Montefiori, DC, and Gottardo, R. "A computational framework for the analysis of peptide microarray antibody binding data with application to HIV vaccine profiling." Journal of Immunological Methods 395, no. 1-2 (September 2013): 1-13. Full Text
  - Schiffner, T, Kong, L, Duncan, CJA, Back, JW, Benschop, JJ, Shen, X, Huang, PS, Stewart-Jones, GB, DeStefano, J, Seaman, MS, Tomaras, GD, Montefiori, DC, Schief, WR, and Sattentau, QJ. "Immune focusing and enhanced neutralization induced by HIV-1 gp140 chemical cross-linking." Journal of Virology 87, no. 18 (September 2013): 10163-10172. Full Text
  - Liu, P, Yates, NL, Shen, X, Bonsignori, M, Moody, MA, Liao, H-X, Fong, Y, Alam, SM, Overman, RG, Denny, T, Ferrari, G, Ochsenbauer, C, Kappes, JC, Polonis, VR, Pitisuttithum, P, Kaewkungwal, J, Nitayaphan, S, Rerks-Ngarm, S, Montefiori, DC, Gilbert, P, Michael, NL, Kim, JH, Haynes, BF, and Tomaras, GD. "Infectious virion capture by HIV-1 gp120-specific IgG from RV144 vaccinees." J Virol 87, no. 14 (July 2013): 7828-7836. Full Text Open Access Copy Link to Item
  - Yates, NL, Stacey, AR, Nolen, TL, Vandergrift, NA, Moody, MA, Montefiori, DC, Weinhold, KJ, Blattner, WA, Borrow, P, Shattock, R, Cohen, MS, Haynes, BF, and Tomaras, GD. "HIV-1 gp41 envelope IgA is frequently elicited after transmission but has an initial short response half-life." Mucosal Immunol 6, no. 4 (July 2013): 692-703. Full Text Link to Item
  - Fouda, GGA, Amos, JD, Wilks, AB, Pollara, J, Ray, CA, Chand, A, Kunz, EL, Liebl, BE, Whitaker, K, Carville, A, Smith, S, Colvin, L, Pickup, DJ, Staats, HF, Overman, G, Eutsey-Lloyd, K, Parks, R, Chen, H, Labranche, C, Barnett, S, Tomaras, GD, Ferrari, G, Montefiori, DC, Liao, H-X, Letvin, NL, Haynes, BF, and Permar, SR. "Mucosal immunization of lactating female rhesus monkeys with a transmitted/founder HIV-1 envelope induces strong Env-specific IgA antibody responses in breast milk." Journal of Virology 87, no. 12 (June 2013): 6986-6999. Full Text
  - Tomaras, GD, Ferrari, G, Shen, X, Alam, SM, Liao, H-X, Pollara, J, Bonsignori, M, Moody, MA, Fong, Y, Chen, X, Poling, B, Nicholson, CO, Zhang, R, Lu, X, Parks, R, Kaewkungwal, J, Nitayaphan, S, Pitisuttithum, P, Rerks-Ngarm, S, Gilbert, PB, Kim, JH, Michael, NL, Montefiori, DC, and Haynes, BF. "Vaccine-induced plasma IgA specific for the C1 region of the HIV-1 envelope blocks binding and effector function of IgG." Proc Natl Acad Sci U S A 110, no. 22 (May 28, 2013): 9019-9024. Full Text Link to Item
  - Eckels, J, Nathe, C, Nelson, EK, Shoemaker, SG, Nostrand, EV, Yates, NL, Ashley, VC, Harris, LJ, Bollenbeck, M, Fong, Y, Tomaras, GD, and Piehler, B. "Quality control, analysis and secure sharing of Luminex® immunoassay data using the open source LabKey Server platform. (Published online)" BMC Bioinformatics 14 (April 30, 2013): 145-. Full Text Link to Item
  - Alam, SM, Liao, H-X, Tomaras, GD, Bonsignori, M, Tsao, C-Y, Hwang, K-K, Chen, H, Lloyd, KE, Bowman, C, Sutherland, L, Jeffries, TL, Kozink, DM, Stewart, S, Anasti, K, Jaeger, FH, Parks, R, Yates, NL, Overman, RG, Sinangil, F, Berman, PW, Pitisuttithum, P, Kaewkungwal, J, Nitayaphan, S, Karasavva, N, Rerks-Ngarm, S, Kim, JH, Michael, NL, Zolla-Pazner, S, Santra, S, Letvin, NL, Harrison, SC, and Haynes, BF. "Antigenicity and immunogenicity of RV144 vaccine AIDSVAX clade E envelope immunogen is enhanced by a gp120 N-terminal deletion." J Virol 87, no. 3 (February 2013): 1554-1568. Full Text Link to Item
  - Patel, V, Jalah, R, Kulkarni, V, Valentin, A, Rosati, M, Alicea, C, von Gegerfelt, A, Huang, W, Guan, Y, Keele, BF, Bess, JW, Piatak, M, Lifson, JD, Williams, WT, Shen, X, Tomaras, GD, Amara, RR, Robinson, HL, Johnson, W, Broderick, KE, Sardesai, NY, Venzon, DJ, Hirsch, VM, Felber, BK, and Pavlakis, GN. "DNA and virus particle vaccination protects against acquisition and confers control of viremia upon heterologous simian immunodeficiency virus challenge." Proceedings of the National Academy of Sciences of the United States of America 110, no. 8 (February 2013): 2975-2980. Full Text
  - Pegu, P, Vaccari, M, Gordon, S, Keele, BF, Doster, M, Guan, Y, Ferrari, G, Pal, R, Ferrari, MG, Whitney, S, Hudacik, L, Billings, E, Rao, M, Montefiori, D, Tomaras, G, Alam, SM, Fenizia, C, Lifson, JD, Stablein, D, Tartaglia, J, Michael, N, Kim, J, Venzon, D, and Franchini, G. "Antibodies with high avidity to the gp120 envelope protein in protection from simian immunodeficiency virus SIV(mac251) acquisition in an immunization regimen that mimics the RV-144 Thai trial." Journal of Virology 87, no. 3 (February 2013): 1708-1719. Full Text
  - Liao, H-X, Bonsignori, M, Alam, SM, McLellan, JS, Tomaras, GD, Moody, MA, Kozink, DM, Hwang, K-K, Chen, X, Tsao, C-Y, Liu, P, Lu, X, Parks, RJ, Montefiori, DC, Ferrari, G, Pollara, J, Rao, M, Peachman, KK, Santra, S, Letvin, NL, Karasavvas, N, Yang, Z-Y, Dai, K, Pancera, M, Gorman, J, Wiehe, K, Nicely, NI, Rerks-Ngarm, S, Nitayaphan, S, Kaewkungwal, J, Pitisuttithum, P, Tartaglia, J, Sinangil, F, Kim, JH, Michael, NL, Kepler, TB, Kwong, PD, Mascola, JR, Nabel, GJ, Pinter, A, Zolla-Pazner, S, and Haynes, BF. "Vaccine induction of antibodies against a structurally heterogeneous site of immune pressure within HIV-1 envelope protein variable regions 1 and 2." Immunity 38, no. 1 (January 24, 2013): 176-186. Full Text Link to Item
  - Zolla-Pazner, S, deCamp, AC, Cardozo, T, Karasavvas, N, Gottardo, R, Williams, C, Morris, DE, Tomaras, G, Rao, M, Billings, E, Berman, P, Shen, X, Andrews, C, O'Connell, RJ, Ngauy, V, Nitayaphan, S, de Souza, M, Korber, B, Koup, R, Bailer, RT, Mascola, JR, Pinter, A, Montefiori, D, Haynes, BF, Robb, ML, Rerks-Ngarm, S, Michael, NL, Gilbert, PB, and Kim, JH. "Analysis of V2 Antibody Responses Induced in Vaccinees in the ALVAC/AIDSVAX HIV-1 Vaccine Efficacy Trial." Plos One 8, no. 1 (January 17, 2013). Full Text Link to Item
  - Excler, J-L, Tomaras, GD, and Russell, ND. "Novel directions in HIV-1 vaccines revealed from clinical trials." Current Opinion in HIV and AIDS 8, no. 5 (2013): 421-431. Full Text
  - Gottardo, R, Bailer, RT, Korber, BT, Gnanakaran, S, Phillips, J, Shen, X, Tomaras, GD, Turk, E, Imholte, G, Eckler, L, Wenschuh, H, Zerweck, J, Greene, K, Gao, H, Berman, PW, Francis, D, Sinangil, F, Lee, C, Nitayaphan, S, Rerks-Ngarm, S, Kaewkungwal, J, Pitisuttithum, P, Tartaglia, J, Robb, ML, Michael, NL, Kim, JH, Zolla-Pazner, S, Haynes, BF, Mascola, JR, Self, S, Gilbert, P, and Montefiori, DC. "Plasma IgG to linear epitopes in the V2 and V3 regions of HIV-1 gp120 correlate with a reduced risk of infection in the RV144 vaccine efficacy trial.(Published online)" Plos One 8, no. 9 (2013): e75665-null. Full Text Link to Item
  - Bonsignori, M, Alam, SM, Liao, H-X, Verkoczy, L, Tomaras, GD, Haynes, BF, and Moody, MA. "HIV-1 antibodies from infection and vaccination: insights for guiding vaccine design." Trends in Microbiology 20, no. 11 (November 2012): 532-539. (Review) Full Text
  - Bonsignori, M, Pollara, J, Moody, MA, Alpert, MD, Chen, X, Hwang, K-K, Gilbert, PB, Huang, Y, Gurley, TC, Kozink, DM, Marshall, DJ, Whitesides, JF, Tsao, C-Y, Kaewkungwal, J, Nitayaphan, S, Pitisuttithum, P, Rerks-Ngarm, S, Kim, JH, Michael, NL, Tomaras, GD, Montefiori, DC, Lewis, GK, DeVico, A, Evans, DT, Ferrari, G, Liao, H-X, and Haynes, BF. "Antibody-dependent cellular cytotoxicity-mediating antibodies from an HIV-1 vaccine efficacy trial target multiple epitopes and preferentially use the VH1 gene family." J Virol 86, no. 21 (November 2012): 11521-11532. Full Text Link to Item
  - Karasavvas, N, Billings, E, Rao, M, Williams, C, Zolla-Pazner, S, Bailer, RT, Koup, RA, Madnote, S, Arworn, D, Shen, X, Tomaras, GD, Currier, JR, Jiang, M, Magaret, C, Andrews, C, Gottardo, R, Gilbert, P, Cardozo, TJ, Rerks-Ngarm, S, Nitayaphan, S, Pitisuttithum, P, Kaewkungwal, J, Paris, R, Greene, K, Gao, H, Gurunathan, S, Tartaglia, J, Sinangil, F, Korber, BT, Montefiori, DC, Mascola, JR, Robb, ML, Haynes, BF, Ngauy, V, Michael, NL, Kim, JH, de Souza, MS, and MOPH TAVEG Collaboration, . "The Thai Phase III HIV Type 1 Vaccine trial (RV144) regimen induces antibodies that target conserved regions within the V2 loop of gp120." Aids Res Hum Retroviruses 28, no. 11 (November 2012): 1444-1457. Full Text Link to Item
  - Petrovas, C, Yamamoto, T, Gerner, MY, Boswell, KL, Wloka, K, Smith, EC, Ambrozak, DR, Sandler, NG, Timmer, KJ, Sun, X, Pan, L, Poholek, A, Rao, SS, Brenchley, JM, Alam, SM, Tomaras, GD, Roederer, M, Douek, DC, Seder, RA, Germain, RN, Haddad, EK, and Koup, RA. "CD4 T follicular helper cell dynamics during SIV infection." The Journal of Clinical Investigation 122, no. 9 (September 2012): 3281-3294. Full Text
  - Lynch, RM, Tran, L, Louder, MK, Schmidt, SD, Cohen, M, CHAVI 001 Clinical Team Members, , Dersimonian, R, Euler, Z, Gray, ES, Abdool Karim, S, Kirchherr, J, Montefiori, DC, Sibeko, S, Soderberg, K, Tomaras, G, Yang, Z-Y, Nabel, GJ, Schuitemaker, H, Morris, L, Haynes, BF, and Mascola, JR. "The development of CD4 binding site antibodies during HIV-1 infection." J Virol 86, no. 14 (July 2012): 7588-7595. Full Text Link to Item
  - Moody, MA, Yates, NL, Amos, JD, Drinker, MS, Eudailey, JA, Gurley, TC, Marshall, DJ, Whitesides, JF, Chen, X, Foulger, A, Yu, J-S, Zhang, R, Meyerhoff, RR, Parks, R, Scull, JC, Wang, L, Vandergrift, NA, Pickeral, J, Pollara, J, Kelsoe, G, Alam, SM, Ferrari, G, Montefiori, DC, Voss, G, Liao, H-X, Tomaras, GD, and Haynes, BF. "HIV-1 gp120 vaccine induces affinity maturation in both new and persistent antibody clonal lineages." Journal of Virology 86, no. 14 (July 2012): 7496-7507. Full Text
  - Freel, SA, Picking, RA, Ferrari, G, Ding, H, Ochsenbauer, C, Kappes, JC, Kirchherr, JL, Soderberg, KA, Weinhold, KJ, Cunningham, CK, Denny, TN, Crump, JA, Cohen, MS, McMichael, AJ, Haynes, BF, and Tomaras, GD. "Initial HIV-1 antigen-specific CD8+ T cells in acute HIV-1 infection inhibit transmitted/founder virus replication." Journal of Virology 86, no. 12 (June 2012): 6835-6846. Full Text Open Access Copy
  - Frahm, MA, Picking, RA, Kuruc, JD, McGee, KS, Gay, CL, Eron, JJ, Hicks, CB, Tomaras, GD, and Ferrari, G. "CD4+CD8+ T cells represent a significant portion of the anti-HIV T cell response to acute HIV infection." J Immunol 188, no. 9 (May 1, 2012): 4289-4296. Full Text Link to Item
  - Haynes, BF, Gilbert, PB, McElrath, MJ, Zolla-Pazner, S, Tomaras, GD, Alam, SM, Evans, DT, Montefiori, DC, Karnasuta, C, Sutthent, R, Liao, H-X, DeVico, AL, Lewis, GK, Williams, C, Pinter, A, Fong, Y, Janes, H, DeCamp, A, Huang, Y, Rao, M, Billings, E, Karasavvas, N, Robb, ML, Ngauy, V, de Souza, MS, Paris, R, Ferrari, G, Bailer, RT, Soderberg, KA, Andrews, C, Berman, PW, Frahm, N, De Rosa, SC, Alpert, MD, Yates, NL, Shen, X, Koup, RA, Pitisuttithum, P, Kaewkungwal, J, Nitayaphan, S, Rerks-Ngarm, S, Michael, NL, and Kim, JH. "Immune-correlates analysis of an HIV-1 vaccine efficacy trial." N Engl J Med 366, no. 14 (April 5, 2012): 1275-1286. Full Text Link to Item
  - Bonsignori, M, Montefiori, DC, Wu, X, Chen, X, Hwang, K-K, Tsao, C-Y, Kozink, DM, Parks, RJ, Tomaras, GD, Crump, JA, Kapiga, SH, Sam, NE, Kwong, PD, Kepler, TB, Liao, H-X, Mascola, JR, and Haynes, BF. "Two distinct broadly neutralizing antibody specificities of different clonal lineages in a single HIV-1-infected donor: implications for vaccine design." Journal of Virology 86, no. 8 (April 2012): 4688-4692. Full Text Open Access Copy
  - Montefiori, D, Tang, H, Gnanakaran, S, Gao, F, Bonsignori, M, Binley, J, Tomaras, G, Morris, L, Cohen, M, Rosenberg, E, Seaman, M, Robinson, J, Shaw, G, LaBranche, C, Liao, H-X, Mascola, J, Haynes, B, and Korber, B. "116 Autologous and Heterologous Neutralizing Antibody Responses in HIV-1 Infection." JAIDS Journal of Acquired Immune Deficiency Syndromes 59 (April 2012): 47-47. Full Text
  - Bolton, DL, Song, K, Wilson, RL, Kozlowski, PA, Tomaras, GD, Keele, BF, Lovingood, RV, Rao, S, and Roederer, M. "Comparison of systemic and mucosal vaccination: impact on intravenous and rectal SIV challenge." Mucosal Immunology 5, no. 1 (January 2012): 41-52. Full Text
  - Friedman, J, Alam, SM, Shen, X, Xia, S-M, Stewart, S, Anasti, K, Pollara, J, Fouda, GG, Yang, G, Kelsoe, G, Ferrari, G, Tomaras, GD, Haynes, BF, Liao, H-X, Moody, MA, and Permar, SR. "Isolation of HIV-1-neutralizing mucosal monoclonal antibodies from human colostrum." Plos One 7, no. 5 (2012): e37648-null. Full Text Open Access Copy Link to Item
  - Yates, NL, Lucas, JT, Nolen, TL, Vandergrift, NA, Soderberg, KA, Seaton, KE, Denny, TN, Haynes, BF, Cohen, MS, and Tomaras, GD. "Multiple HIV-1-specific IgG3 responses decline during acute HIV-1: implications for detection of incident HIV infection." Aids 25, no. 17 (November 13, 2011): 2089-2097. Full Text Open Access Copy Link to Item
  - Alam, SM, Liao, H-X, Dennison, SM, Jaeger, F, Parks, R, Anasti, K, Foulger, A, Donathan, M, Lucas, J, Verkoczy, L, Nicely, N, Tomaras, GD, Kelsoe, G, Chen, B, Kepler, TB, and Haynes, BF. "Differential reactivity of germ line allelic variants of a broadly neutralizing HIV-1 antibody to a gp41 fusion intermediate conformation." J Virol 85, no. 22 (November 2011): 11725-11731. Full Text Link to Item
  - Baden, LR, Blattner, WA, Morgan, C, Huang, Y, Defawe, OD, Sobieszczyk, ME, Kochar, N, Tomaras, GD, McElrath, MJ, Russell, N, Brandariz, K, Cardinali, M, Graham, BS, Barouch, DH, Dolin, R, and NIAID HIV Vaccine Trials Network 044 Study Team, . "Timing of plasmid cytokine (IL-2/Ig) administration affects HIV-1 vaccine immunogenicity in HIV-seronegative subjects." The Journal of Infectious Diseases 204, no. 10 (November 2011): 1541-1549. Full Text
  - Liu, P, Overman, RG, Yates, NL, Alam, SM, Vandergrift, N, Chen, Y, Graw, F, Freel, SA, Kappes, JC, Ochsenbauer, C, Montefiori, DC, Gao, F, Perelson, AS, Cohen, MS, Haynes, BF, and Tomaras, GD. "Dynamic antibody specificities and virion concentrations in circulating immune complexes in acute to chronic HIV-1 infection." Journal of Virology 85, no. 21 (November 2011): 11196-11207. Full Text
  - Tomaras, GD, Binley, JM, Gray, ES, Crooks, ET, Osawa, K, Moore, PL, Tumba, N, Tong, T, Shen, X, Yates, NL, Decker, J, Wibmer, CK, Gao, F, Alam, SM, Easterbrook, P, Abdool Karim, S, Kamanga, G, Crump, JA, Cohen, M, Shaw, GM, Mascola, JR, Haynes, BF, Montefiori, DC, and Morris, L. "Polyclonal B cell responses to conserved neutralization epitopes in a subset of HIV-1-infected individuals." Journal of Virology 85, no. 21 (November 2011): 11502-11519. Full Text
  - Zhu, Z, Qin, HR, Chen, W, Zhao, Q, Shen, X, Schutte, R, Wang, Y, Ofek, G, Streaker, E, Prabakaran, P, Fouda, GG, Liao, H-X, Owens, J, Louder, M, Yang, Y, Klaric, K-A, Moody, MA, Mascola, JR, Scott, JK, Kwong, PD, Montefiori, D, Haynes, BF, Tomaras, GD, and Dimitrov, DS. "Cross-reactive HIV-1-neutralizing human monoclonal antibodies identified from a patient with 2F5-like antibodies." J Virol 85, no. 21 (November 2011): 11401-11408. Full Text Link to Item
  - Liao, H-X, Chen, X, Munshaw, S, Zhang, R, Marshall, DJ, Vandergrift, N, Whitesides, JF, Lu, X, Yu, J-S, Hwang, K-K, Gao, F, Markowitz, M, Heath, SL, Bar, KJ, Goepfert, PA, Montefiori, DC, Shaw, GC, Alam, SM, Margolis, DM, Denny, TN, Boyd, SD, Marshal, E, Egholm, M, Simen, BB, Hanczaruk, B, Fire, AZ, Voss, G, Kelsoe, G, Tomaras, GD, Moody, MA, Kepler, TB, and Haynes, BF. "Initial antibodies binding to HIV-1 gp41 in acutely infected subjects are polyreactive and highly mutated." The Journal of Experimental Medicine 208, no. 11 (October 10, 2011): 2237-2249. Full Text Open Access Copy
  - Bonsignori, M, Hwang, K-K, Chen, X, Tsao, C-Y, Morris, L, Gray, E, Marshall, DJ, Crump, JA, Kapiga, SH, Sam, NE, Sinangil, F, Pancera, M, Yongping, Y, Zhang, B, Zhu, J, Kwong, PD, O'Dell, S, Mascola, JR, Wu, L, Nabel, GJ, Phogat, S, Seaman, MS, Whitesides, JF, Moody, MA, Kelsoe, G, Yang, X, Sodroski, J, Shaw, GM, Montefiori, DC, Kepler, TB, Tomaras, GD, Alam, SM, Liao, H-X, and Haynes, BF. "Analysis of a clonal lineage of HIV-1 envelope V2/V3 conformational epitope-specific broadly neutralizing antibodies and their inferred unmutated common ancestors." Journal of Virology 85, no. 19 (October 2011): 9998-10009. Full Text
  - Jiang, C, Parrish, NF, Wilen, CB, Li, H, Chen, Y, Pavlicek, JW, Berg, A, Lu, X, Song, H, Tilton, JC, Pfaff, JM, Henning, EA, Decker, JM, Moody, MA, Drinker, MS, Schutte, R, Freel, S, Tomaras, GD, Nedellec, R, Mosier, DE, Haynes, BF, Shaw, GM, Hahn, BH, Doms, RW, and Gao, F. "Primary infection by a human immunodeficiency virus with atypical coreceptor tropism." J Virol 85, no. 20 (October 2011): 10669-10681. Full Text Link to Item
  - De Rosa, SC, Thomas, EP, Bui, J, Huang, Y, deCamp, A, Morgan, C, Kalams, SA, Tomaras, GD, Akondy, R, Ahmed, R, Lau, C-Y, Graham, BS, Nabel, GJ, McElrath, MJ, and National Institute of Allergy and Infectious Diseases HIV Vaccine Trials Network, . "HIV-DNA priming alters T cell responses to HIV-adenovirus vaccine even when responses to DNA are undetectable." J Immunol 187, no. 6 (September 15, 2011): 3391-3401. Full Text Link to Item
  - Fouda, GG, Yates, NL, Pollara, J, Shen, X, Overman, GR, Mahlokozera, T, Wilks, AB, Kang, HH, Salazar-Gonzalez, JF, Salazar, MG, Kalilani, L, Meshnick, SR, Hahn, BH, Shaw, GM, Lovingood, RV, Denny, TN, Haynes, B, Letvin, NL, Ferrari, G, Montefiori, DC, Tomaras, GD, Permar, SR, and Center for HIV/AIDS Vaccine Immunology, . "HIV-specific functional antibody responses in breast milk mirror those in plasma and are primarily mediated by IgG antibodies." Journal of Virology 85, no. 18 (September 2011): 9555-9567. Full Text Open Access Copy
  - Gnanakaran, S, Bhattacharya, T, Daniels, M, Keele, BF, Hraber, PT, Lapedes, AS, Shen, T, Gaschen, B, Krishnamoorthy, M, Li, H, Decker, JM, Salazar-Gonzalez, JF, Wang, S, Jiang, C, Gao, F, Swanstrom, R, Anderson, JA, Ping, L-H, Cohen, MS, Markowitz, M, Goepfert, PA, Saag, MS, Eron, JJ, Hicks, CB, Blattner, WA, Tomaras, GD, Asmal, M, Letvin, NL, Gilbert, PB, Decamp, AC, Magaret, CA, Schief, WR, Ban, Y-EA, Zhang, M, Soderberg, KA, Sodroski, JG, Haynes, BF, Shaw, GM, Hahn, BH, and Korber, B. "Recurrent signature patterns in HIV-1 B clade envelope glycoproteins associated with either early or chronic infections." Plos Pathog 7, no. 9 (September 2011): e1002209-null. Full Text Link to Item
  - Ma, B-J, Alam, SM, Go, EP, Lu, X, Desaire, H, Tomaras, GD, Bowman, C, Sutherland, LL, Scearce, RM, Santra, S, Letvin, NL, Kepler, TB, Liao, H-X, and Haynes, BF. "Envelope deglycosylation enhances antigenicity of HIV-1 gp41 epitopes for both broad neutralizing antibodies and their unmutated ancestor antibodies." Plos Pathog 7, no. 9 (September 2011): e1002200-null. Full Text Link to Item
  - Gray, ES, Moody, MA, Wibmer, CK, Chen, X, Marshall, D, Amos, J, Moore, PL, Foulger, A, Yu, J-S, Lambson, B, Abdool Karim, S, Whitesides, J, Tomaras, GD, Haynes, BF, Morris, L, and Liao, H-X. "Isolation of a monoclonal antibody that targets the alpha-2 helix of gp120 and represents the initial autologous neutralizing-antibody response in an HIV-1 subtype C-infected individual." Journal of Virology 85, no. 15 (August 2011): 7719-7729. Full Text
  - Pollara, J, Hart, L, Brewer, F, Pickeral, J, Packard, BZ, Hoxie, JA, Komoriya, A, Ochsenbauer, C, Kappes, JC, Roederer, M, Huang, Y, Weinhold, KJ, Tomaras, GD, Haynes, BF, Montefiori, DC, and Ferrari, G. "High-throughput quantitative analysis of HIV-1 and SIV-specific ADCC-mediating antibody responses." Cytometry A 79, no. 8 (August 2011): 603-612. Full Text Link to Item
  - Ferrari, G, Pollara, J, Kozink, D, Harms, T, Drinker, M, Freel, S, Moody, MA, Alam, SM, Tomaras, GD, Ochsenbauer, C, Kappes, JC, Shaw, GM, Hoxie, JA, Robinson, JE, and Haynes, BF. "An HIV-1 gp120 envelope human monoclonal antibody that recognizes a C1 conformational epitope mediates potent antibody-dependent cellular cytotoxicity (ADCC) activity and defines a common ADCC epitope in human HIV-1 serum." Journal of Virology 85, no. 14 (July 2011): 7029-7036. Full Text
  - Flynn, BJ, Kastenmüller, K, Wille-Reece, U, Tomaras, GD, Alam, M, Lindsay, RW, Salazar, AM, Perdiguero, B, Gomez, CE, Wagner, R, Esteban, M, Park, CG, Trumpfheller, C, Keler, T, Pantaleo, G, Steinman, RM, and Seder, R. "Immunization with HIV Gag targeted to dendritic cells followed by recombinant New York vaccinia virus induces robust T-cell immunity in nonhuman primates." Proc Natl Acad Sci U S A 108, no. 17 (April 26, 2011): 7131-7136. Full Text Link to Item
  - Freel, SA, Saunders, KO, and Tomaras, GD. "CD8(+)T-cell-mediated control of HIV-1 and SIV infection." Immunol Res 49, no. 1-3 (April 2011): 135-146. (Review) Full Text Link to Item
  - Spearman, P, Lally, MA, Elizaga, M, Montefiori, D, Tomaras, GD, McElrath, MJ, Hural, J, De Rosa, SC, Sato, A, Huang, Y, Frey, SE, Sato, P, Donnelly, J, Barnett, S, Corey, LJ, and HIV Vaccine Trials Network of NIAID, . "A trimeric, V2-deleted HIV-1 envelope glycoprotein vaccine elicits potent neutralizing antibodies but limited breadth of neutralization in human volunteers." The Journal of Infectious Diseases 203, no. 8 (April 2011): 1165-1173. Full Text
  - Goepfert, PA, Elizaga, ML, Sato, A, Qin, L, Cardinali, M, Hay, CM, Hural, J, DeRosa, SC, DeFawe, OD, Tomaras, GD, Montefiori, DC, Xu, Y, Lai, L, Kalams, SA, Baden, LR, Frey, SE, Blattner, WA, Wyatt, LS, Moss, B, Robinson, HL, and National Institute of Allergy and Infectious Diseases HIV Vaccine Trials Network, . "Phase 1 safety and immunogenicity testing of DNA and recombinant modified vaccinia Ankara vaccines expressing HIV-1 virus-like particles." The Journal of Infectious Diseases 203, no. 5 (March 2011): 610-619. Full Text
  - Shen, X, and Tomaras, GD. "Alterations of the B-cell response by HIV-1 replication." Current Hiv/Aids Reports 8, no. 1 (March 2011): 23-30. Full Text
  - Ferrari, G, Korber, B, Goonetilleke, N, Liu, MKP, Turnbull, EL, Salazar-Gonzalez, JF, Hawkins, N, Self, S, Watson, S, Betts, MR, Gay, C, McGhee, K, Pellegrino, P, Williams, I, Tomaras, GD, Haynes, BF, Gray, CM, Borrow, P, Roederer, M, McMichael, AJ, and Weinhold, KJ. "Relationship between functional profile of HIV-1 specific CD8 T cells and epitope variability with the selection of escape mutants in acute HIV-1 infection.(Published online)" Plos Pathog 7, no. 2 (February 10, 2011): e1001273-null. Full Text Link to Item
  - Haynes, BF, Moody, MA, Liao, H-X, Verkoczy, L, and Tomaras, GD. "B cell responses to HIV-1 infection and vaccination: pathways to preventing infection." Trends Mol Med 17, no. 2 (February 2011): 108-116. Full Text Link to Item
  - Keefer, MC, Frey, SE, Elizaga, M, Metch, B, De Rosa, SC, Barroso, PF, Tomaras, G, Cardinali, M, Goepfert, P, Kalichman, A, Philippon, V, McElrath, MJ, Jin, X, Ferrari, G, Defawe, OD, Mazzara, GP, Montefiori, D, Pensiero, M, Panicali, DL, Corey, L, and NIAID HIV Vaccine Trials Network, . "A phase I trial of preventive HIV vaccination with heterologous poxviral-vectors containing matching HIV-1 inserts in healthy HIV-uninfected subjects." Vaccine 29, no. 10 (February 2011): 1948-1958. Full Text
  - Churchyard, GJ, Morgan, C, Adams, E, Hural, J, Graham, BS, Moodie, Z, Grove, D, Gray, G, Bekker, L-G, McElrath, MJ, Tomaras, GD, Goepfert, P, Kalams, S, Baden, LR, Lally, M, Dolin, R, Blattner, W, Kalichman, A, Figueroa, JP, Pape, J, Schechter, M, Defawe, O, De Rosa, SC, Montefiori, DC, Nabel, GJ, Corey, L, Keefer, MC, and NIAID HIV Vaccine Trials Network, . "A phase IIA randomized clinical trial of a multiclade HIV-1 DNA prime followed by a multiclade rAd5 HIV-1 vaccine boost in healthy adults (HVTN204)." Plos One 6, no. 8 (January 2011): e21225-null. Full Text
  - Dennison, SM, Sutherland, LL, Jaeger, FH, Anasti, KM, Parks, R, Stewart, S, Bowman, C, Xia, S-M, Zhang, R, Shen, X, Scearce, RM, Ofek, G, Yang, Y, Kwong, PD, Santra, S, Liao, H-X, Tomaras, G, Letvin, NL, Chen, B, Alam, SM, and Haynes, BF. "Induction of antibodies in rhesus macaques that recognize a fusion-intermediate conformation of HIV-1 gp41." Plos One 6, no. 11 (2011): e27824-null. Full Text Link to Item
  - Koblin, BA, Casapia, M, Morgan, C, Qin, L, Wang, ZM, Defawe, OD, Baden, L, Goepfert, P, Tomaras, GD, Montefiori, DC, McElrath, MJ, Saavedra, L, Lau, C-Y, Graham, BS, and NIAID HIV Vaccine Trials Network, . "Safety and immunogenicity of an HIV adenoviral vector boost after DNA plasmid vaccine prime by route of administration: a randomized clinical trial." PLoS One 6, no. 9 (2011): e24517-. Full Text Link to Item
  - Moody, MA, Zhang, R, Walter, EB, Woods, CW, Ginsburg, GS, McClain, MT, Denny, TN, Chen, X, Munshaw, S, Marshall, DJ, Whitesides, JF, Drinker, MS, Amos, JD, Gurley, TC, Eudailey, JA, Foulger, A, DeRosa, KR, Parks, R, Meyerhoff, RR, Yu, J-S, Kozink, DM, Barefoot, BE, Ramsburg, EA, Khurana, S, Golding, H, Vandergrift, NA, Alam, SM, Tomaras, GD, Kepler, TB, Kelsoe, G, Liao, H-X, and Haynes, BF. "H3N2 influenza infection elicits more cross-reactive and less clonally expanded anti-hemagglutinin antibodies than influenza vaccination." Plos One 6, no. 10 (January 2011): e25797-null. Full Text
  - Morris, L, Chen, X, Alam, M, Tomaras, G, Zhang, R, Marshall, DJ, Chen, B, Parks, R, Foulger, A, Jaeger, F, Donathan, M, Bilska, M, Gray, ES, Abdool Karim, SS, Kepler, TB, Whitesides, J, Montefiori, D, Moody, MA, Liao, H-X, and Haynes, BF. "Isolation of a human anti-HIV gp41 membrane proximal region neutralizing antibody by antigen-specific single B cell sorting." Plos One 6, no. 9 (2011): e23532-null. Full Text Link to Item
  - Saunders, KO, Ward-Caviness, C, Schutte, RJ, Freel, SA, Overman, RG, Thielman, NM, Cunningham, CK, Kepler, TB, and Tomaras, GD. "Secretion of MIP-1β and MIP-1α by CD8(+) T-lymphocytes correlates with HIV-1 inhibition independent of coreceptor usage." Cell Immunol 266, no. 2 (2011): 154-164. Full Text Link to Item
  - Peiperl, L, Morgan, C, Moodie, Z, Li, H, Russell, N, Graham, BS, Tomaras, GD, De Rosa, SC, McElrath, MJ, and NIAID HIV Vaccine Trials Network, . "Safety and immunogenicity of a replication-defective adenovirus type 5 HIV vaccine in Ad5-seronegative persons: a randomized clinical trial (HVTN 054)." PloS one 5, no. 10 (October 27, 2010): e13579-. Full Text Open Access Copy
  - Liu, J, Keele, BF, Li, H, Keating, S, Norris, PJ, Carville, A, Mansfield, KG, Tomaras, GD, Haynes, BF, Kolodkin-Gal, D, Letvin, NL, Hahn, BH, Shaw, GM, and Barouch, DH. "Low-dose mucosal simian immunodeficiency virus infection restricts early replication kinetics and transmitted virus variants in rhesus monkeys." Journal of Virology 84, no. 19 (October 2010): 10406-10412. Full Text
  - Haynes, BF, Liao, H-X, and Tomaras, GD. "Is developing an HIV-1 vaccine possible?." Current Opinion in Hiv and Aids 5, no. 5 (September 2010): 362-367. (Review) Full Text
  - Saunders, KO, Freel, SA, Overman, RG, Cunningham, CK, and Tomaras, GD. "Epigenetic regulation of CD8(+) T-lymphocyte mediated suppression of HIV-1 replication." Virology 405, no. 1 (September 2010): 234-242. Full Text
  - Tomaras, GD, and Haynes, BF. "Strategies for eliciting HIV-1 inhibitory antibodies." Current Opinion in Hiv and Aids 5, no. 5 (September 2010): 421-427. (Review) Full Text
  - Freel, SA, Lamoreaux, L, Chattopadhyay, PK, Saunders, K, Zarkowsky, D, Overman, RG, Ochsenbauer, C, Edmonds, TG, Kappes, JC, Cunningham, CK, Denny, TN, Weinhold, KJ, Ferrari, G, Haynes, BF, Koup, RA, Graham, BS, Roederer, M, and Tomaras, GD. "Phenotypic and functional profile of HIV-inhibitory CD8 T cells elicited by natural infection and heterologous prime/boost vaccination." Journal of Virology 84, no. 10 (May 2010): 4998-5006. Full Text
  - Moody, MA, Liao, H-X, Alam, SM, Scearce, RM, Plonk, MK, Kozink, DM, Drinker, MS, Zhang, R, Xia, S-M, Sutherland, LL, Tomaras, GD, Giles, IP, Kappes, JC, Ochsenbauer-Jambor, C, Edmonds, TG, Soares, M, Barbero, G, Forthal, DN, Landucci, G, Chang, C, King, SW, Kavlie, A, Denny, TN, Hwang, K-K, Chen, PP, Thorpe, PE, Montefiori, DC, and Haynes, BF. "Anti-phospholipid human monoclonal antibodies inhibit CCR5-tropic HIV-1 and induce beta-chemokines." J Exp Med 207, no. 4 (April 12, 2010): 763-776. Full Text Open Access Copy Link to Item
  - Shen, X, Dennison, SM, Liu, P, Gao, F, Jaeger, F, Montefiori, DC, Verkoczy, L, Haynes, BF, Alam, SM, and Tomaras, GD. "Prolonged exposure of the HIV-1 gp41 membrane proximal region with L669S substitution." Proceedings of the National Academy of Sciences of the United States of America 107, no. 13 (March 15, 2010): 5972-5977. Full Text
  - Nandi, A, Lavine, CL, Wang, P, Lipchina, I, Goepfert, PA, Shaw, GM, Tomaras, GD, Montefiori, DC, Haynes, BF, Easterbrook, P, Robinson, JE, Sodroski, JG, Yang, X, and NIAID Center for HIV/AIDS Vaccine Immunology, . "Epitopes for broad and potent neutralizing antibody responses during chronic infection with human immunodeficiency virus type 1." Virology 396, no. 2 (January 20, 2010): 339-348. Full Text Link to Item
  - McMichael, AJ, Borrow, P, Tomaras, GD, Goonetilleke, N, and Haynes, BF. "The immune response during acute HIV-1 infection: clues for vaccine development." Nature Reviews. Immunology 10, no. 1 (January 2010): 11-23. (Review) Full Text
  - Gao, F, Scearce, RM, Alam, SM, Hora, B, Xia, S, Hohm, JE, Parks, RJ, Ogburn, DF, Tomaras, GD, Park, E, Lomas, WE, Maino, VC, Fiscus, SA, Cohen, MS, Moody, MA, Hahn, BH, Korber, BT, Liao, H-X, and Haynes, BF. "Cross-reactive monoclonal antibodies to multiple HIV-1 subtype and SIVcpz envelope glycoproteins." Virology 394, no. 1 (November 2009): 91-98. Full Text
  - Gray, ES, Taylor, N, Wycuff, D, Moore, PL, Tomaras, GD, Wibmer, CK, Puren, A, DeCamp, A, Gilbert, PB, Wood, B, Montefiori, DC, Binley, JM, Shaw, GM, Haynes, BF, Mascola, JR, and Morris, L. "Antibody specificities associated with neutralization breadth in plasma from human immunodeficiency virus type 1 subtype C-infected blood donors." Journal of Virology 83, no. 17 (September 2009): 8925-8937. Full Text
  - Tomaras, GD, and Haynes, BF. "HIV-1-specific antibody responses during acute and chronic HIV-1 infection." Current Opinion in Hiv and Aids 4, no. 5 (September 2009): 373-379. (Review) Full Text
  - Bonsignori, M, Moody, MA, Parks, RJ, Holl, TM, Kelsoe, G, Hicks, CB, Vandergrift, N, Tomaras, GD, and Haynes, BF. "HIV-1 envelope induces memory B cell responses that correlate with plasma antibody levels after envelope gp120 protein vaccination or HIV-1 infection." J Immunol 183, no. 4 (August 15, 2009): 2708-2717. Full Text Link to Item
  - Levesque, MC, Moody, MA, Hwang, K-K, Marshall, DJ, Whitesides, JF, Amos, JD, Gurley, TC, Allgood, S, Haynes, BB, Vandergrift, NA, Plonk, S, Parker, DC, Cohen, MS, Tomaras, GD, Goepfert, PA, Shaw, GM, Schmitz, JE, Eron, JJ, Shaheen, NJ, Hicks, CB, Liao, H-X, Markowitz, M, Kelsoe, G, Margolis, DM, and Haynes, BF. "Polyclonal B cell differentiation and loss of gastrointestinal tract germinal centers in the earliest stages of HIV-1 infection." PLoS Med 6, no. 7 (July 7, 2009): e1000107-. Full Text Open Access Copy Link to Item
  - Miller, HB, Saunders, KO, Tomaras, GD, and Garcia-Blanco, MA. "Tat-SF1 is not required for Tat transactivation but does regulate the relative levels of unspliced and spliced HIV-1 RNAs." Plos One 4, no. 5 (May 27, 2009): e5710-null. Full Text
  - Lambotte, O, Ferrari, G, Moog, C, Yates, NL, Liao, H-X, Parks, RJ, Hicks, CB, Owzar, K, Tomaras, GD, Montefiori, DC, Haynes, BF, and Delfraissy, J-F. "Heterogeneous neutralizing antibody and antibody-dependent cell cytotoxicity responses in HIV-1 elite controllers." Aids (London, England) 23, no. 8 (May 2009): 897-906. Full Text
  - Shen, X, Parks, RJ, Montefiori, DC, Kirchherr, JL, Keele, BF, Decker, JM, Blattner, WA, Gao, F, Weinhold, KJ, Hicks, CB, Greenberg, ML, Hahn, BH, Shaw, GM, Haynes, BF, and Tomaras, GD. "In vivo gp41 antibodies targeting the 2F5 monoclonal antibody epitope mediate human immunodeficiency virus type 1 neutralization breadth." Journal of Virology 83, no. 8 (April 2009): 3617-3625. Full Text
  - Maksaereekul, S, Dubie, RA, Shen, X, Kieu, H, Dean, GA, and Sparger, EE. "Vaccination with vif-deleted feline immunodeficiency virus provirus, GM-CSF, and TNF-α plasmids preserves global CD4 T lymphocyte function after challenge with FIV." Vaccine 27, no. 28 (2009): 3754-3765. Full Text
  - Binley, JM, Lybarger, EA, Crooks, ET, Seaman, MS, Gray, E, Davis, KL, Decker, JM, Wycuff, D, Harris, L, Hawkins, N, Wood, B, Nathe, C, Richman, D, Tomaras, GD, Bibollet-Ruche, F, Robinson, JE, Morris, L, Shaw, GM, Montefiori, DC, and Mascola, JR. "Profiling the specificity of neutralizing antibodies in a large panel of plasmas from patients chronically infected with human immunodeficiency virus type 1 subtypes B and C." Journal of Virology 82, no. 23 (December 2008): 11651-11668. Full Text
  - Tomaras, GD, Yates, NL, Liu, P, Qin, L, Fouda, GG, Chavez, LL, Decamp, AC, Parks, RJ, Ashley, VC, Lucas, JT, Cohen, M, Eron, J, Hicks, CB, Liao, H-X, Self, SG, Landucci, G, Forthal, DN, Weinhold, KJ, Keele, BF, Hahn, BH, Greenberg, ML, Morris, L, Karim, SSA, Blattner, WA, Montefiori, DC, Shaw, GM, Perelson, AS, and Haynes, BF. "Initial B-cell responses to transmitted human immunodeficiency virus type 1: virion-binding immunoglobulin M (IgM) and IgG antibodies followed by plasma anti-gp41 antibodies with ineffective control of initial viremia." Journal of Virology 82, no. 24 (December 2008): 12449-12463. Full Text
  - Sales, AP, Tomaras, GD, and Kepler, TB. "Improving peptide-MHC class I binding prediction for unbalanced datasets. (Published online)" BMC Bioinformatics 9 (September 19, 2008): 385-. Full Text Link to Item
  - Keele, BF, Giorgi, EE, Salazar-Gonzalez, JF, Decker, JM, Pham, KT, Salazar, MG, Sun, C, Grayson, T, Wang, S, Li, H, Wei, X, Jiang, C, Kirchherr, JL, Gao, F, Anderson, JA, Ping, L-H, Swanstrom, R, Tomaras, GD, Blattner, WA, Goepfert, PA, Kilby, JM, Saag, MS, Delwart, EL, Busch, MP, Cohen, MS, Montefiori, DC, Haynes, BF, Gaschen, B, Athreya, GS, Lee, HY, Wood, N, Seoighe, C, Perelson, AS, Bhattacharya, T, Korber, BT, Hahn, BH, and Shaw, GM. "Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection." Proceedings of the National Academy of Sciences of the United States of America 105, no. 21 (May 19, 2008): 7552-7557. Full Text
  - Alam, SM, Scearce, RM, Parks, RJ, Plonk, K, Plonk, SG, Sutherland, LL, Gorny, MK, Zolla-Pazner, S, Vanleeuwen, S, Moody, MA, Xia, S-M, Montefiori, DC, Tomaras, GD, Weinhold, KJ, Karim, SA, Hicks, CB, Liao, H-X, Robinson, J, Shaw, GM, and Haynes, BF. "Human immunodeficiency virus type 1 gp41 antibodies that mask membrane proximal region epitopes: antibody binding kinetics, induction, and potential for regulation in acute infection." Journal of Virology 82, no. 1 (January 2008): 115-125. Full Text
  - Cleghorn, F, Pape, JW, Schechter, M, Bartholomew, C, Sanchez, J, Jack, N, Metch, BJ, Hansen, M, Allen, M, Cao, H, Montefiori, DC, Tomaras, GD, Gurunathan, S, Eastman, DJ, do Lago, RF, Jean, S, Lama, JR, Lawrence, DN, Wright, PF, and 026 Protocol Team and the NIAID HIV Vaccine Trials Network, . "Lessons from a multisite international trial in the Caribbean and South America of an HIV-1 Canarypox vaccine (ALVAC-HIV vCP1452) with or without boosting with MN rgp120." Journal of Acquired Immune Deficiency Syndromes (1999) 46, no. 2 (October 2007): 222-230. Full Text
  - Russell, ND, Graham, BS, Keefer, MC, McElrath, MJ, Self, SG, Weinhold, KJ, Montefiori, DC, Ferrari, G, Horton, H, Tomaras, GD, Gurunathan, S, Baglyos, L, Frey, SE, Mulligan, MJ, Harro, CD, Buchbinder, SP, Baden, LR, Blattner, WA, Koblin, BA, Corey, L, and National Institute of Allergy and Infectious Diseases HIV Vaccine Trials Network, . "Phase 2 study of an HIV-1 canarypox vaccine (vCP1452) alone and in combination with rgp120: negative results fail to trigger a phase 3 correlates trial." Journal of Acquired Immune Deficiency Syndromes (1999) 44, no. 2 (February 2007): 203-212. Full Text
  - Goepfert, PA, Tomaras, GD, Horton, H, Montefiori, D, Ferrari, G, Deers, M, Voss, G, Koutsoukos, M, Pedneault, L, Vandepapeliere, P, McElrath, MJ, Spearman, P, Fuchs, JD, Koblin, BA, Blattner, WA, Frey, S, Baden, LR, Harro, C, Evans, T, and NIAID HIV Vaccine Trials Network, . "Durable HIV-1 antibody and T-cell responses elicited by an adjuvanted multi-protein recombinant vaccine in uninfected human volunteers." Vaccine 25, no. 3 (January 2007): 510-518. Full Text
  - Overman, RG, Llorens, AL, Greenberg, ML, Garcia-Blanco, MA, and Tomaras, GD. "Initiation of human immunodeficiency virus type 1 (HIV-1) transcription is inhibited by noncytolytic CD8 suppression." Open Virol J 1 (2007): 1-7. Full Text Link to Item
  - Shen, X, Leutenegger, CM, Cole, KS, Pedersen, NC, and Sparger, EE. "A feline immunodeficiency virus vif-deletion mutant remains attenuated upon infection of newborn kittens." Journal of General Virology 88, no. 10 (2007): 2793-2799. Full Text
  - McFarland, EJ, Johnson, DC, Muresan, P, Fenton, T, Tomaras, GD, McNamara, J, Read, JS, Douglas, SD, Deville, J, Gurwith, M, Gurunathan, S, and Lambert, JS. "HIV-1 vaccine induced immune responses in newborns of HIV-1 infected mothers." Aids (London, England) 20, no. 11 (July 2006): 1481-1489. Full Text
  - Tomaras, GD, Shen, X, and Greenberg, ML. "Antibody responses and virus escape: implications for HIV-1 vaccine and therapeutic design." Future Virology 1, no. 1 (January 2006): 79-88. Full Text
  - Johnson, DC, McFarland, EJ, Muresan, P, Fenton, T, McNamara, J, Read, JS, Hawkins, E, Bouquin, PL, Estep, SG, Tomaras, GD, Vincent, CA, Rathore, M, Melvin, AJ, Gurunathan, S, and Lambert, J. "Safety and immunogenicity of an HIV-1 recombinant canarypox vaccine in newborns and infants of HIV-1-infected women." The Journal of Infectious Diseases 192, no. 12 (December 2005): 2129-2133. Full Text
  - Goepfert, PA, Horton, H, McElrath, MJ, Gurunathan, S, Ferrari, G, Tomaras, GD, Montefiori, DC, Allen, M, Chiu, Y-L, Spearman, P, Fuchs, JD, Koblin, BA, Blattner, WA, Frey, S, Keefer, MC, Baden, LR, Corey, L, and NIAID HIV Vaccine Trials Network, . "High-dose recombinant Canarypox vaccine expressing HIV-1 protein, in seronegative human subjects." The Journal of Infectious Diseases 192, no. 7 (October 2005): 1249-1259. Full Text
  - Betts, MR, Exley, B, Price, DA, Bansal, A, Camacho, ZT, Teaberry, V, West, SM, Ambrozak, DR, Tomaras, G, Roederer, M, Kilby, JM, Tartaglia, J, Belshe, R, Gao, F, Douek, DC, Weinhold, KJ, Koup, RA, Goepfert, P, and Ferrari, G. "Characterization of functional and phenotypic changes in anti-Gag vaccine-induced T cell responses and their role in protection after HIV-1 infection." Proceedings of the National Academy of Sciences of the United States of America 102, no. 12 (March 7, 2005): 4512-4517. Full Text
  - Kaplan, SS, Ferrari, G, Wrin, T, Hellmann, NS, Tomaras, GD, Gryszowka, VE, Fiscus, SA, Weinhold, KJ, and Hicks, CB. "Longitudinal assessment of immune response and viral characteristics in HIV-infected patients with prolonged CD4(+)/viral load discordance." Aids Research and Human Retroviruses 21, no. 1 (January 2005): 13-16. Full Text
  - Blattner, WA, Oursler, KA, Cleghorn, F, Charurat, M, Sill, A, Bartholomew, C, Jack, N, O'Brien, T, Edwards, J, Tomaras, G, Weinhold, K, and Greenberg, M. "Rapid clearance of virus after acute HIV-1 infection: correlates of risk of AIDS." The Journal of Infectious Diseases 189, no. 10 (May 2004): 1793-1801. Full Text
  - Morris, KV, Higgins, J, Shen, X, Stine, JT, and Pedersen, NC. "The effects of HHV-8 vMIP-II on SIVmac251 infection and replication competent and incompetent SIVmac239Delta3 vectors." Virus Research 94, no. 2 (August 2003): 103-112. Full Text
  - Sufka, SA, Ferrari, G, Gryszowka, VE, Wrin, T, Fiscus, SA, Tomaras, GD, Staats, HF, Patel, DD, Sempowski, GD, Hellmann, NS, Weinhold, KJ, and Hicks, CB. "Prolonged CD4+ cell/virus load discordance during treatment with protease inhibitor-based highly active antiretroviral therapy: immune response and viral control." J Infect Dis 187, no. 7 (April 1, 2003): 1027-1037. Full Text Link to Item
  - Tomaras, GD, and Greenberg, ML. "CD8+ T cell mediated noncytolytic inhibition of human immunodeficiency virus type I." Frontiers in Bioscience : a Journal and Virtual Library 6 (March 2001): D575-D598. (Review) Full Text
  - Tomaras, GD, and Greenberg, ML. "Mechanisms for HIV-1 Entry: Current Strategies to Interfere with This Step." Curr Infect Dis Rep 3, no. 1 (February 2001): 93-99. Link to Item
  - Hu, Q, Trent, JO, Tomaras, GD, Wang, Z, Murray, JL, Conolly, SM, Navenot, JM, Barry, AP, Greenberg, ML, and Peiper, SC. "Identification of ENV determinants in V3 that influence the molecular anatomy of CCR5 utilization." Journal of Molecular Biology 302, no. 2 (September 2000): 359-375. Full Text
  - Tomaras, GD, Lacey, SF, McDanal, CB, Ferrari, G, Weinhold, KJ, and Greenberg, ML. "CD8+ T cell-mediated suppressive activity inhibits HIV-1 after virus entry with kinetics indicating effects on virus gene expression." Proceedings of the National Academy of Sciences of the United States of America 97, no. 7 (March 2000): 3503-3508. Full Text
  - Tomaras, GD, Foster, DA, Burrer, CM, and Taffet, SM. "ETS transcription factors regulate an enhancer activity in the third intron of TNF-alpha." J Leukoc Biol 66, no. 1 (July 1999): 183-193. Link to Item
  - Brown, MC, Tomaras, GD, Vincenti, MP, and Taffet, SM. "Two forms of NF-kappa B1 (p105/p50) in murine macrophages: differential regulation by lipopolysaccharide, interleukin-2, and interferon-gamma." Journal of Interferon & Cytokine Research 17, no. 5 (May 1997): 295-306. Full Text
- Other Articles
  - &NA, and, . "Editorial introductions." Current Opinion in HIV and AIDS 9, no. 3 (May 2014): v-vi. Full Text
  - Zhu, Z, Qin, HR, Chen, W, Zhao, Q, Shen, X, Schutte, R, Wang, Y, Ofek, G, Streaker, E, Prabakaran, P, Fouda, GG, Liao, H-X, Owens, J, Louder, M, Yang, Y, Klaric, K-A, Moody, MA, Mascola, JR, Scott, JK, Kwong, PD, Montefiori, D, Haynes, BF, Tomaras, GD, and Dimitrov, DS. "Cross-Reactive HIV-1-Neutralizing Human Monoclonal Antibodies Identified from a Patient with 2F5-Like Antibodies (vol 85, pg 11401, 2011)." JOURNAL OF VIROLOGY 87, no. 24 (December 2013): 13936-13936. Full Text Link to Item
  - Zhu, Z, Qin, HR, Chen, W, Zhao, Q, Shen, X, Schutte, R, Wang, Y, Ofek, G, Streaker, E, Prabakaran, P, Fouda, GG, Liao, HX, Owens, J, Louder, M, Yang, Y, Klaric, KA, Anthony Moody, M, Mascola, JR, Scott, JK, Kwong, PD, Montefiori, D, Haynes, BF, Tomaras, GD, and Dimitrov, DS. "Erratum to Cross-reactive HIV-1-neutralizing human monoclonal antibodies identified from a patient with 2F5-like antibodies [Journal of Virology, 85, 21, (2011) 11401-11408] DOI: 10.1128/JVI.05312-11." Journal of Virology 87, no. 24 (December 1, 2013): 13936-null. Full Text
  - Frahm, MA, Tomaras, GD, and Ferrari, G. "Response to comment on "CD4 ⁺CD8 ⁺ T cells represent a significant portion of the anti-HIV T cell response to acute HIV infection"." Journal of Immunology 188, no. 12 (2012): 5809-5810. Full Text
  - Shen, X, and Tomaras, GD. "Erratum to: Alterations of the B-Cell Response by HIV-1 Replication." Current Hiv/Aids Reports 8, no. 1 (March 2011): 73-73. Full Text
Scholarly, Clinical, & Service Activities
Outreach & Engaged Scholarship
- Research for Prevention (R4P) Meeting. Chair and PI. 2018 - 2018 2018
- Organizer, HIV Vaccines/B Cell Meeting, Keystone Symposia, Keystone, CO, February 10-15. February 10, 2013 - February 15, 2013 2013
Service to the Profession

Some information on this profile has been compiled automatically from Duke databases and external sources. (Our About page explains how this works.) If you see a problem with the information, please write to Scholars@Duke and let us know. We will reply promptly.

Education, Training, & Certifications

Duke Appointment History

In the News

Awards & Honors

Global Scholarship

Research

Selected Grants

Selected Publications

Conference Papers

Journal Articles

Other Articles

Outreach & Engaged Scholarship

Service to the Profession